The impact and importance of voluntary counselling and testing for HIV in sub-Saharan Africa by Cremin, Ide & Cremin, Ide
 
 
 
 
 
 
 
The Impact and Importance of 
Voluntary Counselling and Testing 
for HIV in sub-Saharan Africa 
 
 
 
 
 
 
 
Íde Cremin 
 
 
 
 
 
 
Department of Infectious Disease Epidemiology, Imperial 
College London 
 
 
Thesis submitted for the degree of Doctor of Philosophy 
July 2010 
 
 
 
 
 
 2
Abstract 
 
Voluntary counselling and testing (VCT) for HIV is promoted as a primary prevention 
strategy to reduce the heterosexual transmission of HIV in sub-Saharan Africa. A 
theoretical framework for the determinants of uptake of VCT and behavioural outcomes 
following VCT was developed. Demographic and Health Survey (DHS) data collected 
from 2003 to 2005 from ten countries were analysed to test the framework by comparing 
nationally representative trends in uptake of testing. Data from a population-based open 
cohort study in Manicaland, Zimbabwe was also used to test this framework by analysing 
trends in sexual behaviour and behaviour change associated with having received VCT.  
 
DHS data indicate that knowledge of serostatus varied widely between countries and 
ranged from 2% among women in Guinea to 27% among women in Rwanda. Despite 
these varied levels of testing, univariate analysis showed the profile of testers to be 
remarkably similar across countries with respect to socio-demographic characteristics. 
Adjusted analyses indicate that a secondary or higher level of education and an awareness 
that treatment exists are key determinants of uptake of VCT. Uptake of VCT in the 
Manicaland cohort is low, at 8.6% in the most recent survey. Against a background of 
behavioural risk reduction in the general population, there was no evidence for additional 
risk reduction associated with having received VCT in the Manicaland cohort.  
 
This work provides a baseline for monitoring trends in testing and exploring changes in 
the profile of those who get tested as provision of testing and treatment services increase. 
Within the Manicaland study population, these results do not provide evidence that VCT 
can promote behavioural risk reduction, in a context of background reductions in risk. 
Uptake of VCT is expected to increase in this population as treatment becomes available. 
It is important that VCT services are monitored and evaluated and the importance of risk 
reduction is emphasised through good quality counselling. To succeed as a prevention 
measure, VCT must attain a high coverage of the sexually active population and lead to 
sustained risk reduction among both infected and uninfected individuals.               
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Outline and structure of thesis 
 
Key research questions  
The overall aim of this thesis is to understand the determinants of uptake of HIV 
counselling and testing and how sexual behaviour changes following counselling and 
testing, through the development and testing of a theoretical framework. Data from: (i) 
nationally representative DHS and (ii) a population-based cohort study in Manicaland, 
Zimbabwe are analysed to address this aim. This analysis is guided by the following key 
questions, which fall into two broad categories: 
 
(i) Uptake of HIV counselling and testing 
• What is the level of uptake of HIV counselling and testing? 
• What are the determinants of uptake HIV counselling and testing? 
¾ These questions are addressed in Chapter 4 using data from DHS and in Chapter 6 
using data from the Manicaland cohort in Zimbabwe. 
 
 
(ii) Behavioural outcomes following HIV counselling and testing 
• What are the general trends in sexual behaviour, regardless of receiving 
counselling and testing?  
¾ This is addressed in Chapter 5 using data from the Manicaland cohort in Zimbabwe. 
• What is the impact of receiving VCT on subsequent sexual behaviour? 
¾ This question is addressed in Chapter 6 using data from the Manicaland cohort in 
Zimbabwe. 
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Organisation of chapters 
Chapter 1 provides a general background to the thesis by outlining a broad overview of 
various aspects of counselling and testing for HIV. A theoretical framework for the 
determinants of uptake and behavioural outcomes following HIV counselling and testing 
is developed in Chapters 2 and 3. The determinants of uptake of testing are reviewed in 
Chapter 2, which outlines how contextual factors, type of service provision and 
individual level characteristics influence the uptake and testing. Behavioural outcomes 
following counselling and  testing are discussed in Chapter 3, which provides an 
overview of behavioural theories, a discussion of the role of counselling and testing for 
changing risk behaviour, and a comprehensive review of studies from sub-Saharan Africa 
analysing the impact of counselling and testing on sexual behaviour. 
    
The socio-demographic profile of individuals testing for HIV has implications for 
equitable access to treatment and has not been described at a nationally representative 
level in an African context. Chapter 4 presents a cross-country comparison of trends in 
uptake of testing in sub-Saharan Africa. DHS data from ten African countries are 
analysed to describe patterns of uptake of HIV testing. To understand the impact of 
counselling and testing on sexual behaviour, trends in behaviour must first be described. 
Thus, in Chapter 5 behavioural data from the Manicaland cohort study are analysed to 
examine trends in behavioural indicators. In Chapter 6 this longitudinal behavioural data 
is analysed to determine the patterns of behaviour change associated with receiving 
counselling and testing. The provision and uptake of counselling and testing services in 
the Manicaland study are also described in Chapter 6.  
 
The main findings of this thesis and directions for future research are outlined in the final 
chapter. Appendix A contains results of multivariate analyses of characteristics 
associated with having tested for HIV in six countries, as a supplement to chapter 4. 
Appendices B and C contain published manuscripts based on work included in this thesis.  
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Chapter 1: Introduction 
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1.1 Background  
The first cases of acquired immunodeficiency syndrome (AIDS) were identified in the 
United States in 1981 [1]. The discovery of the retrovirus, subsequently named Human 
Immunodeficiency Virus (HIV), which causes AIDS was announced in 1984 [2, 3]. Since 
then, HIV has become one of the leading causes of death worldwide [4]. 
  
As of November 2009, it is estimated that 33.4 million [95% confidence interval, 31.1 
million – 35.8 million] people worldwide are infected with HIV [5]. Global HIV 
incidence is estimated to have peaked in 1996, when 3.5 million new infections occurred 
in this year [5]. Despite some success in HIV prevention efforts, the global rate of new 
infections remains high; an estimated 2.7 million people were newly infected in 2008 [5].  
 
Sub-Saharan Africa bears the largest burden of disease, with an estimated 22.4 million 
[95% confidence interval, 20.8 million – 24.1 million] HIV positive people in 2008, 
accounting for 67% of all HIV infections worldwide [5]. Although the rate of new 
infections in sub-Saharan Africa is declining, it exceeds AIDS-related mortality; in 2008, 
an estimated 1.9 million people became newly infected with HIV, while an estimated 1.4 
million AIDS-related deaths occurred [5].  
 
The adult HIV prevalence for sub-Saharan Africa is estimated to be 5.2% [95% 
confidence interval, 4.9 -5.4] overall, notwithstanding large variations among and within 
countries. The epidemic is most severe in southern Africa, with seven countries in the 
region having HIV prevalence of greater than 15% among adults aged 15 to 49 years 
(Botswana (23.9%), Lesotho (23.2%), Namibia (15.3%), South Africa (18.1%), 
Swaziland (26.1%), Zambia (15.2%) and Zimbabwe (15.3%) [6]. The demographic 
impact of this epidemic has been severe. For example, in Swaziland, average life 
expectancy has fallen from 72 years in 1990 to 37 years in 2007, largely as a result of 
HIV-related mortality [7].   
 
The primary mode of transmission of HIV in sub-Saharan Africa is unprotected 
heterosexual intercourse, and women are disproportionately affected, especially among 
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younger age groups [5]. In the nine countries in southern Africa most affected by HIV 
(those listed above, Malawi and Mozambique), prevalence among women aged 15-24 
years was three times greater, on average, than that of men of the same age [8].  
 
Despite the severity of the epidemic in sub-Saharan Africa, the majority of infected 
individuals are unaware of their serostatus, due to the long asymptomatic period of 
infection. Consequently, counselling and testing for HIV can play an important role in the 
response to the HIV epidemic as an entry point for prevention, treatment, care and 
support services.   
 
This chapter provides a general background for various aspects of HIV counselling and 
testing. In the following section, the importance of HIV counselling and testing for 
prevention and treatment is outlined. Next, the history of HIV testing and policy 
recommendations regarding HIV testing are summarised. This is followed by an 
overview of types of service provision for HIV counselling and testing, developments in 
diagnostic tests for HIV, and a brief discussion of the approaches to counselling. Finally, 
a synopsis of increases in provision and uptake of counselling and testing services is 
provided.  
 
1.2 Importance of HIV counselling and testing 
Counselling and testing plays a key role in both treatment and prevention of HIV, as 
testing is necessary to identify those in need of treatment, and counselling provides an 
opportunity to encourage safer sexual behaviour so that: (i) those who are infected can 
avoid infecting others and (ii) those who are uninfected can prevent themselves from 
acquiring infection.  
 
Testing for HIV is an entry point into a number of prevention, treatment and care services 
(Figure 1.1). HIV testing alone does not guarantee appropriate services, but without 
testing many services are unattainable, for example prevention of mother-to-child 
transmission (PMTCT) services.  
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Figure 1.1 Voluntary counselling and testing (VCT) as an entry point for prevention and 
care. Source: UNAIDS  [9].  
 
Pre- and post-test counselling sessions are a means of encouraging behavioural risk 
reduction by assisting with risk assessment, encouraging disclosure of serostatus to 
partners and discussing a risk reduction plan if necessary [10]. In addition to encouraging 
behavioural risk reduction, counselling and testing can contribute to prevention by 
enabling those who are infected to receive treatment, thus reducing their viral load and 
therefore their infectiousness [11, 12]. 
 
Given low uptake of testing, it has been shown that the majority of new infections occur 
through transmission from persons who are unaware of their HIV-positive status [13]. 
Furthermore, low uptake of testing is one of the reasons for late diagnosis of infection, 
late entry into medical care and access to treatment, and hence, high mortality in the 
months following treatment initiation [14, 15]. Late diagnosis is also a lost opportunity to 
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reduce onward transmission, either behaviourally, through reducing sexual risk behaviour 
or biologically, through reducing an individual’s infectivity [16].  
 
Thus, HIV counselling and testing has become increasingly important in the response to 
the AIDS epidemic. The WHO made HIV testing its first strategic priority for tackling 
the AIDS epidemic [17]. Furthermore, there have been calls for universal HIV testing in 
Africa [18], and the WHO have frequently called for knowledge of serostatus among all 
citizens in high-prevalence countries to be a goal of prevention efforts [19, 20].  
 
1.3 History of HIV counselling and  testing  
Early debate regarding HIV testing  
The history of HIV testing is rooted in a debate between public health and human rights. 
The initial response to HIV was influenced by disputes between civil liberty proponents 
and the public health establishment in the United States. When HIV tests first became 
available in the mid 1980s, standard public health measures such as surveillance testing, 
contact investigation and tracing and quarantine, were highly controversial. The stigma 
associated with an HIV diagnosis and fears that a traditional public health approach could 
“drive the epidemic underground” meant that HIV testing was largely a voluntary 
practice [21]. However, this policy was criticised for maintaining “HIV exceptionalism”, 
which was blamed for low testing rates [22]. 
  
The public health approach (i.e. standard public health measures for disease control) 
argues that HIV should be treated like other diseases, for which consent for testing is 
implicitly assumed by virtue of medical consultation. Most medical tests, even those for 
lifelong illnesses such as diabetes and cancer, are offered and explained by health 
providers in a manner such that the majority of patients have the test; they are told that 
they need a particular test, why they need the test and what is going to be done if the test 
indicates disease.  
 
The criticisms of AIDS exceptionalism and “rights-based” approaches, with respect to 
HIV testing, have been outlined in hindsight [23]. First, the international response to HIV 
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was largely determined by early experience in the United States, rather than in sub-
Saharan Africa where the epidemic is most severe. Second, the exceptionalist approach 
focused on individuals, whereas in severely-affected countries in sub-Saharan Africa, 
HIV has affected families and whole societies. Third, failure to diagnose HIV co-
infection with diseases such as tuberculosis, lead to compromised medical care. Fourth, a 
focus on an individual’s privacy as a priority, and under-emphasis of prevention, may 
have had the adverse outcome of increasing HIV-related stigma. Finally, HIV testing was 
not initially advocated for prevention and care. 
 
Official guidelines and policies regarding HIV testing  
The guidelines and policies regarding HIV counselling and testing have evolved as the 
response to the epidemic has progressed and key developments, such as the discovery of 
treatment and increased financial resources for HIV/AIDS, have taken place. Prior to the 
development of treatment, the only situations in which HIV testing was recommended 
were: (i) screening of blood and organs for transplantation; (ii) unlinked anonymous 
testing for epidemiological surveillance; (iii) diagnosis of symptomatic infection among 
patients suspected of having AIDS; and (iv) for those who wish to know their status [24].  
 
Subsequent to the development of treatment, policy recommendations became 
increasingly supportive of expanding testing. In 1997, UNAIDS issued a policy statement 
which encouraged countries to make good-quality voluntary HIV counselling and testing 
available and accessible [25]. In 2003, WHO and UNAIDS published a report 
introducing new approaches to HIV counselling and testing [26]. This emphasised the 
need to expand access to counselling and testing and make HIV testing widely available 
in tuberculosis clinics, sexually transmitted infection (STI) clinics and antenatal clinics 
(ANC), as well as for those who want to know their status. This was followed by a policy 
statement in 2004 that recognised the different reasons for testing and was permissive of 
different approaches to HIV testing in different settings [27]. This policy recommended a 
routine offer of testing, with the choice to opt-out, for pregnant women, all patients 
assessed in an STI clinic, and all patients seen in health service settings where HIV is 
prevalent and treatment is available. However, this policy failed to be widely put into 
 21
practice due to lack of adequate follow-up and some ambiguity in the text [28]. Thus, in 
2007, in the context of accelerating access to treatment, WHO and UNAIDS issued 
guidance on provider-initiated HIV counselling and testing in health facilities in countries 
with generalised HIV epidemics explicitly recommending an opt-out approach [29]. In 
practice, this means that health care workers should recommend a HIV test to all patients 
regardless of their symptoms or reason for attending the health facility. The policy for 
provider-initiated opt-out testing acknowledges a rights-based approach to expanding 
HIV testing, which emphasises that the voluntariness of testing must remain central [30]. 
It has been also emphasised that testing should not be carried out against a patient’s will, 
without their knowledge, without information and counselling and without referral to 
appropriate services [28]. 
 
The adoption and implementation of testing policies is a gradual process and has varied 
by country. In 2008, twenty countries in sub-Saharan Africa with generalized HIV 
epidemics reported having testing policies which encouraged health care workers to offer 
testing and counselling to everyone, regardless of the patients symptoms and type of 
facility. For example, Cameroon adopted provider-initiated testing in 2007 and Zambia 
has done so since 2008 [31, 32]. Provider-initiated testing initiatives and outreach testing 
programmes have been successfully established in many countries including Kenya, 
Malawi, Uganda and Zimbabwe [33-35]. In many countries this policy is being 
implemented in a phased manner. The early implementation of provider-initiated 
counselling and testing in Botswana, in 2004, and the subsequent increase in uptake of 
counselling and testing are discussed in Chapter 2 (section 2.5.1 regarding provision of 
testing and treatment services). In addition to implementing the policy of provider-
initiated testing, there is increasing promotion of testing in many countries with Burkina 
Faso, Kenya, Lesotho, Malawi, Namibia, Rwanda, South Africa, Swaziland, Uganda and 
Tanzania having already held, or are planning to hold, national HIV testing and 
counselling campaigns [17].  
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Similar policy developments to increase levels of HIV testing have occurred in the 
United States [10]. In 2006, guidance which recommended routinely testing all 
individuals (aged 13 to 64 years) attending health-care facilities was issued by the 
Centers for Disease Control and Prevention (CDC) [36]. Although there is verbal consent 
and the option to refuse, separate written consent for testing is no longer required and 
these guidelines also state that risk reduction counselling is advisable but not mandatory.  
 
Recent debate regarding HIV testing  
The availability of treatment and increased financial resources to expand access to 
treatment means that an AIDS exceptionalism approach to HIV testing has become less 
justifiable [23]. Thus, the discussion of a rights-based approach versus a public-health 
based approach to HIV testing has been surpassed by a debate regarding the recent policy 
of provider-initiated opt-out testing.   
 
Advocates of provider-initiated opt-out testing emphasise the importance of testing for 
identifying those in need of treatment and the missed opportunities of not diagnosing 
infected individuals when they present at health care facilities [18, 28]. It has been 
suggested that routine testing may lead to reductions in stigma through normalising HIV 
testing, as stigma may persist in areas where uptake of testing is low and only a small 
proportion of individuals know their status [26, 28].  
 
Critics of opt-out testing, albeit a minority, question the feasibility of providing the 
needed referral, treatment and prevention services given the weak health system, 
shortages of health care workers and a culture of low health service utilization in sub-
Saharan Africa [37]. There are also concerns regarding ensuring consent and 
confidentiality [38]. In particular, provider-initiated opt-out testing has been criticized for 
implicitly compromising the voluntariness of HIV testing as it may potentially be 
coercive, given that many individuals may feel obliged to agree to a test recommended by 
a health care professional [38]. There are also concerns that provider-initiated testing 
could deter individuals from accessing health services, that counselling will no longer be 
practiced, that there will be a lack of protection for those testing positive and that stigma 
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and HIV-related violence against women could increase (as women are more likely to 
come into contact with health services and hence are more likely to get tested) [37, 39, 
40]. However, both advocates and critics agree that there is a need to increase access to 
HIV testing services and that these services should be evaluated [41, 42]. Importantly, 
where provider-initiated opt-out testing has been implemented, in Botswana for example,  
there is little evidence to support the concerns outlined above [43, 44]. 
 
1.4 Provision of HIV counselling and testing 
Type of provision of HIV counselling and testing services 
There are many contexts for HIV testing [45]. Testing can be mandatory for certain 
groups such as sex offenders and prisoners, and mandatory testing is also used in some 
countries for immigration purposes and pre-employment screening for armed services. 
HIV testing without consent has also been used in medical circumstances, for example, 
for unconscious patients. However, because of human rights issues, the vast majority of 
HIV testing is voluntary and requires consent.  
 
There are many types of service provision for voluntary counselling and testing, which 
include free-standing services, integrated services and outreach services. Free-standing 
services involve a “stand-alone” clinic, which is only used for HIV counselling and 
testing. These services have the advantage of flexible opening hours and strong 
community links, but AIDS-related stigma may deter individuals from attending.  
Counselling and testing is often integrated into existing health facilities such as STI 
clinics, tuberculosis clinics, family planning services and mother and child health 
services (e.g. PMTCT programmes). Integrated services allow ease of cross-referrals and 
can be less expensive than free-standing services. However, as with free-standing 
services, they rely on individuals presenting at a health facility. Outreach services 
typically involve mobile counselling and testing to provide access for “hard-to-reach” 
populations, most typically relatively isolated rural areas. However, they often require 
community mobilization and can be expensive.   
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Developments in diagnostic tests for HIV 
There are three types of HIV diagnostic test: antibody, antigen and Nucleic Acid Test. In 
1985, one year after the HIV virus was discovered; the first test for HIV was approved 
and licensed by the United States Food and Drug Administration (FDA) [46]. This was 
an antibody test, with a high sensitivity but low specificity, and was used for screening 
blood donations for transfusion. Since then, there have been many advances in HIV 
testing technology. In 1996, the first antigen test was approved [47]. The p24 antigen test 
has much higher specificity than the original antibody test as it detects the virus itself (i.e. 
the p24 surface protein), hence it does not require an immune response. In 1999, the first 
Nucleic Acid Test was licensed [47]. This test detects and amplifies precisely defined 
regions of the viral genome and is thus highly sensitive and specific. In 2004, the 
OraQuick Rapid HIV-1 antibody test for oral fluid was approved [47]. There are many 
HIV diagnostic tests currently available and as of 2009, the FDA had licensed 15 HIV 
diagnostic tests, 5 viral load assays, 12 assays for donor screening and 2 genotyping kits 
[47].  
 
Initially the window period (the time during which someone is infected but antibody 
negative) was estimated to be six months [48]. However, with each generation of 
antibody assay, the timing of identification of infection has reduced. Third generation 
antibody-tests have narrowed this period to 20-30 days after viremia. Currently, the 
earliest at which HIV can be detected is 10 days after infectious viremia, using Reverse 
transcription polymerase chain reaction (RT-PCR) for HIV Ribonucleic Acid [49].  
 
Current HIV tests are highly accurate in terms of sensitivity and specificity. A study of 
HIV testing in 752 laboratories in the United States from 1988-1989 reported a sensitivity 
of 99.7% and specificity of 98.5% for enzyme immunoassays [50]. Furthermore, a study 
among blood donors in the United States found that with a confirmatory Western blot the 
probability of a false-positive test result in a low-prevalence setting is approximately 1 in 
250,000 (95% C.I. 1 in 173,000 to 1 in 379,000) [51]. Advances in HIV testing, such as 
the development of rapid testing, have allowed counselling and testing services to better 
meet client needs.  
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There are a number of enzyme immunoassay and rapid tests which detect HIV-1, HIV-2 
and both HIV-1 and HIV-2. According to the FDA, of the available enzyme 
immunoassay tests: four detect HIV-1; one detects HIV-2; and two detect both HIV-1 
and HIV-2, and of the rapid tests available: two detect HIV-1; and three detect both HIV-
1 and HIV-2 [47]. Tests approved for detecting either HIV-1 or HIV-2 are highly 
sensitive for HIV-1 and for HIV-2 (mostly found in West Africa). For example, the 
OraQuick rapid HIV-1/2 antibody test has a sensitivity of 100% for detecting HIV-2 and 
a sensitivity ranging from 99.3%  (for oral fluid) to 99.6% (for plasma and whole blood) 
for HIV-1 [52]. The specificity of this test ranges from 99.8% for oral fluid to 99.9% for 
plasma and 100% for whole blood [52]. Importantly, a positive test result with any rapid 
test is preliminary and requires a confirmatory test before HIV infection is diagnosed 
[53]. Different sensitivities for HIV-1 and HIV-2 have implications for the provision of 
testing services (i.e. the choice of test used) in different settings. In addition, there may be 
slight differences in sensitivity for different subtypes of HIV-1 [54]. It is recommended 
that HIV tests should be evaluated for sensitivity and specificity in a local population 
prior to widespread use [55].   
 
Pre- and post-test counselling  
There are a number of different approaches to counselling for HIV testing. These include 
client-centred, psychodynamic, cognitive-behavioural, existential and systemic [56, 57].   
Although approaches, protocols and standards for counselling vary, a common set of key 
elements are usually covered during counselling sessions. Pre-test counselling can be 
provided to an individual, a couple or in some cases to a group and involves a face-to-
face session with a trained counsellor. During pre-test counselling, the counsellor 
generally addresses the client’s needs for support, provides accurate information about 
HIV/AIDS, corrects any misconceptions, discusses the implications of the test, assists the 
client in conducting a personalized risk assessment, negotiates a risk reduction plan in 
preparation for receiving the test results and provides advice, encouragement and support 
to reach behaviour change goals [9]. Following the test, post-test counselling is required 
to discuss the test results, review the risk reduction plan and provide support and referrals 
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as needed. For those who test negative, it is recommended that at a minimum the 
counsellor should explain and discuss the test result, provide advice on prevention 
methods as well as providing condoms and guidance on their use [29]. Those who test 
negative may also be alerted to the pre-seroconversion window period and be advised to 
re-test in 2-3 months if recent exposure to HIV may have occurred [58]. For those who 
test positive, the focus of post-test counselling is to provide psychosocial support to cope 
with the emotional impact of diagnosis. In addition, it is necessary for the counsellor to 
discuss prevention of onward transmission, disclosure to sexual partners and to facilitate 
access to treatment and care services. It is recommended that counsellors should also 
allow the patient to ask questions, discuss any immediate concerns, describe the follow-
up services that are available and provide information on other relevant preventive health 
measures such as good nutrition and use of co-trimoxazole for opportunistic infections 
[29].        
 
1.5 Uptake of HIV counselling and testing 
Access to counselling and testing services in sub-Saharan Africa has increased 
considerably in recent years, as provision of anti-retroviral treatment (ART) expands 
[59]. Zambia represents a model of rapid expansion of counselling and testing services, 
having progressed from a few services in 1999 to some 100 VCT sites nationwide two 
years later [60]. Similarly, in Kenya only three sites provided VCT in 2000 and by the 
end of 2005 there were 680 sites [61]. In Malawi, there were 70 VCT sites in 2002; three 
years later this number had increased to almost 250 [62]. These examples indicate the 
rapid rate at which testing services are being rolled out.  
 
In accordance with the increased provision of counselling and testing services, uptake of 
testing is increasing. During the period 2003 to 2005, a median of only 12% of men and 
10% of women in twelve high-prevalence countries in sub-Saharan Africa had tested for 
HIV and received their results [63]. More recent data indicate that between 2006 and 
2008 a median of 22% of people aged 15-49 years old knew their HIV status in sub-
Saharan African countries [17]. Despite these increases, knowledge of serostatus is still 
inadequate, and HIV infection is often diagnosed late. For example, in Kenya, although 
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uptake of testing doubled between 2003 and 2007 an estimated 83% of Kenyans living 
with HIV remained undiagnosed in 2007 [5].  
 
These increases in uptake of testing have been concomitant with increased treatment 
provision. By December 2008, almost three million people in sub-Saharan Africa were 
receiving ART [17]. This represents an estimated 44% [41%-48%] coverage of those in 
need of treatment, and is a dramatic increase in provision as in 2005 estimated coverage 
of treatment in the region was only 2% [17].  
 
Given the self-selection of individuals who come forward for VCT, the determinants of 
uptake of testing are of importance. Furthermore, although testing is necessary to provide 
treatment, its efficacy for promoting behavioural risk reduction is uncertain. A theoretical 
framework for the determinants of uptake of HIV testing and the behavioural outcomes 
following HIV testing is outlined in the following two chapters.  
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Chapter 2:  
A theoretical framework for the determinants of uptake and 
behavioural outcomes following HIV counselling and testing:  
Part I 
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2.1 Aims and organisation of chapter 
The aim of this chapter is to develop a theoretical framework for the determinants of HIV 
testing and the behavioural outcomes following HIV testing. This chapter begins by 
providing the rationale for developing a theoretical framework and giving an overview of 
the proposed framework. The framework is structured in three parts. First, the broader 
contextual factors which influence the uptake of testing and behavioural outcomes 
following testing are considered. These contextual factors are categorised as social, 
political and cultural. Second, a range of motivations for and determinants of uptake of 
testing are discussed. The final section of the framework, regarding behavioural 
outcomes following testing, is outlined in chapter 3.  
 
2.2 Background 
The literature regarding HIV counselling and testing is extensive but fragmented. Studies 
have broadly been concerned with: attitudes to testing, barriers to testing, socio-
demographic characteristics associated with having tested, behavioural outcomes 
following testing, acceptability and cost-effectiveness of testing, and evaluations of 
various models of service provision, including couple counselling. These have been 
carried out in many settings, often among specific population sub-groups (e.g. pregnant 
women).  
 
The purpose of a theoretical framework is to structure concepts and ideas so as to identify 
causal connections between events, experiences and exposures. A theoretical framework 
also provides a means for identifying gaps in knowledge and for structuring research 
required to fill these gaps.  
 
A number of theoretical frameworks have been developed to understand factors 
influencing HIV transmission. The most well known and widely used is the proximate 
determinants framework, originally developed for demographic studies of the 
determinants of fertility and subsequently adapted for the study of child survival, it was 
then modified further for the study of the distribution and determinants of HIV infection 
in populations [64].  
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Overall, the proximate determinants framework serves to link social and epidemiological 
systems with biological systems. It has a multilevel structure consisting of: (i) three levels 
of determinants; underlying, proximate and biological, and (ii) two levels of outcome; 
health and demographic. The underlying determinants are social, economic and 
environmental. The proximate determinants have both biological components (e.g., viral 
load) and behavioural components (e.g., abstinence). The underlying determinants act 
through the proximate determinants to affect the biological determinants and outcome. 
By describing the determinants which lead to exposure, transmission of infection, disease 
and death, this framework provides an explanatory sequence of events while capturing 
the multilevel nature of the determinants.  
 
The validity of the proximate determinants framework has been evaluated using data 
from the Manicaland cohort in Zimbabwe [65]. Such an appraisal is useful as it shows 
that much of the variation in risk of HIV infection at the individual level can be explained 
through proximate determinants. The authors suggest that the proximate determinants 
may not have been measured adequately. In addition, this framework may not be as 
appropriate for HIV research as it is for fertility, as the factors affecting HIV infection are 
more complex than those affecting fertility [65].  
 
Poundstone et. al. use a different research paradigm, that of social epidemiology, to 
propose an heuristic framework for the social epidemiology of HIV/AIDS [66]. This 
framework outlines three levels of determinants of transmission: individual (e.g. 
behaviour and socio-demographic characteristics), social (e.g. social capital and cultural 
context) and structural (e.g. demographic change, violence and discrimination, policy 
environment and war) [66]. Despite the absence of an explanatory sequence, this 
framework is useful for conceptualizing the hierarchical nature of factors that affect HIV 
transmission and population-level HIV incidence.  
 
The frameworks outlined above consider the determinants of HIV infection. Other 
theoretical frameworks use the HIV epidemic as their basis to understand, for example, 
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the mechanisms by which the HIV epidemic acts as a determinant of socio-demographic 
change [67]. Unlike these, this proposed framework considers an intervention, namely 
HIV counselling and testing, with the aim of understanding the determinants of uptake 
testing and behavioural outcomes following testing.  
 
HIV tests are carried out for different purposes and in different circumstances. The 
various factors influencing uptake of counselling and testing services in different contexts 
and how they interrelate has not been addressed. In a review of the social and behavioural 
evidence regarding the utilization of counselling and testing for HIV, Obermeyer and 
Osborn note that although gender, stigma and poverty are frequently cited as barriers to 
HIV testing, the reasons for differential uptake of counselling and testing are not well 
understood [68].  
 
Understanding the context for testing, attitudes towards testing, motivations for testing 
and barriers to testing is important, as testing can only be successful as an entry-point for 
treatment and prevention if barriers to testing are overcome, adverse outcomes following 
testing are avoided, and effective referral systems are in place. Thus, an understanding of 
the various contextual factors that hinder or facilitate testing in different settings is 
required. Although a formal theoretical framework has not been proposed for the 
determinants of uptake and outcomes following HIV counselling and testing, many 
potential determinants of uptake of testing and outcomes following testing have been 
hypothesised and described.  
 
With respect to determinants of uptake, in an evaluation of provider-initiated opt-out 
testing policy in Botswana, Weiser et. al. present an overview of predictors of testing, 
that includes: socio-economic characteristics, HIV-risk behaviours, health status, access 
to high quality medical care, HIV knowledge and HIV-related stigma [43]. With respect 
to outcomes, in a meta-analysis of VCT and behavioural risk reduction, Denison et. al. 
use the decision to seek testing as a starting point and outline potential outcomes 
following VCT [69]. Immediate outcomes are categorised as individual psychosocial, 
relational level and community level, which lead to individual behavioural outcomes, 
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resulting in reduced HIV and STI transmission [69]. The framework proposed here 
consolidates previous work by Denison, Weiser and others to capture (i) the determinants 
of uptake of testing and (ii) the potential behavioural outcomes following testing.  
 
2.3 Framework overview 
The proposed framework is contained within a broad background which consists of 
social, political and cultural contexts. Determinants of uptake of testing act at different 
levels, including at the individual and community levels. At an individual-level, marital 
status, sexual behaviour and health status may influence uptake of counselling and 
testing. At a community-level, accessibility of health services and testing facilities and 
the availability of treatment can be key determinants for the uptake of testing. Social 
factors such as the extent of HIV-related stigma in the area and social support may also 
influence the decision to test.  
 
In this framework uptake of testing refers to testing through client-initiated testing and 
provider-initiated testing, as well as through other forms of service provision such as 
home-based and workplace based testing. However, with respect to uptake of testing 
much of the framework is regarding client-initiated VCT whereby an individual actively 
seeks counselling and testing.  
 
Following testing, the immediate individual-level effects are largely emotional and 
psychological. Subsequent effects are changes in sexual behaviour. At the community-
level, outcomes such as a reduction in stigma may occur through raising community 
awareness. A schematic illustration of the proposed framework is provided in Figure 2.1. 
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Figure 2.1 A theoretical framework for the determinants of uptake and behavioural outcomes following HIV counselling and testing. 
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2.4 Context – social, political, and cultural  
In this section, the broader contextual issues surrounding HIV counselling and testing are 
discussed: firstly, the social context; secondly, the political context; and finally, the 
cultural context.  
 
2.4.1 Social context   
Social context plays an important role in the effectiveness of HIV prevention programs 
[70]. One aspect of social context is social capital, which can be defined as: “social 
networks, the reciprocities that arise from them, and the value of these for achieving 
mutual goals” [71]. The theory of social capital hypothesises that individuals living in 
communities which are characterized by a positive identity, trust, reciprocal help and 
support, in addition to having  well-functioning local groups and organizations (i.e. high 
levels of social capital), are more likely to change behaviour to improve their health [72, 
73]. Despite an extensive literature on social capital and health, few studies have 
explicitly examined social capital in the context of HIV and AIDS in Africa. Campbell et. 
al. investigated civic participation as a proxy for understanding the community influences 
on HIV infection in South Africa and found that membership in some organizations such 
as youth clubs and sports groups was protective for HIV infection, whereas participation 
in other types of groups increased risk [74]. Gregson et. al. produced similar findings by 
examining community group participation and HIV avoidance among young women in 
Zimbabwe [75].  
 
Social networks refer to how individuals or groups are connected and so may be regarded 
as the “structural element of social capital” [76]. Social networks have been studied in 
relation to HIV transmission, among injecting drug users (IDUs) in particular [77, 78]. 
Social networks have also been studied in relation to how information and attitudes about 
HIV are shared. Qualitative data on informal conversations in social networks in rural 
Malawi, as recorded in journals by diarists, provide an insight into everyday discussions 
regarding HIV/AIDS and how these have changed over time (from 1999 onwards) [79].  
Initially, there was much debate among men regarding behaviour change [80]. Over the 
years this dialogue has changed with most individuals coming to believe that behaviour 
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change for HIV prevention is effective and feasible. These ethnographic data show that 
individuals were discussing HIV testing before it was widely available in rural Malawi. 
The introduction of free treatment and the expansion of testing services introduced a new 
debate: the advantages and disadvantages of knowing one’s HIV status. The most 
frequently expressed concern regarding testing was that a positive test result would cause 
intense fear and anxiety and that this would hasten death. Accessing treatment and 
knowing “the truth about one’s body” were the most frequently expressed benefits of 
HIV testing. However, negative aspects of HIV testing were more frequently discussed 
(63% of all references to HIV testing in everyday conversations), than positive aspects. 
Despite this, when participants of a survey carried out in these communities were offered 
home-based HIV testing, 91% agreed [81].  
 
Social support is often considered to be one of the most important aspects of social 
networks and has been demonstrated to influence a variety of health-related behaviours 
(e.g. smoking cessation) [82]. Social support may be emotional (e.g. understanding and 
sympathy) or behavioural (e.g., assistance with tangible needs) [73]. Social support may 
influence the decision to test and influence risk behaviour following testing. High levels 
of social support experienced by an individual (e.g., emotional support and 
understanding) may encourage or facilitate the decision to test. For example, 
encouragement or support from someone who tested previously has been reported as a 
facilitator for testing in Botswana [43]. In addition, advice, approval and encouragement 
from family members and friends has been shown to influence the decision to test among 
adolescents in Zambia [83].  
 
Just as strong social support can positively influence uptake of testing, a lack of social 
support can also impede it. For example, worry over damaging relationships with family 
members and with friends [84], and an anticipated lack of social support if infected, have 
been cited as barriers to testing [43]. Other aspects of social issues such as fear of 
discrimination and violence, concerns about confidentiality, and fear of unsolicited 
disclosure have also been highlighted as barriers to HIV testing [85]. Subsequent to 
counselling and testing, the initiation and maintenance of behaviour change may be 
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influenced by an individual’s ability to cope and adapt, which can be facilitated by strong 
social support or inhibited by lack of social support.     
 
Stigma and discrimination against people living with HIV have been well-documented 
[86, 87], and stigma has been reported to be a barrier to HIV testing in Tanzania [88], 
Nigeria [89], Uganda [90-92], Zambia [93], Botswana [93] and in particular, South 
Africa [94-97]. Despite being frequently cited as an obstacle to testing, few studies 
actually quantify the effect of stigma on HIV testing, as surveys typically collect data on 
cognitive measures of stigma, which focus on an individual’s beliefs and attitudes rather 
than measures of stigmatising behaviours and their consequences [68]. In addition to a 
fear of experiencing stigma deterring individuals from testing, those expressing 
stigmatising attitudes have been shown to have lower uptake of testing. A study assessing 
the effects of HIV-related stigma on the uptake of counselling and testing in Zimbabwe 
found that expressing social rejection (e.g. refusing to buy vegetables from a vendor with 
HIV) was predictive of not having tested [98]. Kalichman and Simbayi propose that 
seeking VCT is a function of social barriers to getting tested, particularly stigma 
surrounding HIV/AIDS, rather than a lack of perceived value of knowing one’s HIV 
status and receiving counselling [94]. 
 
2.4.2 Political context 
AIDS has become a top political priority [99]. The AIDS epidemic has the potential to 
impede and even reverse the economic development of many countries [100]. Besides 
potentially threatening national security, AIDS undermines the three components of the 
human development index – education, life expectancy, and standard of living [101].  
 
The uptake of testing may be influenced by political context via factors such as the level 
of political commitment and leadership in the response to AIDS, the capacity to provide 
and scale-up testing services and treatment, the level of involvement of NGOs and 
support from external donors, and government policies determining how testing and 
treatment are provided. Political leaders have the power to raise awareness of testing for 
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HIV. For example, President Kaunda of Zambia was the first African leader to publicly 
test for HIV, saying: 
“I urge all Zambians without exception to take their tests because this is the only 
way that will help us to fight the disease”  [102, 103].  
 
Bor presents a theoretical framework to outline the role of political commitment in 
government response to HIV and AIDS. Within this framework he defines political 
commitment to be the extent to which government leaders support the response to AIDS 
as a priority on the national agenda [104]. A key aspect of this framework is that political 
commitment acts through government policies, programmes and interventions to 
influence epidemiological outcomes. However, political commitment and leadership 
requires concomitant political action and social mobilization. 
 
Parkhurst and Lush provide an analysis of political circumstances that influence the 
implementation of HIV prevention programs using a comparison of Uganda and South 
Africa [105]. Uganda’s “zero grazing” and “love carefully” slogans illustrated how 
population level risk behaviour can be influenced by key messages disseminated to the 
public from a top political level  [106]. In Uganda, President Museveni spoke often and 
openly about AIDS and published articles on the subject [107]. He highlighted AIDS as a 
serious problem that all Ugandans must face. In contrast, in South Africa, HIV/AIDS was 
surrounded by much controversy, denial and stigma [108-110].  
 
These political contexts (not limited to political commitment) have influenced the 
response to HIV, and hence provision and uptake of HIV testing in both Uganda and 
South Africa. In Uganda, the provision of testing services and uptake of testing have 
increased rapidly. Community surveys have found high levels of willingness to test and 
some studies have achieved over 90% uptake of testing [34, 111, 112]. However, in 
South Africa there is a reluctance to test among some individuals, even in the context of 
treatment availability [113]. A survey in Cape Town found that almost half (48%) of 
those who had never tested for HIV reported that they would prefer not to know if they 
had HIV [94]. Such resistance to testing has been attributed to high levels of stigma 
 38
surrounding HIV/AIDS [113, 114]. Kalichman and Simbayi note that given the 
discrimination experienced by black South Africans during apartheid, it is not surprising 
that some refuse a medical test that potentially adds another source of stigma and 
discrimination [94]. One consequence of the extreme racial discrimination of apartheid, 
and the subsequent HIV denialism, is the theory of HIV as a genocidal conspiracy, belief 
in which has been shown to be a barrier to testing among South Africans (30% of 
individuals surveyed endorsed this theory)  [115].  
 
However, there have been many efforts to reduce these social barriers to HIV testing 
through mass media campaigns and public demonstrations and the level of uptake of 
testing has increased in recent years. From 2005 to 2008 nationally representative surveys 
show that the percentage of those aged 15 years and older who tested for HIV in the 12 
months preceding the survey increased from 12% to 25%  [116]. Furthermore, a large 
campaign to mobilise all South Africans to get tested for HIV was announced in 
December 2009 [117].  
 
2.4.3 Cultural context 
Aspects of cultural context such as the respective gender roles of men and women in 
society can determine the uptake of testing and behaviour change following testing. 
Gender influences attitudes toward HIV testing, with women generally reporting more 
fears regarding testing and potential negative consequences following testing than men 
[68]. Women’s decisions to test, however, are influenced by their plans to have children 
and their intentions for breastfeeding. There are often strong cultural pressures on women 
to bear children, for example, to prove that they are fertile [118]. This may act as a barrier 
to HIV testing (through fear of a positive test result) and also as a deterrent to the use of 
contraception, such as condoms. In addition, gender influences risk perception (e.g. men 
tend to underestimate their risk of HIV infection [68]), which influences the decision to 
test.  
 
Traditionally, males are the “dominant” gender in many African cultures [119]. For 
example, in Botswana, customary Tswana law regarded women as socially inferior to 
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men [120]. The relative infrequency of marriage in Botswana is said to be due, partly, to 
the significant loss of legal rights that women experience within marriage. However, the 
law has been reviewed and Abolition of Marital Power Bill was passed in 2004 (the same 
year the policy of provider-initiated opt-out testing was introduced) to ensure “full gender 
equality under the law with respect to all civil marriages in Botswana” [121]. Restrictions 
on female autonomy may influence uptake of counselling and testing among women. For 
example, qualitative work from Tanzania has found that the pattern of decision-making 
between partners can be a barrier to testing for some women, with participants discussing 
the need to “seek permission” from their partner prior to testing [85].  
 
In addition, some cultural norms restrict female sexual autonomy while placing men in a 
dominant position with greater decision-making power [122]. Sexual coercion or the 
inability to insist on or discuss condom use may make intended behavioural risk 
reduction for women difficult or unattainable [123]. In Tanzania, a qualitative study 
found that restrictive norms on female sexual behaviour apply largely to married women. 
Men were unanimous in stating that they would not accept their spouse having an extra-
marital relationship, although it was acceptable for non-marital partners (both casual and 
longer-term) to do so [124].  
 
Social, political and cultural contexts are often interrelated. For example, high levels of 
political commitment and leadership can help to increase awareness of testing which may 
in turn reduce stigma surrounding testing. Conversely, poor political leadership may 
negatively influence aspects of social context such as the level of stigma. South Africa 
provides an example whereby the political history of apartheid and HIV denialism by 
political leaders may have negatively influenced the social context surrounding HIV 
testing by maintaining high levels of stigma and discrimination [94]. However, there has 
recently been much effort to reduce social barriers to testing in South Africa, as discussed 
above.   
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2.5 Determinants of uptake of counselling and testing   
In this section, the determinants of uptake counselling and testing are considered. Each 
component of the framework is discussed (see Figure 2.1). Firstly, the role of provision of 
testing and treatment services in determining uptake is outlined. This is followed by a 
discussion of individual-level determinants, which include marital status, sexual 
behaviour, health status and psychosocial status.  
 
2.5.1 Provision of testing and treatment services 
 
Testing service provision     
Type of service provision influences uptake of HIV counselling and testing [45]. The 
traditional VCT delivery systems of free-standing and health-centre-based VCT services 
have often had disappointingly low uptake (often below 15% among the general 
population) [91, 125, 126].  However, easily accessible testing services are important, as 
long distances and transport costs may deter people from seeking testing [92, 97, 127-
129]. Other logistical barriers such as the cost of testing and long and unpredictable 
waiting times have been reported as frequent reasons for not having attended VCT [128]. 
Newer, more convenient delivery approaches such as home-based VCT, workplace-based 
VCT, same-day mobile VCT, and provider-initiated opt-out HIV testing have achieved 
much higher levels of uptake [45]. Each of these approaches to service provision are 
discussed in the following section.  
 
Home-based testing 
Offering HIV counselling and testing services in clients’ homes makes testing accessible 
and convenient, avoids transport costs, improves privacy and avoids potential stigma 
associated with going to a free-standing VCT centre [45, 130].   
 
Fylkesnes and Siziya carried out a randomized trial (RCT) assessing the acceptability of 
VCT in Zambia [131]. Participants were randomly allocated to either receive VCT at a 
local clinic or at an “optional location” (i.e., the home, the clinic, or a place suggested by 
the respondent). Of those offered VCT at the local clinic, only 12% completed VCT (i.e. 
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received their results and post-test counselling), whereas of those allocated an optional 
location, 56% completed VCT. Furthermore, of those who were allocated to an optional 
location, 84% chose to receive counselling and testing at home.   
 
In Rakai, Uganda, the option of home-based VCT increased uptake, in the absence of 
treatment availability; from 10% in 1990 [132] to 33% in 1994-1995 [133] to 62% in 
1999–2000 [134]. By 2000, the majority of participants requesting to receive counselling 
and testing insisted that the service be provided in their homes, rather than at a 
community-based counselling office [135]. Rakai provides an interesting example of 
increasing uptake of HIV testing in a changing context: in the early 1990s awareness of 
HIV/AIDS was high but treatment did not yet exist;  by the mid to late 1990s treatment 
for HIV/AIDS existed but was not yet available; by 2004 treatment had been introduced 
and knowledge of one’s serostatus was common, and even repeat testing was widespread 
[112]. The observed increase in uptake of HIV testing may reflect increased exposure to 
testing services and changing attitudes towards testing, and HIV/AIDS generally, over 
time.  
 
In Masaka, Uganda, annual VCT uptake at a free-standing facility remained below 10% 
for the first 10 years of a cohort study (1989 – 2000) and by 1999 only 20% of adults had 
ever tested for HIV [91]. However, in 2001 VCT uptake increased to 37% following the 
introduction of home-based services. Uptake of home-based VCT was almost six times 
greater than uptake of facility-based VCT among 15-24 year olds. Provision of home-
based VCT also increased uptake among women, which had previously been 40% lower 
than men. Elsewhere in Uganda, in 2003 Were et. al. reported near complete uptake of 
home-based VCT in a community in Mukono district, with 98% consenting to HIV 
testing and requesting to receive results, and 93% of these actually receiving their results 
and post-test counselling [111]. The study sample (n=3338) consisted of 94% of the total 
population of the community. Importantly, this high level of uptake was in the context of 
very limited access to treatment, but it had been preceded by extensive community-wide 
mobilization. These different levels of testing observed in rural Uganda (37% in Masaka 
and over 90% in Mukono) indicate considerable variability in uptake of counselling and 
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testing through home-based VCT. A key factor influencing uptake of counselling and 
testing is the availability, or perceived availability, of treatment. The widespread roll-out 
of treatment in Uganda began in 2003 [136]. Thus, those in the Mukono district may have 
anticipated treatment availability in the near future. Also, increased awareness of the 
benefits of testing as promoted through community-wide mobilization may have 
contributed to the exceptionally high uptake of home-based testing in Mukono district. 
 
Given the success of home-based testing in increasing levels of uptake [130], its use, 
along with an increased emphasis on couple counselling and testing, has recently been 
advocated for achieving universal coverage of HIV counselling and testing in Africa [18]. 
Some countries have already adopted this approach. Lesotho, with the highest levels of 
HIV prevalence in the world, began implementing a national level home-based VCT 
program in 2005 [137]. It is envisaged that all households will be offered HIV 
counselling and testing services. This intensive approach is relatively achievable given 
that Lesotho is a geographically small country with a population of two million people.   
 
While home-based VCT has been shown to increase convenience, remove logistical 
barriers to testing, reduce the inequalities in access to services [91, 127], and  potentially 
offers more privacy than facility-based VCT, the shortcomings of home-based testing are 
that it is logistically challenging and can be expensive to provide, especially if multiple 
visits are required. It is also may lead to domestic conflict, for example among couples 
with conflicting attitudes regarding HIV testing [91]. Concerns have been raised 
regarding lack of confidentiality and inadvertent disclosure of the test results when given 
at home.  However, in the Masaka cohort, there were no reports of lack of confidentiality 
among those who received counselling and testing at home [91].  
 
Workplace-based testing 
As with home-based VCT, workplace VCT makes testing services more accessible. In 
Zimbabwe, a randomized trial investigating the uptake of rapid HIV testing at the 
workplace found that uptake was significantly greater (adjusted risk ratio 12.5, 95% CI 
8.2 – 16.8) when provided at the workplace (51.1% uptake), than when a voucher was 
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provided for non-workplace VCT (4.3% uptake) [138]. In Rwanda, a workplace testing 
and treatment program at Heineken Breweries was found to be similarly successful, with 
73% of employees going for counselling and testing [139]. Infected employees were also 
offered treatment when they were identified to be in need of treatment, based on CD4 
monitoring. 
 
In South Africa, HIV testing has been available since 1991 through employee health 
services provided by the mining industry [140]. Initially, voluntary uptake was low and 
the majority of testing carried out was that which was routinely offered to those 
diagnosed with tuberculosis or an STI. A workplace-based clinic for HIV infected 
mineworkers in the Free State province, set up in 1999, was found to be effective for 
delivering counselling and support as well as preventive therapy for tuberculosis [140]. 
Subsequently, a workplace ART programme, covering seven provinces of South Africa, 
was successfully established in 2002 [141]. Thus, workplace testing programmes have 
been shown to be acceptable and effective; however, while convenient, workplace-based 
services can only reach those in formal employment and may lead to discrimination or 
even job loss. 
  
Mobile testing 
Mobile VCT removes the logistical barriers for those who want to receive counselling 
and testing in areas where access to VCT services is limited. In Kenya, a large-scale 
mobile VCT program has been implemented to meet the demand for testing among 
remote rural populations [61]. In Ethiopia, mobile VCT has been used to provide services 
for hard-to-reach populations since 2004 [142]. This Ethiopian outreach service has been 
successful for diagnosing infected individuals and referring them to receive treatment and 
support [142]. In Cameroon, mobile VCT has also been found to be highly acceptable, 
with 99.7% of those who received pre-test counselling opting to receive their results and 
post-test counselling on the same-day as testing [143]. 
 
In Zimbabwe, 40% of PSI’s clients are reached through mobile VCT services, with 
demand for VCT often exceeding  the capacity of staff and supply of equipment [144]. 
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These services are primarily delivered to rural communities where access to VCT is 
limited. PSI also use mobile VCT at brothels and nightclubs to target high-risk groups 
(such as commercial sex workers), in an effort to avoid these individuals experiencing  
stigma at traditional counselling and testing facilities [144]. Morin et. al. reported high 
acceptability of same-day mobile VCT in Zimbabwe, with demand for testing exceeding 
the available resources and 99% of participants opting for same-day results [128]. In a 
separate qualitative component to this study, women reported that community-based 
testing services meant that they did not have to ask men for permission or money to go to 
receive VCT [128]. 
 
Although mobile VCT programmes are effective in reaching populations, communities 
and individuals who would not have access to services otherwise, referral following VCT 
can be difficult given the transitory nature of mobile services. One other limitation of 
mobile VCT programmes is that participation and refusal rates are difficult to calculate, 
as many clients voluntarily request testing, whereas others accept VCT that has been 
offered to them.  
 
Provider-initiated opt-out testing  
The WHO and UNAIDS guidance on provider-initiated opt-out testing recommends that 
a HIV test should be recommended to all patients attending health care facilities, in 
countries with generalised epidemics, regardless of the patient’s symptoms and the 
patients reason for attending the health facility [29]. This applies to all health facilities: 
public and private hospitals and clinics, medical and surgical services, inpatient and 
outpatient settings as well as mobile or outreach medical services. Given that provider-
initiated testing may require phased implementation, it is recommended that the priority 
settings for implementation are hospital medical wards, tuberculosis clinics, antenatal 
services for pregnant women and STI services [29].  
 
Where implemented, provider-initiated opt-out testing in general medical settings has 
substantially increased access to and uptake of HIV counselling and testing. For example, 
in Uganda, provider-initiated testing was initiated in two large tertiary hospitals in 2004 
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[34]. Previously, testing was only available upon request and cost US$3. Over a 16 month 
period 51,624 patients were offered HIV testing. Of these 98% accepted. HIV prevalence 
among those who accepted testing and had not previously tested HIV positive was 25%, 
four times greater than the national prevalence of 6.4% [145].  Importantly, 81% of those 
who tested had not tested previously. In addition to the introduction of provider-initiated 
testing, the provision of testing free of charge and improved access to treatment and care 
are also likely to have contributed to the exceptionally high level of acceptance of testing 
observed. Nonetheless, this study illustrates the feasibility of provider-initiated testing for 
achieving high levels of uptake and identifying previously undiagnosed infections in a 
medical setting.  
 
In Botswana, the national policy of provider-initiated opt-out HIV testing, implemented 
since 2004, has led to increases in testing uptake. A population-based survey almost a 
year after the introduction of provider-initiated opt-out testing found that almost half of 
respondents (48%)  reported to have ever received HIV counselling and testing [43]. 
Furthermore, there was widespread support for the policy of provider-initiated opt-out 
testing, with 81% of respondents being extremely or very much in favour, and 8% being 
somewhat in favour [43]. A more recent survey found that over half (55%) of respondents 
had tested within the last year and 94% of respondents reported to be in favour of 
provider-initiated opt-out testing [146].   
 
In addition to general medical settings, provider-initiated testing has been widely 
implemented within PMTCT programmes, which involve offering HIV counselling and 
testing to pregnant women when they attend ANC. Women testing positive are then 
offered treatment, if available, around the time of delivery to prevent transmission to their 
newborn. In the past, PMTCT programmes have had low uptake largely due to: (i) 
women not being offered testing (due to insufficient staff to test and counsel all ANC 
attendees and lack of test-kits) and (ii) women refusing testing when offered [147]. 
However, in recent years, a rapid expansion of provision of PMTCT services in sub-
Saharan Africa and the move towards opt-out testing has led to increased uptake.  
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In Zimbabwe, an acceptability study in two rural districts found that 79% of women who 
had not received an HIV test at ANC would accept opt-out testing [35]. The subsequent 
introduction of provider-initiated opt-out testing for women attending ANC in one of 
these districts actually achieved a higher uptake of 93% [148]. In Malawi, offering opt-
out testing as part of a PMTCT programme in Thyolo district hospital resulted in 95% of 
new antenatal mothers completing VCT [149]. In Botswana, the introduction of provider-
initiated opt-out testing at ANC in Francistown increased the proportion of infected 
pregnant women who learned their status from 47% to 78% and increased the proportion 
receiving PMTCT interventions from 29% to 56% [150]. In Uganda, following the 
introduction of provider-initiated opt-out testing in two large hospitals in 2004, 98% of 
patients accepted HIV testing [34]. Provider-initiated opt-out intra-partum HIV 
counselling and testing integrated with PMTCT, in a rural Ugandan hospital, has also 
been found to have high uptake (86% among women and 98% among their male partners) 
[151]. 
 
By 2007, provision of PMTCT services at ANCs had increased to 38%, and in Eastern 
and Southern Africa an estimated 28% of women received testing during their last 
pregnancy [152]. Consequently, the provision of testing through PMTCT programmes is 
increasing; a trend largely attributable to the expansion of provider-initiated opt-out 
testing in health care settings and the use of rapid testing with same day results [17].  
 
Provider-initiated opt-out testing in general medical settings and integrated into antenatal 
care is acceptable, achieves higher uptake and causes less anxiety than opt-in testing 
[153]. In addition to being well-accepted, opt-out testing identifies many previously 
undiagnosed individuals [34, 151], enables early referral for prevention, treatment and 
care services [150], allows women to receive testing without having to receive permission 
from their partner [154], and is perceived to reduce HIV-related stigma [43]. Unlike 
testing which is actively sought, opt-out ANC testing is done for the benefit of the baby 
(as well as the mother) and thus avoids an implication of promiscuity [68]. However, 
integrated opt-out HIV testing services may be more successful than free-standing 
services in achieving high levels of uptake as they avoid potential stigma surrounding 
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HIV (i.e. the possible speculation and rumours of HIV infection associated with being 
seen going for a HIV test as a free-standing facility) [91].  
 
Rapid testing 
In addition to more convenient forms of service provision, the development of rapid HIV 
tests has been a major improvement to how HIV testing is delivered [155, 156]. Clients 
can receive their test results and post-test counselling on the same day as testing, often 
within an hour, removing the need for them to make a return visit to collect their results. 
Prior to the introduction of rapid tests, enzyme-linked immunosorbent assay (ELISA) 
testing was used. This process can take a week or longer [157]. Thus, the time taken to 
receive test results was typically one to two weeks. However, with ELISA testing the 
time taken to receive results is typically longer in rural areas as compared to urban areas, 
as samples have to be sent to a laboratory with the facilities to perform ELISAs. Thus, the 
time taken to receive results in remote rural areas is variable - depending on the distance 
from a laboratory and the frequency at which samples are sent to the laboratory - and may 
even take months. For example, participants waited two to four months to receive their 
HIV test results in a panel survey in rural Malawi in 2004 [129].   
 
Besides convenience, provision of results as soon as possible after the test may help to 
alleviate anxiety and has been shown to increase the proportion of clients who collect 
their test result [158]. For example, in Uganda, receipt of test results increased from 79% 
to 100% following the introduction of rapid tests at the AIDS Information Centre 
counselling and testing sites [159]. Previously, clients had to return after two weeks for 
their results and post-test counselling. In Nairobi, Kenya, a randomized clinical trial 
among pregnant women found that receipt of test results was significantly higher for 
those randomized to receive rapid testing as compared to ELISA testing (96% vs. 73%, 
OR 1.3; 95% CI 1.2-1.4, P<0.001) [160]. The median time to receiving results was 0 days 
and 11 days for those receiving rapid testing and ELISA testing, respectively.   
 
Although rapid testing has been shown to increase the proportion of clients who receive 
their test results, it is not clear if rapid testing increases uptake of testing. A survey in 
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rural Malawi offering home-based testing in 2004 found that 91% of participants agreed 
to be tested and 70% of those who tested received their results [161]. In a subsequent 
survey in 2006 ELISA testing was replaced with rapid testing. Uptake of testing remained 
high, at 92%, but receipt of results increased to 98% [161]. Given that acceptance of 
testing in this study was high prior to the introduction of rapid testing it is not known if 
rapid testing would have increased uptake from a lower level.    
 
Mkwanazi et. al. argue that rapid testing may not improve uptake of HIV testing and 
receipt of same day results, based on a study among pregnant women in KwaZulu-Natal, 
South Africa, carried out from 2001 to 2004 [162]. Acceptance of testing remained 
unchanged at 74.6% following the introduction of rapid testing. However, only 3.45% 
(166/4810) of women who received rapid testing at ANCs requested to receive their 
results on the same day as testing, with the remainder opting to receive their results at a 
later appointment [162]. Importantly, however, this exceptionally low uptake of results 
collection is not uncharacteristic of this population, as a population-based survey in the 
same area found that although 58% of participants consented to receive counselling and 
testing, less than 5% of those tested returned for their results [162].  
 
Counselling provision 
Counselling is an integral part to the provision of HIV testing. Despite many guidelines 
on the provision of counselling, the quality and duration of the counselling session can 
vary considerably [68]. The importance of providing counselling has been questioned. 
Koo et. al. called for reducing or even omitting pre-test counselling completely in the US, 
on the grounds that lengthy counselling sessions may be a barrier to testing [163]. 
However, it is not clear if the removal of pre-test counselling would facilitate testing by 
omitting a potentially “cumbersome” time-consuming practice or if it would hinder 
testing as clients do not receive the necessary information and advice [68]. Although it 
has been suggested that an aversion to counselling may deter some individuals from 
receiving testing and counselling, this hypothesis has not been tested as it would not be 
ethical to provide testing without counselling. Also, it is not clear if different approaches 
to counselling influence the uptake of testing. 
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Treatment availability 
Lack of treatment is an important barrier to HIV testing, as knowledge of one’s infection 
may be viewed as futile if treatment is unavailable. In theory, the availability of treatment 
transforms HIV from a deadly disease into a chronic disease, therefore changing the 
context of HIV testing.  
 
Botswana was the first African country to institute universal access to ART, and therefore 
it provides an opportunity to examine the effect of provision and scale-up of treatment on 
testing behaviour. The national ART treatment programme, which aims to provide free 
ART to all HIV-positive individuals with a CD4+ count below 200 or with an AIDS-
defining illness and to those under 13 years of age, commenced in January 2002 [164, 
165]. Initially uptake of treatment was low due to under-utilisation of HIV testing 
services [44]. In an effort to identify infected individuals, the policy of provider-initiated 
opt-out testing was therefore introduced in 2004, whereby all patients are tested as a 
routine part of a medical visit, unless they explicitly refuse. 
  
Nationally, a greater than two-fold increase in uptake of HIV testing was observed 
between 2001 and 2004 in Botswana [166]. The introduction of opt-out testing increased 
the population testing rate from 40 per 1000 persons in 2004, to 93 per 1000 persons in 
2005 and 104 per 1000 persons in 2006 [44]. An increasing demand for testing services 
was also noted. A cross-sectional survey of a probability sample of adults in Botswana 11 
months after the introduction of provider-initiated opt-out testing found that 71% of those 
who had not tested intended to do so in the next six months [43]. Furthermore, one of the 
most commonly reported reasons for having tested was the knowledge that treatment was 
available. In the district of Tutume, Botswana, the introduction of ART in 2003 led to a 
five-fold increase in uptake of HIV testing by reportedly removing the residual reluctance 
to test for HIV as some individuals were previously averse to HIV counselling and 
testing, largely due to stigma [164].  
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Elsewhere in sub-Saharan Africa, the availability of treatment has led to large increases 
in uptake of testing. In Uganda, a 27-fold increase in volume of clients accessing VCT 
services was observed following the introduction of treatment in Masaka district [167]. 
Before the introduction of ART, uptake of testing was low (297 clients from January to 
December 2000). VCT was not available throughout 2001, and with the resumption of 
VCT and introduction of ART in 2002, a large client volume was observed (8286 clients 
in 2002). In Namibia, a 41% increase in the uptake of HIV testing from free-standing 
VCT centres was observed following the introduction of ART in government hospitals in 
2003 [168].  
 
Knowledge that treatment is available may allay the fears of those who would otherwise 
refuse to test for fear that they are be infected. The availability, or perceived availability, 
of treatment strongly influences the decision to test, as receipt of a positive result when 
treatment is available is entirely different to receipt of a positive result when treatment is 
not available. In terms of outcomes following testing, initiation of treatment for those 
who are infected leads to improved health outcomes and survival [169]. Improved health 
following treatment initiation may influence sexual behaviour, for example a resumption 
of sexual activity, if an individual was previously abstaining due to illness (Figure 2.1).   
 
2.5.2 Marital status  
Marriage can influence uptake of testing as a couple may decide to test for HIV before 
getting married. Moreover, many churches actively encourage pre-marital testing. For 
example, in Ghana, Pentecostal churches imposed obligatory HIV testing for couples 
intending to get married (“no medical certificate, no marriage” [170]), whereby the test 
results are given to the couple who, in turn, give these to a member of the clergy who 
discusses the implications of their results as part of the church’s marriage preparation and 
counselling process [170]. Qualitative work among pastors and marriage counsellors 
found a strong defence of obligatory pre-marital testing, with the view that those who 
may be HIV positive should not be spreading infection to those who are HIV negative 
[170]. Indeed, if one member of a couple tested positive, the church would advise for the 
marriage not go ahead. Although pre-marital obligatory testing was widespread, churches 
 51
switched to strongly encouraging, rather than imposing, testing following public 
criticisms regarding human rights violations and opposition from the National Anti-AIDS 
Commission [170].  
 
In Uganda, nearly 80% of couples attending the AIDS Information Centre request HIV 
testing as a pre-marital screening process, described as “planning for marriage” [171, 
172]. However, going for testing may raise issues of trust in a relationship, for example a 
woman receiving counselling and testing may be viewed by her partner as a sign that she 
has been unfaithful. In addition, concern that the first member of a couple who is tested 
will be blamed for bringing HIV into the relationship has been reported in Botswana and 
Zambia [93]. 
 
2.5.3 Sexual behaviour 
Sexual behaviour is strongly determined by an individual’s marital status and also family 
planning intentions [173]. Sexual behaviour (number of partners, types of partnership and 
frequency of unprotected sex within these partnerships) is central to the framework 
(Figure 2.1). The relationship between receiving counselling and testing and subsequent 
sexual behaviour is complex, as behaviour is mediated by several factors and events 
including partnership formation and dissolution, and pregnancy.  
 
Anxiety or guilt over past risky behaviour, or worry due to a partner’s risky sexual 
behaviour, may prompt an individual to receive counselling and testing [43, 85, 128, 
166]. Having to stop some sexual practices, if infected, has been reported as a barrier to 
HIV testing in Botswana [43].  
 
2.5.4 Health status 
An individual’s health status may be another motivator for seeking testing, as many 
individuals will decide to go for testing only once they are ill and showing symptoms of 
an AIDS-related illness [43, 128, 131, 133].  Death of one’s spouse or partner, through 
AIDS or other ill health, may act as a motivator for testing, as it prompts an individual to 
consider their own serostatus.   
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2.5.5 Psychosocial status 
An individual’s psychosocial status (knowledge, risk perception, personal experiences of 
HIV morbidity and mortality) is illustrated adjacent to the uptake of testing (Figure 2.1), 
as all processes act through one’s psychosocial status to influence the decision to test.  
 
An individual’s own risk perception is important with regard to HIV testing; if one 
believes that they have not been at risk of HIV infection then they may not see the need 
to undergo a counselling session and receive a HIV test. For example, a survey in 
Botswana found that of those who had not tested, 43% had not done so because they had 
no reason to believe they were infected [43]. However, an individual’s perception of their 
risk does not always correspond to their actual level of risk. Denial, indifference or 
misunderstanding may lead an individual who is putting themselves at risk of HIV 
infection to mistakenly believe that they are not at risk. Equally, some individuals may 
have convinced themselves that they are already infected, in which case they may regard  
going for testing to be futile. In a discussion of uncertainties regarding the benefits and 
detriments of HIV testing by Kaler and Watkins, going for counselling and testing with 
the belief that one is infected is expressed by a rural Malawian as “Asking god about the 
date you will die” [84].  
 
The principal psychological barrier to testing is fear of a positive result and the associated 
anxiety and worry [35, 43, 68, 84, 91, 95, 154, 174]. However, it has been shown that 
perceived risk of being infected is frequently overestimated. In rural Malawi it was found 
that of those who reported a high likelihood that they are HIV positive, 95% of women 
and 96% of men were incorrect [175].  Qualitative work in rural Uganda found that most 
people mentally prepare to be told that they are infected with HIV before going to collect 
their test results [91].  
 
There are many possible motivations for seeking HIV testing, however, often the decision 
to test is not an easy one [113]. The perceived benefits of testing will be balanced against 
the perceived consequences of testing when considering whether or not to test for HIV. 
 53
One’s own belief about one’s serostatus will strongly influence this process. Prochaska’s 
stages of change theory: pre-contemplation, contemplation, preparation, action and 
maintenance is a useful model when considering the mechanisms involved in wanting to 
know one’s HIV status and actually going for counselling and testing [176]. In practice, 
an expression of willingness to test, or desire to know one’s HIV status does not always 
translate into actually going for counselling and testing [126, 131, 177]. However, 
individuals reporting a desire to know their status may be at the preparation stage but not 
yet ready to test. For example, a survey in Uganda found that while 70% expressed a 
desire to be tested, only 15% had actually done so [177].  
 
2.6 Discussion 
This section of the framework outlines the many influences on the utilisation of HIV 
testing and counselling services. There are many reasons and motivations for testing as 
well as many deterrents from testing. In considering the determinants of uptake of testing, 
two broad themes emerge: firstly psychological determinants, which include social 
barriers to uptake of VCT (such as stigma) and individual factors (such as anxiety and 
fear); secondly practical determinants, such as service constraints (availability and access 
to services) and the availability of treatment.   
 
Uptake of testing is increased by removing the logistical barriers to testing, although the 
psychological barriers may remain. However, removing the logistical barriers to testing 
may create a positive-feedback effect: whereby an increasing proportion of individuals 
who know their HIV status leads to a change in social norms regarding counselling and 
testing (i.e. normalizing HIV testing) and hence reduces the psychological barriers to 
testing and increases the uptake of testing.   
 
In addition to making testing more conveniently available, alternative ways to remove 
barriers to knowing one’s serostatus are being investigated. For example, in Malawi, a 
small randomly assigned monetary incentive (ranging from zero to three dollars, the 
average - $1.04 - was worth less than a day’s wage) doubled the proportion of individuals 
returning for their test results (from 39% to 80%) in a population-based survey  [129]. 
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Overall, uptake of testing among study participants was high, with 91% of those 
approached agreeing to test. Although offering a cash incentive may be ethically dubious 
(in effect paying people to know their serostatus) and not a feasible intervention outside 
of a research setting, Thornton argues that barriers to testing can be easily overcome by 
offering an incentive [129].  
 
Corbett et. al. suggest that convenience, a direct offer of testing, and positive attitudes of 
staff may outweigh individual-related factors with regard to uptake of HIV counselling 
and testing [138].  However, Wolff et. al. argue that convenience is important, but must 
be balanced against social consequences, such as stigma [91].  
 
This framework has placed much emphasis on the motivations for testing, barriers to 
testing and the considerations involved in the decision to test, however not all individuals 
will be particularly concerned about knowing their HIV status as they may have more 
immediate issues (e.g. other illnesses) to cope with.  
 
Given the potential importance of behavioural risk reduction for HIV prevention, the 
effectiveness of counselling and testing in achieving such risk reduction has received 
much attention. A comprehensive review of published analyses regarding the impact of 
receiving HIV counselling and testing on subsequent sexual behaviour is provided in the 
following chapter.  
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A theoretical framework for the determinants of uptake and 
behavioural outcomes following HIV counselling and testing: 
Part II 
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3.1 Aims and organisation of chapter 
The aim of this chapter is to complete the theoretical framework by considering the 
outcomes following counselling and testing, in terms of impact on sexual behaviour.  
Firstly, an overview of behavioural theories and a discussion of the role of counselling 
and testing for changing risk behaviour is provided. This is followed by a comprehensive 
review to address the question: What impact does receiving HIV counselling and testing 
have on subsequent sexual behaviour? Within this review, an overview of studies from 
both Western and African settings which have been reviewed and analysed to date (1986 
-2009) is provided. Next, individual studies based in sub-Saharan Africa are considered 
in more depth, organized by study design. Observational studies are reviewed, organized 
by behavioural outcome. Studies with respect to sero-discordant couples are then 
considered. Finally, a discussion of the main findings and methodological issues is given.  
 
3.2 Background 
Behavioural risk reduction is promoted to reduce the spread of HIV. The provision of 
counselling and testing services is a potential means of facilitating such behaviour 
change. Thus, determining the impact of counselling and testing on subsequent sexual 
behaviour is of importance. However, there are a number of potential challenges to using 
counselling and testing as a successful prevention measure. These include changing long-
term behaviour based on a single point-in-time intervention, poor quality prevention 
counselling, denial and stigma as barriers to uptake, maintaining quality counselling with 
widespread scale-up and the inability of current HIV tests to detect acute infections  
[178]. It has also been argued that clinics are not appropriate places for prevention, as 
people are positioned as patients and prevention is individualistic [40]. Despite these 
concerns, given the necessity of counselling and testing, it is argued that the use of 
counselling and testing for prevention must be maximised. Behavioural theories and the 
individual-level psychosocial mechanisms - by which combining knowledge of one’s 
serostatus with personalised risk reduction counselling may motivate individuals to 
change their behaviour to prevent infection - are outlined in the following section. 
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3.3 Behavioural theories and the role of HIV counselling and testing for changing 
risk behaviour 
Counselling and testing is one approach to encourage behaviour change; other approaches 
include providing information and education (e.g. mass media education, peer education, 
and small group education) [179]. Providing information and education are necessary for 
prevention, but not always sufficient. Thus, a number of theories of determinants of 
behaviour and behavioural change have been developed, some which are HIV/AIDS 
specific, others have been applied from other areas of health research and psychology 
[180, 181]. An overview of behavioural theories is presented in Table 3.1. 
 
Theories such as the Transtheoretical Model, the AIDS Risk Reduction Model and the 
Precaution Adoption Process Model describe the process of behavioural change by 
outlining an individual’s progression through a series of stages of “readiness” to change 
their behaviour. In contrast, the other theories presented above focus on predicting and 
explaining behaviours, rather than on behaviour change specifically. Theories such as the 
AIDS Risk Reduction Model, the Information-Motivation-Behavioral Skills model, the 
Integrated Model and the Multiple Domain model were all developed specifically to 
understand sexual risk behaviour in the context of HIV/AIDS. The other, more general, 
theories such as the Theory of Planned Behavior, which was established before the AIDS 
epidemic, have been used to explain and predict other health-related behaviour (e.g., 
smoking cessation) [182]. 
 
Each of the behavioural theories summarized in Table 3.1 focus principally on individual-
level psychosocial factors (e.g. attitudes, intentions and beliefs) to understand and predict 
risk behaviour (with the exception of the Theory of Gender and Power). However, sexual 
behaviour is not determined by an individual’s psychological processes alone. In 
addition, many behavioural theories have been based on the assumption that counselling 
leads to a rational, considered decision to change behaviour. However, for many 
individuals and women in particular, sex is tied with livelihood, duty and even survival, 
in poor societies [183]. Thus, the broader social, cultural and environmental influences 
also need to be considered. To capture the context in which behaviour occurs (i.e. beyond 
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the individual level) a number of social theories, such as the diffusion of innovation 
theory and the social influence model, have been developed that include factors such as 
relationships, societal norms, religious criteria and gender-power relations [181, 184].  
 
The behavioural theories presented in Table 3.1 share a number of constructs, including: 
attitudes; social norms (behavioural expectations within society); self-efficacy (the belief 
that one is capable of attaining certain goals); risk perception; knowledge and intentions. 
However, the importance of each varies among theories. For example, the Theory of 
Reasoned Action is defined using three central tenets: attitudes, perceptions of social 
norms and intentions. In a comparison of behavioural theories, Noar points out that the 
concepts of attitude and self-efficacy are of importance in almost all of these theories 
[180].  
 
These behavioural theories are useful when considering the behavioural impact of VCT. 
Receiving counselling may facilitate behavioural risk reduction through improving risk 
perception, increasing self-efficacy, reinforcing social norms, providing support for 
sustaining risk reduction and increasing an individuals ability to communicate about sex 
[181, 185]. Factors such as the test result, the individual’s level of risk, receptiveness to 
counselling messages and readiness to reduce risk (if necessary) and the quality of 
counselling may influence the behavioural outcomes following testing. Additionally, the 
psychological “determinants” of behaviour are likely to be differentially influenced by 
the HIV test result. Learning that one is not infected may motivate an individual to reduce 
their risk, if necessary, to avoid acquiring infection in the future. De Zoysa et. al. outline 
how receiving a negative test result may increase self-efficacy and reinforce confidence 
in the effectiveness of risk avoidance, conversely, however, it may also reinforce a low 
risk perception [185]. Equally, learning that one is infected may have a direct effect on 
sexual behaviour, as learning that one is HIV positive is often highly emotionally 
distressing. Obermeyer and Osborn outline how the significance of a HIV test result goes 
beyond conveying medical information (one is simply infected or not infected), as a test 
result may have impact on an individual’s life by leading to a “complete redefinition of a 
person’s social relationships” [68]. 
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Theoretical model 
 
Description 
Behavioural change theories:  
Transtheoretical Model [176] Outlines stages which individuals move through when changing behaviour: (i) pre-contemplation, (ii) 
contemplation, (iii) preparation, (iv) action and (v) maintenance.  Movement between stages depends on 
cognitive-behavioural processes. 
AIDS Risk Reduction Model [186] Outlines three stages involved in reducing risk: (i) behaviour labelling, (ii) commitment to change (iii) and 
action. Based on a combination of previous models and developed specifically to understand HIV risk. 
Precaution Adoption Process Model 
[187] 
The adoption of behaviour change is a dynamic process with many determinants. Change is conceptualised 
as an orderly sequence of qualitatively different cognitive stages.     
Behavioural theories:  
Health Belief Model [188] Health behaviour is a function of an individual’s socio-demographic characteristics, knowledge and 
attitudes. Prompting behavioural change involves changing individual personal beliefs. 
Theory of Reasoned Action [189] Focuses on the role of personal intention as a determinant of behaviour. Intention is a function of attitudes, 
intentions and social influence. Assumes that behaviour is under volitional control and is rationally 
considered.  
Theory of Planned Behaviour [190] Revision and extension of Theory of Reasoned Action. Composed of three constructs: behavioural 
intention, attitude and subjective norms. A person’s attitude, combined with subjective norms, forms their 
behavioural intention. 
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Integrated model [191] 
 
Integration of several theories of behavioural prediction and behaviour change. Behavioural change occurs 
if an individual has strong intention to change their behaviour, has the necessary skills and abilities required 
and if there are no environmental constraints preventing behavioural change.   
Social Cognitive Theory [192] Regards behaviour as a continuous interaction between cognitive behavioural and environmental 
determinants. Focuses on the ideas of self-efficacy and outcome expectancies.  
Information-Motivation-Behavioral 
Skills Model [193] 
Risk reduction, with respect to HIV/AIDS, is a function of an individual’s information about transmission 
and prevention of HIV, motivation to reduce their risk, and behavioural skills to carry out risk reduction. 
Multiple Domain Model [194] Behaviour is determined by personality characteristics (e.g. sensation seeking and impulsivity) and 
psychosocial characteristics (e.g. attitudes, norms and self-efficacy).  
Extended Parallel Process Model 
[195] 
Extension of “Protection Motivation Theory” for fear appeal research (i.e. fear-based messages). When an 
individual fears a significant threat and when they perceive a response that would avert the threat, they are 
motivated to control the danger and think of strategies to avert the threat.  
Protection Motivation Theory [196] Aims to understand how individuals react to fear-based messages. Consists of three components: (i) 
magnitude of harm of a potential event (e.g. infection with HIV); (ii) the probability of that events 
occurrence; and (iii) the efficacy of a protective response. Each of these three factors initiates cognitive 
appraisal processes that mediate attitude and behaviour.    
Theory of Gender and Power [197] A social structural theory. Encompasses issues including power and authority, affective influences, and 
gender-specific norms within heterosexual relationships, with a focus on women.  
Table 3.1 Overview of behavioural theories. This table is based on work by Noar [180].  
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3.4 The impact of HIV counselling and testing on subsequent sexual behaviour 
To identify the relevant literature, a PubMed search was performed using combinations of 
the terms “HIV”, “counselling”, “testing”, and “sexual behaviour”. The reference list of 
each study included was also fully checked to identify any additional relevant studies. 
Results that were only available as conference abstracts were not included in this review 
as they did not contain sufficient detail. 
 
3.4.1 An overview of the epidemiological evidence regarding the impact of VCT on 
sexual behaviour 
Two reviews and two meta-analyses have provided an overview of the literature 
regarding the efficacy of HIV counselling and testing on behavioural risk reduction in a 
wide range of contexts. Higgins et. al. reviewed 50 studies published between 1986 and 
1990 [198]. A broad range of studies were included, categorised as those on homosexual 
and bisexual men, IDUs, pregnant women and other heterosexuals at high risk of 
infection. Only three of the fifty studies reviewed were based in an African setting. 
Furthermore, these three studies were referenced as conference proceedings and not 
published papers. Overall, dramatic reductions in risk among homosexual men were 
found; both tested and untested, indicating that risk reductions were independent of 
having received counselling and testing. Reductions in risk were observed among sero-
discordant couples following counselling and testing. However, on the whole, the authors 
concluded that HIV counselling and testing does not affect behavioural change, as 
reductions in risk were reported regardless of having received counselling and testing.  
 
As a follow-up to Higgins’s review, Wolitski et. al. carried out a systematic review of 
published studies from 1990 to 1996 [199]. Studies were classified according to 
participants: (i) men who have sex with men (MSM); (ii) injecting and other drug users; 
(iii) women and heterosexual couples; and (iv) mixed samples recruited from STI clinics 
and other settings. Of the 35 articles reviewed, eight were from an African setting. 
Overall, the findings were mixed, with the most consistent evidence for reduced risk 
following counselling and testing among sero-discordant couples. Despite finding some 
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evidence that counselling and testing influences risk behaviour many studies did not, and 
so the review was largely inconclusive.  
 
Weinhardt et. al. carried out the first meta-analysis of the effects of HIV counselling and 
testing on sexual risk behaviour [200]. This meta-analysis included 27 studies published 
between 1985 (the year an HIV antibody test was first licensed) and 1997. Six of these 
studies were based in African countries, with the majority being based in the United 
States. The inclusion criteria required that studies report sexual behaviour outcome data 
assessed before and after counselling and testing. However, the studies included were 
diverse with respect to study design, length of follow-up and recruitment of participants. 
In particular, a number of the studies reported behavioural outcomes among IDUs. The 
conclusions from this analysis were that infected individuals who received counselling 
and testing reduced their risk behaviour, whereas uninfected individuals did not (relative 
to untested participants). Consequently, the authors concluded that counselling and 
testing is a means of secondary, but not primary, prevention of HIV. Of note, the CDC 
immediately issued a cautionary letter on the conclusions of this meta-analysis with 
respect to client-centred counselling. This letter stated that the findings were not a 
reflection of the impact of client-centred counselling in clinical settings, as the majority 
of the studies analysed were published before a client-centred approach was 
recommended in 1993 [201].   
 
A more recent meta-analysis has been conducted by Denison et. al. using studies in 
developing countries occurring between 1990 and 2005 [69]. Only seven studies met the 
inclusion criteria, largely due exclusion of studies from Western settings. Of the seven 
included, four were based in Africa and three in Thailand. The analysis was structured to 
analyse the impact of VCT using two outcome measures: (i) number of sex partners; and 
(ii) occurrence of unprotected sex. Based on data from three studies, it was found that 
VCT had no effect on number of sex partners. With respect to unprotected sex, the pooled 
effect size from all seven studies showed that those who received VCT were significantly 
less likely to engage in unprotected sex compared to before they received VCT or 
compared to participants who had not received VCT [OR 1.69; 95%CI 1.25 – 2.31, where 
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an OR>1 indicates reduced risk] [69]. The greatest effect sizes for unprotected sex were 
observed among HIV positive individuals and sero-discordant couples. The authors 
concluded that this analysis provides moderate evidence to support counselling and 
testing as a prevention strategy.  
 
In addition to these reviews and meta-analyses, a UNAIDS report on the benefits and 
challenges of VCT included a brief review of thirteen studies carried out between 1990 
and 2000 [58]. This review only included studies in sub-Saharan Africa and concluded 
that VCT can promote reductions in risk behaviour among sero-discordant couples in 
particular, but that long-term changes in behaviour are unknown and need to be 
understood. 
 
Much work has been carried out in the United States regarding the efficacy of HIV 
counselling and testing in promoting behavioural risk reduction. A multi-centre RCT 
carried out by the CDC in STI clinics, known as project RESPECT, demonstrated that 
personalized risk reduction counselling can increase condom use [202]. However, the 
effects were short-lived as the significant reported increases in condom use were not 
maintained at 12-month follow-up. A more recent RCT, known as the EXPLORE study, 
has provided evidence for risk reduction among MSM in the United States [203]. Despite 
the evidence that counselling and testing can reduce risk behaviour in these settings, it 
has been estimated that in the United States in 2005 individuals who knew that they were 
HIV positive accounted for 30-46% of new infections, whereas those unaware of their 
serostatus contributed to 54%-70% of new infections [13]. However, those unaware of 
their serostatus had a disproportionately large contribution to the transmission rate of new 
infections (at least 3.5 times that of the aware group), as only 25% of infected individuals 
in the United States were estimated to be unaware of their serostatus at the time of the 
study. Thus, it was concluded that the spread of HIV can be reduced by increasing the 
number of HIV positive individuals who know their status. 
 
In summary, the available data that has been reviewed to date provides some evidence for 
risk reductions among those testing positive and sero-discordant couples. However, the 
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studies reviewed were mostly conducted among high-risk groups (MSM and IDUs) and 
based in Western settings (mostly the United States); few studies from African settings 
were either available or met inclusion criteria. Overall, the results vary considerably, both 
across and within populations. Given this heterogeneity and diversity in results among 
different population groups, it is useful to focus on studies from sub-Saharan Africa. A 
review of these studies is found in the following sections.  
 
3.4.2 Evidence from a randomized controlled trial: The VCT Efficacy Study Group 
Given the heterogeneity among individuals with respect to patterns of risk behaviour, as 
well as intention and motivation for behaviour change, the ideal study design to 
determine the impact of VCT on sexual behaviour is a randomized controlled trial (RCT). 
Furthermore, individuals who self-select to attend VCT may be more likely to have low 
risk behaviour and may be more likely to be more receptive to prevention messages than 
those who do not self-select for VCT. A RCT minimises this bias.   
 
To date, there has been a single RCT to investigate the impact of VCT in reducing 
unprotected intercourse [204]. This trial was carried out in 1995-1998 by the VCT 
Efficacy Study group, in Nairobi (Kenya), Dar es Salaam (Tanzania) and Port of Spain 
(Trinidad). Recruitment was carried out among individuals and couples seeking HIV-
related services. Individuals and couples were randomly assigned either VCT or health 
information (representing best practice). VCT was provided at free-standing facilities. 
Sexual behaviour in the previous two months was assessed by face-to-face interview at 
baseline and two follow-up surveys. At the first follow-up (mean 7.3 months after 
baseline) VCT participants were offered a repeat test and health information participants 
were offered VCT. Sexually transmitted infections were diagnosed and treated among all 
participants. HIV incidence was not used as an outcome due to ethical issues. 
 
Those individuals receiving VCT reduced reported levels of unprotected sex with non-
primary partners (i.e. casual or commercial partner). Among men, a reduction of 35% 
was observed in those receiving VCT compared to 13% in those receiving health 
information. Among women, a reduction of 39% was observed in those receiving VCT 
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compared to 17% in those receiving health information. Importantly, these reductions 
were maintained (i.e. reported unprotected sex remained at a similar level to that 
observed at first follow-up) at the second follow-up (mean 13.9 months after baseline).  
 
Individuals infected at baseline were significantly more likely to reduce unprotected 
intercourse with their primary partner (i.e. spouse or “steady” partner) between baseline 
and first follow-up, compared to those who were uninfected (OR = 0.60, 95% CI = 0.40 – 
0.89). These reductions were maintained at second follow-up. Individuals infected at 
baseline were also more likely to reduce unprotected intercourse with their non-primary 
partners between baseline and first follow-up.  However, this effect was confounded by 
gender as greater reductions were observed among infected men (OR = 0.19, 95% CI = 
0.05 – 0.81), than infected women (OR = 0.90, 95% CI = 0.49 – 1.66), compared to 
uninfected men and women respectively.     
 
Among couples, those assigned to receive VCT significantly reduced unprotected 
intercourse with their enrolment partners compared to those assigned to receive health 
information (OR = 0.72, 95% CI = 0.53 – 0.99). However, no differences were found in 
reported unprotected sex with non-enrolment partners, although levels of unprotected 
intercourse were much lower with non-enrolment partners than with enrolment partners. 
Sero-discordant and sero-concordant-positive couples were significantly less likely to 
report unprotected intercourse with enrolment partners at both follow-ups than couples 
who were concordant-negative. However, rates of unprotected intercourse with non-
enrolment partners remained unchanged among sero-discordant and sero-concordant 
couples receiving VCT.  
 
The validity of self-reported sexual behaviour data is supported by the finding that 
unprotected intercourse with a non-enrolment partner was significantly associated with an 
increased risk of STI acquisition - gonorrhoea, chlamydia or syphilis - (OR = 2.97, 95% 
CI = 1.12 – 7.24). Moreover, agreement between couple’s reports of behaviour was high, 
at about 90%. 
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Although there is evidence for the efficacy of VCT for reported risk reduction among 
individuals with their non-primary partners, reported risk reductions with individual’s 
primary partners were not observed. Conversely, among couples, strong evidence is 
found for reported risk reduction with enrolment partners but no reported reductions in 
risk were observed with non-enrolment partners. Furthermore, in the meta-analysis 
conducted by Denison et. al., the frequency of unprotected sex is averaged [205]. When 
combined, these data show no impact of VCT on the reported levels of unprotected sex, 
for neither individuals nor couples in this trial. This suggests that the behaviour change 
observed is very specific to the type of sex partner. 
 
Importantly, significant reported reductions in risk were also observed among the control 
group receiving health information as well as those receiving VCT. This trial is 
frequently cited as definitive evidence that VCT is effective in changing behaviour and 
thus can be a successful and cost-effective HIV prevention measure [206]. While the 
results do provide some support for the efficacy of VCT in promoting behavioural risk 
reduction, it must be acknowledged that there are some mixed findings. On the whole, the 
finding that VCT is more effective for risk reduction among infected individuals and 
sero-discordant couples is consistent with the conclusions drawn from the meta-analyses 
conducted by Weinhardt et. al. [200] and by Denison et. al. [69]. 
  
3.4.3 Evidence from observational studies 
In this section, behaviour change is considered with respect to two broad categories (i) 
condom use and unprotected sex, and (ii) number of sexual partners. Studies among sero-
discordant couples are then considered separately, in more detail, where the findings are 
somewhat different. A summary of published studies in sub-Saharan African settings that 
evaluate the impact of VCT on sexual behaviour is provided in Table 3.2. 
  
Condom use and unprotected sex   
Data from four cohort studies indicate increases in reported condom use following VCT. 
Firstly, Allen et. al. report increased condom use following testing among a cohort of 
women attending an outpatient clinic in Kigali, Rwanda in 1988. Before counselling and 
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testing 7% of women reported ever having used a condom, whereas 22% reported using 
condoms regularly after one year follow-up, following testing [207]. The strongest 
predictor of condom use was receipt of a positive test result. Furthermore, women whose 
partner also received counselling and testing were twice as likely to “become condom 
users”, than women whose partners had not. All the spouses and cohabiting partners of 
these women were subsequently enrolled in a male-focused HIV counselling and testing 
programme, carried out in 1991 [208]. Thirty-seven percent of these men had previously 
received counselling and testing from the study. Large increases in condom use were 
reported following testing, except for sero-concordant negative couples. These increases 
were greatest among couples in which the male partner had not previously tested (from 
<30% to >70%).  
 
Secondly, a health centre based cohort in Kenya, carried out from 1999 to 2001, found 
significantly less reporting of unprotected sex with any partner type (primary or non-
primary) following VCT [209]. Reporting of unprotected intercourse decreased from 95% 
before VCT to 89% following VCT (P = 0.021). Thirdly, in Mozambique, Mola et. al. 
report that the percentage of individuals reporting condom use (always or sometimes) 
increased between a baseline survey in 2002 and two follow-up surveys in 2003, among 
those who received VCT [210]. However, an increase in reported condom use was also 
observed among those who did not receive VCT. Nonetheless, reported condom use was 
significantly higher among those who had received VCT than those who had not, at 6 
month follow-up (76% vs. 63%, P = 0.01). Despite this, reported rates of casual sex also 
increased among those who received VCT and those who didn’t.  
 
Fourthly, Sherr et. al. analysed two rounds of data, from a population-based cohort in 
Manicaland, Zimbabwe, during the period 1998 to 2003, and reported that women who 
tested positive increased their reported levels of consistent condom use (i.e. use in 100% 
of sex acts) in the last two weeks, with their regular partners [125]. Men and women 
testing negative did not increase consistent condom use with their regular partners. A 
follow-up analysis, using an additional round of data, is presented in detail in Chapter 6.  
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In addition, Wiktor et. al. found increased levels of reported consistent condom use with 
a partner who was not a sex worker following counselling and testing, among male, but 
not female, tuberculosis patients in Côte d’Ivoire during the period 1995 to 1996 [211]. 
Among males, reported consistent condom use increased from 9.9% prior to counselling 
and testing to 23.6% at a 4 month follow-up visit (4 months after pre-test counselling, 2 
months after post-test counselling). More recently, Turner et. al. analysed data from a 
hormonal contraception study carried out from 1999 to 2004 among 18 to 35 year old 
women in Uganda and Zimbabwe, to compare reported condom use before and after HIV 
testing [212]. Women received counselling and testing every 3 months for 2 years (i.e. up 
to 12 sessions). It was found that the proportion of women reporting any unprotected sex 
decreased from 74% to 56%, following receipt of a positive test result. Importantly, 
however, the proportion of unprotected acts reported changed little (i.e., a 7% reduction). 
No change in either the number or proportion of unprotected acts reported was observed 
among HIV negative women.   
 
Conversely, there is much evidence which suggests that condom use is not increased 
following VCT in a variety of contexts. A study among female sex workers in The 
Gambia in 1989 found no increase in levels of reported condom use two to five months 
following counselling and testing [213]. However, reported levels of condom use among 
these high risk women were relatively high before receiving counselling and testing. 
Infected and uninfected women reported condom use for 89.3% and 88.0% of all client 
contacts respectively (range 31-100%). Thus, the potential to increase levels of condom 
use was small, as many of the women reported levels of condom use of 90-100%, and 
these levels remained unchanged following counselling and testing.  
 
In a community-wide HIV counselling and testing program in Kigoyera, rural western 
Uganda in 1993, Kipp et. al. report that those who tested showed no significant difference 
in reported condom use than those who had not (4.3% vs. 5.5%) [214]. Behavioural data 
were compared for those who had received counselling and testing and those who had 
not, but no data on behaviour previous to testing are presented, so it is not possible to 
determine if there was an actual change in reported condom use attributed to VCT. 
 69
Subsequent focus group discussions in this community revealed that participants felt that 
a single testing program is insufficient and did not cause changes in sexual behaviour to 
occur [215].  
 
A behavioural risk reduction programme providing testing, counselling and condom 
promotion as well as STI diagnosis and management among trucking company workers 
in Kenya carried out from 1993 to 1995, found no change in reported consistent condom 
use during extramarital sex [216]. The percentage of men who reported consistent 
condom use remained at 30%, following counselling, testing, and condom promotion. 
However, no data were available for men who did not receive counselling and testing in 
this setting.    
 
A study among women at a maternity hospital in Nairobi, Kenya in 1998 concluded that 
testing and subsequent post-partum counselling did not increase levels of condom use 
[217]. However, the actual change due to counselling and testing is unknown because no 
baseline data is presented for condom use. The comparison made was between infected 
and uninfected women followed-up one year post-partum. Furthermore, the measure of 
condom use is not defined and is based on reports from only 24 positive women and 33 
negative women who were followed-up, from an initial sample of 107 [217].    
 
Matovu et. al. report no significant changes in reported condom use (none, inconsistent or 
consistent) at one year follow-up among those who either accepted or refused VCT in a 
cohort study in Rakai, Uganda in 1999 [134]. Furthermore, there were no significant 
differences in reported levels of condom use among those who accepted VCT and those 
who refused VCT. Pre-test counselling and testing was provided to all consenting adults 
(n =10618), thus accepting VCT refers to receiving results and post-test counselling. 
Almost half (47.2%) of participants had previously received VCT from the Rakai 
program. The majority, 93% (9910 of 10618), of participants requested their test results. 
Of these, 62% received their results and post-test counselling. Thus, among those who are 
defined as having “refused” VCT, the majority initially requested their results but did not 
receive them. Furthermore, it is important to note that of those who “refused” VCT, only 
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12.4% were no longer interested in receiving their results and the main reasons for not 
receiving results were absenteeism (48.8%) and migration (19.5%). Of the 38% (4016 of 
10618) who “refused” VCT; 48% (1938 of 4016) had previously received VCT either 
from the Rakai program or other providers. For these reasons, it may not be surprising 
that no differences were observed.  
 
Matovu et. al. subsequently published a secondary analysis to describe the effects of 
repeat VCT on reported sexual behaviour and HIV incidence among 6377 initially 
negative participants who had participated in at least two of the annual surveys [112]. 
However, the behavioural data presented are cross-sectional and so it is not possible to 
establish what changes, if any, are occurring subsequent to first-time testing and repeat 
testing. There was no significant difference in HIV incidence between first-time 
acceptors and non-acceptors of VCT (1.6/100 py vs. 1.6/100 py, adjusted IRR = 1.00, 
95% CI 0.72 – 1.39), or between repeat acceptors and non-acceptors (1.4/100 py vs. 
1.6/100 py, adjusted IRR = 0.85, 95% CI 0.58 – 1.23) [112]. However, those who 
actually received VCT are not distinguished from those who accepted VCT, which limits 
these conclusions considerably.   
 
Matambo et. al. report no change in the percentage of participants reporting unprotected 
sex with their primary partners three months after receiving VCT in Harare, Zimbabwe 
(72% pre-VCT vs. 71% post-VCT) [218]. However, this study, which was carried out 
from 2002 to 2004 and nested within a larger trial of the impact of VCT on HIV 
incidence, only presented data for individuals testing negative and no data for individuals 
who did not test are available.   
 
Overall, evidence regarding the efficacy of counselling and testing for increasing condom 
use is varied. One of the caveats for interpreting these results is that many of the 
measures used to define condom use are not comparable. Furthermore, the baseline levels 
of condom use vary widely. Although many studies report that condom use does not 
increase following counselling and testing, the variety of methods and potential 
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limitations in the analysis of the available data make it difficult to conclude no 
association between receiving VCT and subsequent condom use.  
 
Number of sexual partners 
Fewer studies have analysed change in reported number of sexual partners as an outcome 
following VCT. An evaluation of a community-wide counselling and testing programme 
in western Uganda in 1993 concluded that testing is not sufficient to reduce high risk 
behaviour [214]. The findings show no difference in the mean number of reported sexual 
partners in the past three months among those who received counselling and testing (1.8 
partners) and those who didn’t (2.0 partners). However, behaviour was not compared pre- 
and post-testing and so it is not possible to establish if any behaviour change associated 
with having received testing occurred.  
 
Matovu et. al. report no significant change in risk during follow-up among those who 
accepted or refused VCT in Rakai, Uganda in 1999 [134]. Among males, the percentage 
reporting one, two and three or more sexual partners (in the last six months) remained the 
same after a one year follow-up among those initially infected individuals who accepted 
VCT and those who refused VCT. Among females, the percentage reporting three or 
more partners decreased among those who accepted VCT and among those who refused 
VCT. Also, the analysis excludes those who report having no sexual partner. Matovu et. 
al. subsequently carried out a secondary analysis of the effects of repeat-testing in which 
behavioural data for non-acceptors, first-time acceptors and repeat acceptors was 
compared [112]. No significant difference in reported multiple sexual partnerships 
between repeat acceptors and non-acceptors of VCT (18.1% vs. 15.0%, adjusted 
prevalence OR = 0.84, 95% CI: 0.68 – 1.06) was found. However, first time acceptors 
were significantly less likely to report multiple sexual partnerships than non-acceptors of 
VCT (14.1% vs. 15%, adjusted prevalence OR = 0.75, 95% CI: 0.61 – 0.92).   
 
Arthur et. al. report a significant decrease in the proportion of individuals reporting 
having two or more partners in the past six months (16% to 6%, P<0.001) among clients 
receiving counselling and testing at three government health centres in Kenya from 1999 
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to 2000 [209]. In a cohort study in Manicaland, Zimbabwe those testing positive reduced 
their reported number of partners in the last year, subsequent to receiving VCT [125], 
whereas those testing negative increased their reported number of partners in the last 
year, in particular those who did not receive counselling. A follow-up analysis to this 
work, using an additional round of data, collected from 2003 to 2005, is presented in 
detail in Chapter 6.  
 
Behaviour change among sero-discordant couples 
Couple counselling and testing has been identified as a potential “high-leverage” HIV 
prevention intervention, as counselling couples together overcomes the issue of 
disclosing test results and obstacles to risk reduction can be discussed [172]. VCT has 
been shown to be most effective in reducing risk when couples attend VCT together; in 
particular among sero-discordant couples. One of the earliest studies (conducted from 
1987 to 1989) on the efficacy of VCT was carried out by Kamenga et. al. among 149 
sero-discordant married couples at an HIV counselling centre in former Zaire [219]. 
Couples were required to attend monthly counselling sessions and complete a sexual 
activity calendar. Those couples who failed to attend their appointments, or those deemed 
to be at risk of separation, were visited at their homes. In addition, couples were 
requested to retain the condom wrapper each time a condom was used. At each visit to 
the counselling centre numbers of wrappers were counted and the sexual activity calendar 
was discussed. Prior to receiving VCT, less than 5% of couples reported having ever used 
a condom. At 18 months follow-up, 77% of couples reported using condoms for every act 
of intercourse. In addition, 20% of couples reported to be abstaining from sex. Relatively 
low participation (65%) may have influenced these results if those couples most willing 
to increase condom use were also those most likely to participate. The same group of 
researchers carried out a study in the same location two years later to determine the 
impact of HIV counselling and testing on behaviour among child-bearing women [220]. 
Among HIV positive women, 70.8% planned on using condoms; however, 12 months 
later, only 20% actually used condoms. Among HIV negative women, 52.6% planned on 
using condoms but 12 months later, 17% actually used condoms. Furthermore, only 8% 
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of the women who had requested assistance in notifying their partner actually returned 
with their partners for HIV counselling and testing. 
  
Equally dramatic increases in reported levels of condom use following VCT were 
reported by Allen et. al., in a study of sero-discordant cohabiting couples in Rwanda in 
1988 [221]. Among 53 sero-discordant couples, the proportion reporting to use condoms 
increased from 4% before receiving VCT to 57% after one year of follow-up. In 
comparison, reported condom use among couples in which only the woman had tested 
was much lower, at 16%, possibly due to lack of disclosure of serostatus. A similar study 
among sero-discordant cohabiting couples was carried out, also by Allen et. al.,  at a VCT 
centre in Lusaka, Zambia from 1994 to 1999 [222]. Before receiving VCT, less than 3% 
of couples reported current condom use, whereas after a one year follow-up, over 80% of 
couples reported using condoms during all episodes of sexual intercourse. In comparison, 
among concordant negative couples, condom use was reported in 28% of sexual contacts 
at one year follow-up. This suggests that substantial declines in risk may be attributed 
simply to the newly-acquired knowledge of sero-discordance rather than receiving VCT, 
regardless of individual serostatus.  
 
Overall, there is evidence for dramatic increases in reported levels of condom use among 
sero-discordant couples following VCT and rigorous condom promotion. However, 
observed effects may be overestimated due to under-reporting of unprotected sex. The 
prevalence of sero-conversions, the occurrence of pregnancy or the presence of sperm in 
vaginal smears, among couples that reported no unprotected sex, or by positive women in 
a sero-discordant partnership reporting only one lifetime partner, strongly suggests that a 
significant amount of unprotected sex is not reported [219, 221, 222]. In each of these 
three studies, a highly rigorous approach was taken, whereby couples were requested to 
keep a sexual diary or sexual activity calendar, which was discussed with a counsellor 
each month or at 3-month intervals. Such an intensive approach demonstrates substantial 
risk reductions are attainable; nevertheless this approach may be unsustainable outside of 
a research setting. 
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Author & Year Setting & population Study design Service provision Outcome measures Findings
Temmerman et al ., Kenya, Nairobi (urban). Prospective cohort Testing & counselling provided Condom use; No impact. No baseline data for condom use is
1990 Asymptomatic HIV positive Follow-up = 1 year by the study. Contraceptive use & presented. 
women who had recently given N = 1507 pregnancy
birth.
Allen et al ., 1992 Rwanda, Kigali (urban). Prospective cohort Testing & counselling provided Proportion of couples using Increased condom use. The proportion using
Women recruited from an Follow-up = 2 years by the study. Pre-test condoms; condoms increased from 7% (ever using 
outpatient research clinic. N = 1458 counselling consisted of an Spermicide use  condoms) to 22% after 1 year follow-up.
educational video & group 10% reported using spermicide after 1 year
discussion. Results & post test follow-up.  
counselling were given 3 weeks 
later. Participants were obligated  
to receive their results. 
Müller et al ., 1992 Uganda, Kampala (urban). Prospective cohort AIDS Information Center Abstinence; Uncertain. Behaviour at baseline was not
Clients attending the AIDS Follow-up = 6-months provided voluntary & anonymous Unprotected causal sex; compared to that at follow-up. Repeat-testers
Information Center (AIC). (Follow-up only refers to counselling for HIV/AIDS and Number of partners in reported less casual sex than first time testers
repeat testers) testing for HIV. Counselling previous 6 months (6% v 25%). 
N = 500 individuals, 86 given by professional health 
couples, 200 repeat testers workers. 
Allen et al. , 1993 Rwanda, Kigali (urban).  Prospective cohort Testing & counselling provided Hormonal contraceptive use Decrease in contraceptive use. Half of infected
Women recruited  from an Follow-up = 2 years by the study. Pre-test counselling Pregnancy individuals and one third of negative individuals
outpatient research clinic. N = 1458 consisted of an educational using hormonal contraceptives had
video & group discussion. discontinued use one year following testing &
Results & post test counselling counselling. No impact was observed on rates
were given 3 weeks later. of pregnancy. 
Participants were obligated to 
receive their results. 
Pickering et al ., 1993 The Gambia (urban & rural). Prospective cohort Testing & counselling provided Condom use: No impact. Condom use remained at a high
Female sex workers Follow-up = 5 months by the study - medical research (as a % of all contacts, per level overall.
N = 31 clinic staff (trained field workers) individual)
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Lander et al. , 1996 Rwanda, Kigali (urban). Prospective cohort Testing & counselling provided Condom use: Uncertain. Before testing and counselling 14%
Pregnant women Follow-up = 4 months by the study. (% of individuals reporting of women had used a condom at least once. At
after delivery (<6 months to have used a condom at follow-up, 8.8% of infected women and 3.8% of
after post-test counselling) least once) uninfected women reported condom use since
N = 1233 delivery.
Jackson et al ., 1997 Kenya, Mombasa (urban).   Prospective cohort Behavioural intervention Extramarital sex; Reductions in high risk sexual behaviour.
Uninfected male trucking Follow-up at 3 month intervals for high-risk individuals. Condom use (100%); Significant reduction in sex with CSW.
company workers Mean follow-up = 1 year Testing, risk-reduction Sex with commercial sex No change in condom use - 30% of men
(range 21 - 588 days) counselling, condom worker (CSW) reporting consistent condom use during
N = 556 promotion. extramarital sex. 
VCT Efficacy study Kenya, Nairobi (urban). Randomised controlled trial Participants assigned VCT or Unprotected intercourse Reduced levels of unprotected intercourse. 
group, 2000 Tanzania, Dar es Salaam (urban) Mean follow-up  = 7.3 months health information. Testing & Proportion of individuals reporting unprotected
Trinidad, Port of Spain (urban). (1st), 13.9 months (2nd). counselling provided by study - sex with non-primary  partners decreased
General population. N = 3120 individuals & US CDC client-centered HIV-1 significantly more for those receiving VCT than
586 couples, before counselling model. 2 free those receiving health information (Men: VCT
randomization standing clinics 1 hospital 35% reduction vs.health info. 13% reduction;
based clinic. Women: VCT 39% reduction vs. health info.
17% reduction).
Roth et al ., 2001 Rwanda, Kigali (urban). Prospective cohort Men participated in extensive Condom use Increased condom use. Frequency of
Husbands & partners of women Follow-up = 1 year male-focused counselling Frequency of intercourse unprotected sex decreased except for
in a longer term study recruited N = 684 couples programme, based on the (with and without condoms) concordant negative couples. Greatest
into a testing & counselling AIDS risk reduction model. increases in condom use among discordant 
programme. All women had previously couples in which the man had not tested
received standard testing & previously. Large increases in proportion
generic counselling. of couples using condoms regularly (>90%)
Wiktor et al ., 2004 Cóte d'Ivoire, Abidjan (urban). Prospective cohort Testing & counselling provided Consistent condom use; Consistent condom use with a partner who is
Out-patients from TB treatment Follow-up = 4 months by TB treatment centre and Contact with a sex worker; is not a sex worker increased from 9.9% to
centres. (2 months after post-test conducted by medical staff who Contact with a partner who 23.6% among men, and did not change among
counselling) had received training. is not a sex worker women (9.9% to 9.5%). 
N = 457
(approx 50% collected result)
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Farquhar et al ., 2004 Kenya, Nairobi (urban) Prospective cohort Testing & counselling provided Condom use Couple counselling associated with increased
Women attending antenatal care Follow-up = 2 weeks by the study at Nairobi City condom use, but not among those testing   
N = 2104 women; Council clinic. negative.  Women testing negative and 
308 (15%) had partner come counselled with their partner were significantly
for VCT less likely to use a condom post-testing, than
those counselled individually.
Matovu et al. , 2005 Uganda, Rakai (rural). Prospective cohort Testing & counselling provided Condom use in past 6 No impact. No significant difference in risk
General population. Follow-up = 1 year by the study. Trained Rakai  months; number of sexual between those receiving or declining VCT, and 
N = 10618 Program community counsellors partners in past 6 months no significant change in risk between baseline
VCT: 5788, No VCT: 4830 provided VCT in participants & follow-up, among those receiving or refusing
homes or local health units. VCT.
Matambo et al. , 2006 Zimbabwe, Harare (urban). Nested study within a cluster Testing & counselling provided Unprotected sex with No impact. Unprotected sex reported by 82%
Employees recruited from 11 randomised trial. by the study - occupational primary and non-primary before VCT and 83% after VCT, most reported
businesses. Follow-up = 3 months health nurses provided VCT partners a primary partner only. 
N = 388 negative individuals at the workplace.
(87% male)
Mola et al ., 2006 Mozambique, Beira & Chimoio Prospective cohort Provided by VCT centre Sex with friend/prostitute Increased condom use. Condom use at last
(urban). Follow-up at 4 & 6 months in last month; condom use: sex increased from 30% to 71% among those
General population N = 1220 always or sometimes; who received VCT, & from 29% to 47% among
Participants recruited from VCT VCT: 622, No VCT: 598 condom use at last sex those who did not receive VCT. 
centres. 
Sherr et al. , 2007 Zimbabwe, Manicaland (rural). Prospective cohort Testing & counselling provided Visited bar/beer hall; Individuals testing positive reported fewer
General population. Follow-up = 3 years by the study (mobile clinic) New partner in last year; sexual partners in the year prior to follow-up.
N = 5775 and other providers (NGO's). Sexual partner in past month; Infected women reported increased levels of
At follow-up, 12% of men and Multiple concurrent partners; consistent condom use in their regular
10% of women had ever Total partners in last year; partnerships. Those testing negative and
collected an HIV test result. Consistent condom use in receiving counselling were more likely to 
last two weeks with regular increase risk in terms of beer hall attendance,
and non-regular partners new partners in the last year, and concurrent
partnerships. Those testing negative & did not
receive counselling were more likely to become
more risky in terms of partners in the last
month and last year. 
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Matovu et al. , 2007 Uganda, Rakai (rural). Prospective cohort Testing & counselling provided HIV incidence; No impact on behaviour or incidence.
General population. Mean follow-up = 1.9 years by the study. Trained Rakai Consistent condom use; No difference in HIV incidence between repeat
N=6,377 initially negative: Program community counsellors Number of partners in the testers, first time acceptors and non-acceptors
● 2294 non-acceptors provided VCT in participants last 6 months; No difference in condom use. A higher 
● 2539 1st time acceptors homes. Current non-regular proportion of repeat testers reported 2+
● 1544 repeat VCT acceptors partnership partners, compared to first time acceptors  
and non-acceptors.
Arthur et al, . 2007 Kenya, (1 urban & 2 rural sites). Prospective cohort Government health centres Number & type of partners; Proportion of individuals reporting multiple 
Government health centres Mean follow-up = 7.5 months Unprotected intercourse sexual partners reduced significantly from 
N = 540 16% to 6%
Turner et al ., 2009 Uganda and Zimbabwe (urban). Prospective cohort Testing & counselling provided Number of unprotected sex The proportion of infected women reporting
Women using hormonal Follow-up = every 3 months by the study. acts in a typical month any unprotected sex declined from 74% to 56%.
contraception. for up to 2 years Infected women reduced their number  of 
N = 808, in short-term (2 - 6 unprotected acts, however, only a slight change  
month follow-up) analysis. in the proportion  of acts which were unprotected
N = 801, in long-term (12 - 16 was observed. Little behavioural change was  
month follow-up) analysis. observed among uninfected women.
Cremin et al ., 2009 Zimbabwe, Manicaland (rural). Prospective cohort Testing & counselling provided Visited bar/beer hall; Women who received VCT reduced their 
General population. Mean follow-up = 4.2 years by the study (mobile clinic) New partner in last year; number of new partners in the last year, more
N = 17874 and other providers (NGO's). Sexual partner in past month; than those who did not test. Greater reductions
Multiple concurrent partners; were observed among those who were infected,
Consistent condom use in and this reduction was enhanced with time 
last two weeks with regular since testing. No significant risk reduction was
and non-regular partners observed among men, regardless of serostatus.  
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Sero-discordant couples:
Kamenga et al ., 1991 Zaire, Kinshasa (urban).  Prospective cohort Initial interview & testing at Abstinence; condom use Increased condom use. The proportion
Married discordant couples. Follow up = 18 months workplace medical centre. (pre test: % of couples using condoms increased from <5% (ever 
(6 month minimum) Counselling: monthly at a ever having used a condom used a condom) to 70.7% (using a condom 
N = 149 couples specially established centre. post test: % of couples using in all sex acts) one month later. After 18
a condom in all acts) months follow-up, 77.4% of couples  
reported condom use in all sex acts. 
Increased abstinence. 
Allen et al ., 1992 Rwanda, Kigali (urban).  Prospective cohort Testing & counselling provided Condom use: Increased condom use. The proportion
Cohabiting discordant couples. Mean follow-up = 2.2 years by the study. Educational  (% of couples reporting using condoms increased from 4% to 57%
N = 53 couples videos & group discussions. using condoms always after a 1 year follow-up. Decreased 
sometimes and never) seroconversion rates among women whose
partners were tested. 
Allen et al. , 2003 Zambia, Lusaka (urban). Prospective cohort Testing & counselling provided Condom use: Increased condom use. The proportion 
Cohabiting discordant couples. Mean follow-up = 14 months by VCT centre. Same-day (pre test: % of couples using condoms increased from <3% (ever 
N = 963 couples couples services (free syphilis reporting current condom use used a condom) to >80% (using a condom 
treatment) post test: proportion of acts in all sex acts) in the year following testing &
in which a condom is used) counselling.
 
 
Table 3.2 Overview of studies evaluating the impact of VCT on sexual behaviour in sub-Saharan Africa, by year of publication 
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3.5 Discussion 
Evaluating the evidence for the impact of HIV counselling and testing on sexual 
behaviour as a whole is difficult because studies vary with respect to: (i) design, (ii) 
behavioural outcome measures, (iii) statistical analyses and comparison groups, (iv) 
length and frequency of follow-up, (v) participant characteristics, (vi) sampling strategies, 
(vii) service provision (including the nature and quality of counselling provided) and 
(viii) setting. The majority of studies which assess the impact of VCT are observational in 
design and their findings are limited by various confounding factors. However, despite 
methodological limitations and heterogeneities, it is clear that counselling and testing can 
and sometimes does motivate behavioural risk reduction. Overall, the greatest changes in 
behaviour have been observed among those in sero-discordant partnerships in particular 
and among individuals testing positive.  
 
In statistical analyses, VCT has to be considered as a single event at a single point in 
time, potentially giving the impression that something that happens during counselling 
and testing may “cause” behaviour change. In reality however, deciding to test, going for 
testing and what happens before and after testing with respect to motivation for behaviour 
change may be more of a process, rather than a single “trigger” for behaviour change. 
Prochaska’s stages of change model is a useful framework for capturing this process 
[176]. Prochaska’s framework has two applications with respect to counselling and 
testing: (i) uptake – an individual may go through the stages of change process when 
considering to test, with the final stage being actually going for testing; and (ii) impact on 
behaviour – going for counselling and testing may bring about progression through 
successive stages of change i.e. increase an individual’s “readiness” to adopt safe 
behaviour. Individuals may be at different stages of change (in terms of risk reduction) 
when they receive counselling and testing. For example, an individual may be at the 
preparation stage, in which case counselling and testing may move them to the action 
stage i.e. actually reducing risk. If an individual has not previously considered 
behavioural risk reduction, prevention counselling will move them from the pre-
contemplation stage to the contemplation stage (i.e. considering their risk and considering 
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reducing their risk). Thus, risk reduction may be facilitated, but not immediately realised, 
through counselling and testing [185].   
 
The role of counselling and testing in changing sexual risk behaviour is not 
straightforward as there are many psychological and behavioural factors to consider (e.g. 
the individuals level of risk, their willingness to change their behaviour if they are at risk, 
and their control over their risk (e.g. coerced sex)). In terms of psychological factors, 
whether a HIV test confirms an individual’s pre-conceptions of their status may be an 
important influence on their subsequent behaviour (i.e. those who think they are negative, 
testing positive and those who think they are positive testing negative). For example, an 
individual who thinks they are negative and tests positive may have a different reaction, 
both emotionally and behaviourally, to an individual who thinks they are positive and the 
test confirms their own perception of their serostatus. Boozer and Philipson argue that 
those who are most surprised by their results (i.e. individuals who think they are “low-
risk” who test positive and individuals who think they are “high risk” who test negative) 
are most likely to respond to counselling and testing [223]. In terms of behavioural 
factors, while counselling and testing may increase motivation for behavioural risk 
reduction, a conscious decision to adopt safer sexual behaviour may be difficult to put 
into practice, as it depends on circumstances such as a partner’s willingness to also adopt 
safer behaviours (e.g. consistent condom use). This highlights the advantages of couple 
counselling and testing, whereby a couple receive their test results and prevention 
counselling together [172].   
 
An important feature by which studies vary is the participant’s volition for counselling 
and testing. Participants may have independently sought testing themselves, accepted 
testing when offered as part of the study, or have been assigned to receive testing as part 
of the study, following consent. In the meta-analysis by Weinhardt et. al., it was found 
that behaviour change, with respect to unprotected intercourse, was greater among those 
who actively sought VCT compared to those who were approached by researchers and 
invited to participate in a study and receive counselling and testing [200]. However, no 
difference between these two groups was found with respect to number of sexual 
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partners. The current move towards provider-initiated testing is likely to influence the 
interplay between volition for testing and any subsequent behavioural impact [29]. The 
impact of testing on subsequent behaviour in the context of provider-initiated testing has 
not yet been evaluated.  
 
The epidemiological context (the state and trends in behavioural and biological factors 
that determine transmission dynamics) may influence the results of studies examining the 
efficacy of VCT in reducing risk behaviour [58, 224]. In terms of epidemic stage, as an 
epidemic progresses awareness of HIV increases, concomitant with the level of 
morbidity, mortality and personal experience of HIV/AIDS. These changes may 
influence: sexual behaviour (independently of having tested and received counselling); 
uptake of testing; and also the impact of testing on sexual behaviour, through the 
mechanism of influencing personal risk perception.  
 
In addition to the epidemiological context, the social context of testing may influence the 
impact of testing on sexual behaviour. For example, an increasing proportion of 
individuals in a community going for testing and disclosing their serostatus may lead to 
increased communication and discussions regarding HIV prevention and risk reduction, 
and greater acceptance and support for those who are infected, “diffusing” through the 
community [185], thus indirectly facilitating behaviour change, through the mechanism 
of increased awareness and social support. It has previously  been argued that where only 
a minority of a community know their serostatus individual behaviour change may be 
difficult [125]. In addition, aspects of cultural context such as norms regarding female 
sexual autonomy may influence the behavioural impact of VCT, whereby intended 
behaviour change, such as condom use, may be difficult or unattainable (as discussed in 
chapter 2). This emphasises the importance of couple counselling, as risk reduction can 
be discussed together with the counsellor [172].        
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Despite the large array of observational studies, all are based in urban settings, with the 
exception of two large population-based cohort studies in Rakai, Uganda, and in 
Manicaland, Zimbabwe [112, 125, 134, 225]. Furthermore, the majority of these studies 
took place before the introduction of rapid tests and increased access to treatment, factors 
which are likely to influence the uptake of VCT and the efficacy of VCT for behavioural 
risk reduction. In addition, much of the evidence regarding the efficacy of VCT is 
obtained from studies specifically set up to determine its impact and little is known about 
the efficacy of VCT outside trials of its impact, with the exception of the Rakai and 
Manicaland cohorts.   
 
A population is highly heterogeneous with respect to risk behaviour as well as 
willingness, intention and volition to change behaviour [226]. Sexual behaviour changes 
over time regardless of receiving counselling and testing, as patterns of sexual behaviour 
and behaviour change can be influenced by many factors, which include relationship 
status, motivation for change, risk perception, attitudes towards risk behaviour and 
factors at a partnership level such as fertility intentions, communication and sexual 
decision making [227, 228]. Furthermore, although there is much attention on the 
potential for knowing one’s HIV status and receiving counselling to encourage risk 
reduction, not everyone who goes for HIV counselling and testing will be at risk of 
infection or will be engaging in “risky” behaviour. All of these studies rely on self-
reported behavioural data which may be subject to social desirability bias. In VCT 
evaluation studies, such bias may be greater among individuals testing positive, as they 
may feel under pressure to report less risk subsequent to intensive risk reduction 
counselling.  
 
Approaches to counselling are often poorly described. The provision (for example 
individual, couple or group) and quality of counselling undoubtedly varies widely. Such 
variation is likely to influence the efficacy of counselling. Variations in the content, 
quality and number of sessions of counselling make comparing studies difficult. For 
example a counselling session in a busy STI clinic may be brief and didactic, whereas,  
the counselling described in the studies among sero-discordant couples would have been 
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more in-depth and repeated regularly. Furthermore, prior to HIV, formal counselling 
services were rare and hence, unfamiliar to many people in sub-Saharan Africa [58].  
 
De Zoysa et. al. note that although the HIV/AIDS behavioural literature is voluminous,  
rigorous evaluations of behavioural interventions are limited [185]. Although this 
observation was referring to research up to 1995, to some extent this still applies to the 
literature regarding HIV counselling and testing. An important methodological limitation 
with some previous analyses is comparing cross-sectional behavioural data for those who 
have received VCT to those who have not, or comparing cross-sectional data from first 
time attendees to repeat clients [214, 229], and concluding that any differences are due to 
having received VCT, without measuring how behaviour has changed over time. Such 
comparisons evaluate differences between different groups but do not evaluate if risk has 
increased, decreased or remained the same over time. To correctly establish a change in 
behaviour which can be associated with receiving VCT, pre-test data must be compared 
to post-test data, at the individual level.   
 
Many longitudinal studies only consider behaviour among those who have received 
counselling and testing. Thus, trends in behaviour among those who didn’t test cannot be 
compared to trends among those who did. If there are secular declines in risk behaviour, 
such as those observed in Uganda and Zimbabwe [106, 230], these will be ignored, 
potentially overstating the impact of VCT on sexual behaviour. In a critique of VCT 
evaluation studies, Glick argues that changes in behaviour may reflect general changes 
over time rather than the intervention (counselling and testing), especially when 
awareness and knowledge of the epidemic is increasing [231].  Prospective cohort studies 
and RCTs in which behaviour is recorded prior to receiving VCT and at some interval 
following VCT among participants followed over time are ideal, because comparisons 
can be made between those who received VCT and those who didn’t as well as before 
and after VCT for those who did test.  
 
Many of the analyses regarding the impact of counselling and testing on sexual behaviour 
are descriptive in nature and present the results as dichotomous proportions. Also, many 
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comparisons do not capture the magnitude of behaviour change. There may be large 
increases in risk among some individuals which are masked by slight reductions in risk 
among a greater number of people. For example, Ladner et al. report that before 
counselling and testing, 14% of women reported using condoms at least once, whereas 4 
months after testing, 8.8% of positive women and 3.9% of negative women reported 
using condoms, among a sample of pregnant women in Kigali, Rwanda [232]. While this 
gives the impression that condom use may have increased, it is not clear what the actual 
change is, as different measures relating to different time periods are being compared for 
different groups. However, assessing behavioural change was not the objective of this 
study.  
 
Further study weaknesses include short follow-up times, low participation rates and high 
rates of loss to follow-up. Denison et. al. assess the quality of the studies included in their 
meta-analysis using an eight point score [69]. This score was additive, with one point 
given for each of eight study quality criteria. Of the seven studies included the average 
score was low, at 2.4/8, excluding the RCT by the VCT Efficacy study group, which 
scored 6/8. The Rakai cohort in Uganda was the only cohort to fulfil the criteria of 
comparison of groups equivalent at baseline on the outcome measure. Lack of rigorous 
behavioural research, in these studies up to 2005, is cited as the one of the main 
limitations of this literature.   
 
While this review has focused on the impact of VCT on sexual behaviour, the subsequent 
impact, if any, on incidence is of importance for both prevention and treatment of HIV. 
To establish if counselling and testing is an effective prevention measure, rather than just 
a gateway for treatment provision, the impact on incidence must be measured. Moreover, 
for treatment programmes to be sustainable, reductions in incidence are required [233, 
234].   
 
A recent cluster-randomized trial of workplace VCT, of predominantly male participants, 
in urban Zimbabwe, found no reduction in HIV incidence after a two year intervention 
[235]. In addition, findings from two rural population-based cohorts (namely Rakai in 
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Uganda and Manicaland in Zimbabwe) indicate no difference in HIV incidence between 
those who received VCT and those who did not [125, 134]. However, the 
epidemiological context is important and an intervention, such as provision of VCT, may 
have a large impact on behaviour but may have little impact on HIV incidence if 
inappropriately targeted or implemented late in the epidemic [224, 236]. Notably, early 
work by Allen et. al., among a sample of 1458 women in Kigali, Rwanda, found a much 
greater reduction in incidence among those women whose partners received counselling 
and testing (from 4.1 to 1.8 per 100 person-years; P<0.04), than among women whose 
partners had not received counselling and testing (from 4.1 to 3.4 per 100 person years, 
P=0.06) [207]. Thus, future work should investigate if couple counselling is an effective 
means of reducing incidence.  
 
Insights regarding how the impact of VCT on behaviour at an individual level 
subsequently impacts the spread of HIV at a population level have been gained from 
mathematical modelling.  Hallett et. al. show that the impact of counselling and testing 
services, in terms of infections averted, depends on the magnitude, type and duration of 
behaviour change [237]. In particular, the maintenance of behaviour change was found to 
be of key importance for the prevention potential of counselling and testing services. For 
example, a 20-30% increase in condom use that is maintained permanently was found to 
be equivalent to a three-fold increase in condom use which is maintained only for a 
period of 1 year [237].  
 
Many of the studies included in this review are limited by short follow-up periods (1 to 2 
years) and so the impact of counselling and testing on sexual behaviour over the long 
term is not well understood. The question of duration of behaviour change is addressed in 
Chapter 6, where three rounds of data from the Manicaland cohort in Zimbabwe are 
analysed to determine the impact of testing on subsequent sexual behaviour.  
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Chapter 4: Patterns of uptake of HIV testing in Sub-Saharan 
Africa: 2003-2005. A cross-country comparison of 
Demographic and Health Survey data. 
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4.1 Aims and organisation of chapter 
The aim of this chapter is to compare nationally representative trends in self-reported 
uptake of HIV testing and receipt of results in selected countries and to characterise the 
profile of individuals who report to have tested for HIV with respect to socio-
demographic characteristics and behavioural risk as well as expression of stigma and 
experience of AIDS. The survey methodology and data analysis are described in Section 
4.3. Next, an overview of levels of uptake of HIV testing is given, followed by the results 
of univariate and multivariate analyses of characteristics associated with having tested for 
HIV. Finally, the main findings are discussed in Section 4.5.   
 
4.2 Background 
Prior to provider-initiated opt-out testing, individuals going for HIV testing were 
generally a small self-selecting group of the wider population who chose to access testing 
services. It is important to monitor trends in testing uptake for a number of reasons. 
Firstly, it is useful to look at the patterns of uptake of testing with respect to socio-
demographic characteristics, as this has implications for equitable access to treatment [62, 
126]. Secondly, in terms of prevention, analysing testing patterns with respect to 
behavioural indicators can help identify if those individuals most at risk of acquiring or 
transmitting infection are seeking testing. Finally, understanding the factors affecting the 
use of testing services is essential for the success of testing programmes in achieving high 
levels of coverage. The profile of those coming forward for testing has not previously 
been described at a nationally representative level in an African context. However, Gage 
and Ali analysed Ugandan DHS survey data to determine the factors associated with 
having tested among married men [238].   
 
4.3 Methods 
 
4.3.1 Survey methodology 
DHS programme has been conducting household surveys since 1984 in developing 
countries. A wide range of demographic and reproductive health data are collected [239]. 
The samples are representative at the national level, at the residence level (urban or rural) 
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and at the regional level [240]. Given the focus of the survey on fertility, women of 
reproductive age (15-49 years) were the initial participants of DHS surveys, but men aged 
15-59 years are also now included. Since 2001, survey questionnaires have included 
sections on HIV testing. Standard questionnaires are used, as far as possible, to allow 
cross-country comparisons to be made. Separate questionnaires are used for women and 
men.  
 
A two-stage cluster design is used to obtain the samples [240]. Firstly, random sample 
clusters, called enumeration areas, are selected from a national sampling frame, usually 
the country’s population census. Secondly, a complete list of households is compiled for 
each of these clusters, and households are chosen at random for participation in the 
survey. A household questionnaire is used to identify women and men eligible for the 
individual interview. All women aged 15-49 years and men aged 15-59 years who were 
either permanent residents or visitors present the on the night before the survey in 
selected households are eligible to be interviewed. However, in some surveys a sub-
sample of households is chosen (e.g. every second household), from which men are 
selected to participate. An individual is considered absent after three call-back visits. 
Surveys are usually conducted over a period of 18-20 months (from survey design to 
dissemination of the final report), and fieldwork usually takes four to five months to 
complete.   
 
Consenting participants provide blood for anonymous HIV testing, subsequent to the 
interview. Testing is carried out using dried blood spot samples of capillary blood from a 
finger prick collected on filter paper. A standard testing algorithm which uses two 
different HIV antibody ELISAs, based on different antigens is used.  
  
All participants receive referrals for free counselling, testing, and educational materials, 
whether or not they consent to anonymous testing. In some countries, mobile counselling 
and testing provided by the DHS programme, is made available after the interview, when 
the anonymous test has been completed. 
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4.3.2 Data analysis 
Surveys from sub-Saharan Africa countries with data available on HIV status, and HIV 
testing and results collection for men and women were included in the analysis. Ten 
surveys met these criteria.  
 
To assess levels of uptake of HIV testing, participants were asked “I don’t want to know 
the results, but have you ever been tested to see if you have the AIDS virus?”. The 
question was asked in this way for each of the surveys included, with the exception of the 
Zimbabwean survey, in which “Have you ever been tested to see if you have been 
infected with HIV? was used. Responses to this question and data on receipt of test 
results were used to define an outcome variable for having tested and received the result 
(i.e. knowing one’s HIV status). Thus, the self-reported HIV testing data analysed here 
refer to a wide range of HIV testing services (e.g. from free-standing VCT centres, from 
hospital- and clinic-based services, and through PMTCT programmes), but not to the 
anonymous testing carried out through the DHS programme.  
 
In the construction of the socio-demographic variables, a wealth index was used to 
capture poverty level. This index is constructed by means of a principal component 
analysis using any indicator variable that reflects economic status (e.g. type of toilet and 
type of flooring) [241]. Quintiles are calculated based on the distribution of the household 
population.  
 
Univariate logistic regression models were fitted to analyse socio-demographic and 
behavioural characteristics, as well as expression of stigma and experience of AIDS, 
associated with the uptake of testing and collection of results. Following this, a full model 
containing all variables identified a priori as characteristics of interest, with the aid of the 
theoretical framework presented in Chapter 2, was fitted, to identify those characteristics 
which were independently associated with having received HIV counselling and testing. 
Multivariate results are presented in detail for four selected countries: Zimbabwe, 
Lesotho, Rwanda and Senegal. These four countries were chosen to compare uptake of 
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testing in different contexts with respect to HIV prevalence and uptake of HIV testing. 
Multivariate results for the remaining six countries are presented in Appendix A.   
 
All analyses were carried out separately for males and females and restricted to the non-
virgin population, as those who have never had sex have had no sexual exposure to HIV 
and, thus, are likely to have little impetus for seeking HIV counselling and testing. All 
analyses were carried out using sample weights provided by the DHS [242]. Analyses 
were carried out using STATA version 10 (STATA Corp., College Station, Texas, USA).  
 
4.4 Results 
 
4.4.1 Data overview and response rates 
Table 4.1 shows the household and individual response rates for the ten completed 
surveys, and the response rates for HIV testing.  
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Country Year Household Individual N N eligible HIV
response response interviewed for HIV response
rate (%) rate (%) testing rate (%)
Zimbabwe 2005-06 95.0
Male 81.9 7175 8761 63.4
Female 90.2 8907 9870 75.9
Senegal 2005 98.5
Male 86.0 3761 4375 75.5
Female 93.7 14602 5350 84.5
Rwanda 2005 99.7
Male 97.2 4820 4959 95.6
Female 98.1 11321 5837 97.3
Guinea 2005 99.2
Male 94.5 3174 3360 88.2
Female 97.2 7954 4189 92.5
Cote D'Ivoire 2005 95.5
Male 87.5 4503 5148 76.3
Female 89.8 5183 5772 79.1
Malawi 2004 97.8
Male 85.9 3261 3797 63.3
Female 95.7 11698 4071 70.4
Lesotho 2004 95.2
Male 84.6 2797 3305 68.0
Female 94.3 7095 3758 80.7
Cameroon 2004 97.6
Male 93.0 5280 5676 89.8
Female 94.3 10656 5703 92.1
Kenya 2003 96.3
Male 85.5 3578 4183 70.3
Female 94.0 8195 4303 76.3
Ghana 2003 98.7
Male 93.8 5015 5345 80.0
Female 95.7 5691 5949 89.3  
 
Table 4.1 Response rates, participation and HIV testing in selected DHS surveys.  
Footnote: All data are unweighted, and are compiled from DHS country-specific data and final reports. In 
Rwanda, Guinea, Cameroon and Kenya  all men in 50% of households were sampled. In Senegal and 
Malawi all men in 25% of households were sampled.   
 
 
Overall, household response rates are high and range from 95.0% to 99.7%. The 
individual response rate in each survey is higher among women than among men, and 
ranges from 81.9% among men in Zimbabwe to 98.1% among women in Rwanda. The 
largest gender differential in participation is observed in Malawi. HIV testing response 
rates were lower than participation rates and ranged from 63.3% among men in Malawi to 
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97.3% among women in Rwanda. In each survey the HIV testing response rate was lower 
for men than for women.  
 
4.4.2 Testing and counselling service provision 
The level of provision of HIV testing services in 2007 and 2008 are shown in table 4.2.  
2007 2008 % increase 2007 2008 % decrease
Zimbabwe 791 1560 97.22 8000 4000 50.00
Senegal 190 281 47.89 31000 21000 32.26
Rwanda 312 341 9.29 15000 14000 6.67
Guinea - - - - - -
Côte D'Ivoire 124 457 268.55 79000 21000 73.42
Malawi 504 677 34.33 13000 10000 23.08
Lesotho 163 204 25.15 6000 5000 16.67
Cameroon 1107 1860 68.02 8000 5000 37.50
Kenya - - - - - -
Ghana 422 524 24.17 28000 22000 21.43
testing and counselling facility
Population ≥ 15 years per Number of facilities with HIV 
testing and counselling
 
Table 4.2 Number of health facilities with HIV testing and counselling services and 
number of adult population per testing and counselling facility, by country, 2007 and 
2008. Adapted from: Towards Universal Access. Scaling up priority HIV/AIDS 
interventions in the health sector. Progress report 2009 [17]. Data for Guinea and Kenya 
were not available.      
 
Unsurprisingly, given different population sizes and health service infrastructure, the 
number of testing and counselling facilities varied widely by country. However, adult 
population size per facility also varied widely, from 22,000 in Ghana to 4,000 in 
Zimbabwe, in 2008. The number of facilities offering testing services increased from 
2007 to 2008 in each country, particularly in Côte D’Ivoire where a dramatic scale-up in 
number of facilities was observed.  
 
4.4.3 Overview of levels of uptake of HIV testing 
Levels of reported uptake of HIV testing and collection of results varied widely between 
countries (Figure 4.1). Uptake was highest among women in Rwanda, at 27.4% in 2005. 
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The lowest levels of testing were observed in West African countries, Senegal and 
Guinea in particular. However, not all West African countries had low uptake; for 
example, Cameroon had the third highest percentage of total persons tested. Overall, 
reported receipt of results was at a high level and ranged from 75% to 96%. Gender 
differentials in uptake were observed in many countries; for example, in Zimbabwe, 
Rwanda, Côte D’Ivoire, Lesotho and Cameroon, women were more likely to have tested 
and received their results; whereas, in Guinea, uptake of testing and results collection was 
much higher among men.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1 Uptake of testing and results collection among men and women in selected 
countries. 
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A clear relationship between uptake of testing and HIV prevalence was not observed 
(Figure 4.2). For example, in 2005, HIV prevalence among women in Guinea was 1.9% 
and uptake of testing was low at 2.18%, whereas in Rwanda, although HIV prevalence 
among women was 3.6%, uptake of HIV testing was relatively high at 27.40%. This is in 
contrast to Zimbabwe, where HIV prevalence among women was 21.2% and uptake of 
HIV testing was 24.86%. The correlation coefficients for women and men were 0.36 and 
0.25, respectively, indicating a very weak positive correlation.  
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 Figure 4.2 Uptake of HIV testing with respect to HIV prevalence among women and 
men (aged 15-49 years) in selected countries. Each point on this scatter plot represents a 
national level estimate from the same DHS survey.  
 
4.4.4 Time since testing 
Trends in the reported length of time since testing among women were reasonably similar 
for most countries (figure 4.3). Overall, approximately half of women within each survey 
who had tested reported to have done so within the last year, with the exception of three 
west African countries: Ghana, Côte D’Ivoire and Senegal. In all surveys, the majority of 
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women reported to have tested within the last two years (i.e. <12 months ago or 12-23 
months ago), reflecting the recent scale-up of testing services in these countries. However, 
a considerable proportion reported to have tested two or more years ago, ranging from 
21.5% in Lesotho to 45.8% in Ghana. 
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<12 months 12-23 months >2 years
Figure 4.3 Reported length of time since testing among women reporting VCT uptake in 
selected countries.  
 
Overall, trends in reported time since testing among men were similar to those among 
women (Figure 4.4). Within each country trends were also similar for men and women. 
As for women, approximately half of men within each survey who had tested reported to 
have done so within the last year, again with the exception of Ghana, Côte D’Ivoire and 
Senegal, as well as Zimbabwe. The proportion of men reporting to have tested two or 
more years ago ranged from 25.6% in Rwanda to 47.6% in Côte D’Ivoire. 
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 Figure 4.4 Reported length of time since testing among men reporting VCT uptake in 
selected countries.  
 
In addition, within each survey, the majority of participants who reported not to have 
tested responded that they would like to be tested, indicating a considerable demand for 
HIV testing services.  
 
4.4.5 Univariate analysis of characteristics associated with having tested for HIV 
Overall, HIV positive individuals are more likely to have tested and received their results 
than uninfected individuals, with the exception of women in Senegal and men in Guinea 
(Figure 4.5). However, this association is only statistically significant among men and 
women in Rwanda, Lesotho and Cameroon, men in Senegal, Côte D’Ivoire and Kenya,  
and women in Guinea. In countries with relatively low levels of HIV prevalence and low 
levels of testing, such as those in west Africa, (i.e., Senegal, Guinea and Côte D’Ivoire), 
there is considerable uncertainty around these odds ratios.  
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Figure 4.5 Odds ratios for having tested with respect to HIV status, for men and women. 
HIV uninfected individuals are used as the reference category.  
 
Among women, age was significantly negatively associated with uptake of testing in all 
surveys, except in Senegal, where uptake was lowest amongst 15 to 24 year olds (Figure 
4.6).  
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Figure 4.6 Odds ratios for having tested and received results by ten year age group, 
among women. 
 
Among men, age was also significantly associated with uptake of testing, except in 
Guinea. The general trend was an increase in uptake from 15-24 up to 25-34, a 
subsequent plateau or slight decrease, followed by a decline in the oldest age group 
(Figure 4.7).  This trend was most apparent in Lesotho. In general, men seeking testing 
were older than women seeking testing, across these ten countries.  
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Figure 4.7 Odds ratios for having tested and received results by ten year age group, 
among men. 
 
The majority of participants lived in rural areas, where uptake was significantly lower 
relative to those living in urban areas, in all surveys. Among women, the odds ratios for 
uptake by residence (urban vs. rural) ranged from 1.7 in Lesotho to 7.9 in Guinea (Figure 
4.8). Similar trends were observed among men, where uptake in urban areas was between 
1.9 and 4.3 times greater than in rural areas, in all countries. The greatest differential with 
respect to urban or rural residence was observed in Guinea, among both men and women. 
Uptake was greatest in urban Rwanda at 58.6% and 41.9% among women and men, 
respectively. In addition to large differentials with regard to place of residence, strong 
regional differences within countries were also observed (i.e. much heterogeneity within 
rural areas). For example, large differentials in uptake between rural areas were observed 
in Kenya with 0.57% of respondents in the North Eastern region reporting to have tested 
and received their results as compared to 12.45% of those in the Rift Valley region.  
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Figure 4.8 Odds ratios for having tested and received results by place of residence, for 
women and men. Rural is used as the reference category. 
 
Among women, a strong significant positive association between wealth quintile and 
uptake of testing was observed (Figure 4.9). Those women in the richest quintile were 
more likely to have tested than those in the poorest quintile (OR range 2.8 – 33.7). 
However, these differentials were largest in the West African countries which had 
relatively low testing uptake compared to other sub-Saharan African countries.   
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Figure 4.9 Odds ratios for having tested and received results by wealth quintile, for 
women 
 
A similar trend was observed for men with respect to wealth index. Although statistically 
significant, the differentials in uptake were not as great as those for women. Uptake was 
between 3 and 7 times greater among those in the richest quintile as compared to the 
poorest (Figure 4.10).   
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Figure 4.10 Odds ratios for having tested and received results by wealth quintile, for men 
 
Across all countries large differentials in uptake with respect to level of education were 
observed among both men and women, with uptake being greatest among those with 
higher level education. Overall, with respect to socio-demographic characteristics, the 
trends observed were remarkably similar across all countries analysed, for both men and 
women.  
 
Reported uptake of testing and results collection was varied with respect to various 
indicators of sexual behaviour. However, it was not possible to establish the temporal 
relationship between the reported behaviour and receiving an HIV test. Those who 
reported that they did not know someone who has AIDS, or someone who has died of 
AIDS, were much less likely to report having tested. This trend was consistent across all 
countries. Uptake of testing and results collection was significantly lower among those 
expressing stigmatising attitudes towards HIV. This was true across all countries for both 
men and women.  
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4.4.6 Multivariate analysis  of characteristics associated with having tested for HIV 
Table 4.3 shows the adjusted odds ratios for the determinants of uptake of testing and 
results collection, for women and men in four selected countries. Although univariate 
analyses found a positive HIV status to be significantly associated with having tested 
among men and women in Lesotho and Rwanda (Figure 4.5), adjusted analyses showed 
that being infected was only independently associated with having tested among men and 
women in Lesotho. 
 
Univariate analyses also indicated age to be a significant determinant of uptake of testing 
among men and women in each of these four countries. However, this association was no 
longer significant in multivariate analyses, among women in Lesotho and Senegal and 
men in Zimbabwe. In general, trends in uptake with respect to age differed for men and 
women, with uptake being greatest among younger women, but lowest among younger 
men, except for men in Rwanda. However, divergent trends were observed among men, 
as the OR for uptake among the oldest age group (45 years and older) as compared to the 
youngest (15-24 years) ranged from 0.20 for men in Rwanda to 19.53 for men in Senegal.  
 
Increased odds of testing and results collection were consistently observed with 
increasing level of education for both men and women, in all four countries. Although 
reporting a third level of education was infrequent, it was strongly associated with 
increased HIV testing and results collection (OR range: 1.49 – 50.62).  Living in an urban 
area was also associated with increased uptake in all four populations, but only remained 
significant in adjusted analyses for Rwanda. Similarly, an increasing level of wealth was 
strongly associated with increased uptake, but this association only remained a significant 
determinant of uptake in adjusted analyses among men and women in Zimbabwe and in 
Rwanda.  
 
Generally, there was mixed evidence with respect to marital status and behavioural 
indicators and testing uptake. There was no evidence to suggest that infrequently 
reported, but high-risk behaviours, such as paying for sex among men, were 
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independently associated with uptake of testing. Reporting to have had an STI in the last 
year was generally associated, but not significantly, with increased uptake. 
 
An awareness of the existence of treatment was independently associated with increased 
uptake among men and women in all four countries, with the exception of men in 
Senegal. Those who agreed with stigmatising attitudes, such as people with AIDS should 
be ashamed, were less likely to have tested, with the exception of women in Zimbabwe. 
However, this association only remained significant among women in Rwanda.  Knowing 
someone who has, or has died from, AIDS was associated with increased uptake among 
men and women in all four countries, with the exception of men in Lesotho.  
 
Overall, univariate analyses showed remarkably similar trends across countries and many 
of these associations persisted at the multivariate level. However, the determinants of 
uptake independently associated with testing and results collection differed greatly across 
countries. Level of education and awareness that treatment for HIV exists were 
consistently independently associated with HIV testing across countries, for both men 
and women. 
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Zimbabwe Lesotho
Determinants Women Men Women Men
AOR (95% CI) AOR (95% CI) AOR (95% CI) AOR (95% CI)
HIV status:  positive vs negative               1.10  (0.86 - 1.40) 1.10  (0.83 - 1.47) 1.50  (1.06 - 2.12) 1.85  (1.19 - 2.87)
Demographic characteristics:
Age group:       15-24 1 1 1 1
                       25-34 0.72  (0.59 - 0.87) 1.52  (1.00 - 2.30) ‡ 1.11  (0.71 - 1.71) 4.27  (1.94 - 9.39)
                       35-44 0.52  (0.39 - 0.69) 1.37  (0.83 - 2.26) 0.95  (0.60 - 1.49) 4.27  (1.72 - 10.60)
                       45+ 0.30  (0.18 - 0.50) 1.42  (0.81 - 2.49) 0.82  (0.43 - 1.57) 3.52  (1.33 - 9.30)
Education:       none  0.88  (0.45 - 1.70) 1.63  (0.37 - 7.07) 0.47  (0.14 - 1.57) 0.66  (0.36 - 1.21)
                       primary 1 1 1 1
                       secondary 1.61  (1.28 - 2.04) 1.76  (1.24 - 2.50) 0.99  (0.70 - 1.41) 1.80  (1.10 - 2.95)
                       higher 4.13  (2.37 - 7.21) 3.16  (1.82 - 5.50) 1.49  (0.50 - 4.38) 2.50  (0.62 - 10.12)
Marital status:  married 1 1 1 1
                       never married 0.70  (0.36 - 1.36) 0.73  (0.38 - 1.41) 0.84  (0.44 - 1.61) 0.91  (0.42 - 2.01)
                       previously married 0.96  (0.51 - 1.80) 0.22  (0.07 - 0.65) 1.20  (0.64 - 2.27) 1.58  (0.42 - 5.91)
Residence:       urban vs rural    1.19  (0.75 - 1.87) 1.14  (0.75 - 1.73) 1.48  (0.99 - 2.20) ‡ 1.22  (0.70 - 2.14)
Poverty:          richest quintile vs poorest  2.24  (1.29 - 3.90) 2.63  (1.35 - 5.13) 1.41  (0.75 - 2.65) 1.11  (0.47 - 2.63)
Sexual health & behaviour: 
Condom use at last intercourse a :     yes vs no 0.86  (0.59 - 1.26) 1.60  (1.14 - 2.25) 1.37  (0.90 - 2.08) 1.81  (1.18 - 2.78)
Extra-marital partners in last year:    yes vs no   1.00  (0.60 - 1.66) 1.16  (0.70 - 1.92) 0.80  (0.48 - 1.33) 0.54  (0.32 - 0.90)
Lifetime partners: 
                Women              Men
                    1                    1 1 1 ─ 1
                    2                    2 0.94  (0.73 - 1.22) 0.71  (0.47 - 1.05) ─ 1.23  (0.51 - 2.99)
                   >2                   3 0.96  (0.71 - 1.30) 0.64  (0.41 - 0.99) ─ 1.51  (0.64 - 3.54)
                                          4 0.48  (0.28 - 0.81) 0.78  (0.30 - 2.05)
                                        >4 0.81  (0.55 - 1.17) 1.28  (0.61 - 2.70)
Ever paid for sex (men only):       yes vs no ─ 1.02  (0.48 - 2.14) ─ ─
Had an STD in last year:             yes vs no 1.20  (0.77 - 1.87) 1.33  (0.64 - 2.77) 0.97  (0.44 - 2.16) 1.85  (0.65 - 5.28)
Treatment awareness:                yes vs no/unsure 1.84  (1.48 - 2.29) 1.22  (0.92 - 1.62) 1.64  (1.15 - 2.34) 1.64  (1.07 - 2.50)
Expression of stigma & experience of AIDS: 
People with AIDS should be ashamed:
                               agree vs disagree/don't know 1.13  (0.91 - 1.41) 0.96  (0.72 - 1.29) ─ ─
AIDS bereavement:   yes vs no    1.08  (0.87 - 1.34) 1.32  (1.05 - 1.65) 2.15  (1.59 - 2.91) 0.95  (0.57 - 1.58)
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Rwanda Senegal
Determinants Women Men Women Men
AOR (95% CI) AOR (95% CI) AOR (95% CI) AOR (95% CI)
HIV status:  positive vs negative               1.18  (0.71 - 1.94) 0.99  (0.54 - 1.82) 0.46  (0.03 - 8.26) 1.45  (0.18 - 11.66)
Demographic characteristics:
Age group:       15-24 1 1 1 1
                       25-34 0.61  (0.47 - 0.80) 0.83  (0.56 - 1.23) 0.74  (0.28 - 1.95) 17.91  (1.88 - 170.81)
                       35-44 0.33  (0.24 - 0.44) 0.35  (0.23 - 0.54) 2.33  (0.95 - 5.69) 22.76  (1.80 - 287.35)
                       45+ 0.13  (0.07 - 0.23) 0.20  (0.13 - 0.32) 1.15  (0.41 - 3.25) 19.53  (1.75 - 217.39)
Education:       none  0.81  (0.62 - 1.05) 0.77  (0.56 - 1.06) 0.91   (0.37 - 2.22) 0.89  (0.21 - 3.76)
                       primary 1 1 1 1
                       secondary 1.65  (1.15 - 2.36) 1.45  (1.03 - 2.04) 2.21    (1.12 - 4.36) 4.36  (1.13 - 16.80)
                       higher 7.73  (0.85 - 70.45) 4.47  (1.75 - 11.43) 50.62  (14.35 - 178.60) 9.40  (2.19 - 40.34)
Marital status:  married 1 1 1 1
                       never married 0.66  (0.31 - 1.40) 0.43  (0.20 - 0.95) 0.56  (0.05 - 5.78) 0.92  (0.10 - 8.25)
                       previously married 0.78  (0.30 - 2.05) 2.35  (0.72 - 7.71) 4.70  (1.95 - 11.34)
Residence:       urban vs rural    3.68  (2.68 - 5.06) 1.77  (1.28 - 2.45) 1.73  (0.71 - 4.20) 1.01  (0.35 - 2.88)
Poverty:          richest quintile vs poorest  1.61  (1.09 - 2.37) 1.93  (1.29 - 2.88) 3.24  (0.90 - 11.64) b
Sexual health & behaviour: 
Condom use at last intercourse:     yes vs no 0.92  (0.51 - 1.66) 2.00  (1.05 - 3.78) 2.04  (0.85 - 4.92) 0.58  (0.07 - 4.71)
Extra-marital partners in last year:    yes vs no   0.79  (0.42 - 1.49) 0.69  (0.40 - 1.19) 0.93  (0.50 - 1.72) 1.14  (0.34 - 3.91)
Lifetime partners: 
                Women              Men
                    1                    1 1 1 ─ ─
                    2                    2 1.06  (0.81 - 1.39) 1.46  (1.08 - 1.98) ─ ─
                   >2                   3 0.84  (0.56 - 1.26) 1.40  (0.98 - 2.00) ─ ─
                                          4 1.99  (1.32 - 3.00) ─
                                        >4 1.74  (1.16 - 2.60) ─
Ever paid for sex (men only):       yes vs no ─ 1.02  (0.65 - 1.61) ─ 3.25  (0.35 - 29.95)
Had an STD in last year:             yes vs no 1.30  (0.54 - 3.14) 1.86  (0.74 - 4.69) 0.54  (0.12 - 2.40) c
Treatment awareness:                yes vs no/unsure 2.99  (2.06 - 4.35) 1.99  (1.23 -3.21) 1.73  (0.98 - 3.06)‡ 0.97  (0.30 - 3.20)
Expression of stigma & experience of AIDS: 
People with AIDS should be ashamed:
                               agree vs disagree/don't know 0.75  (0.60 - 0.93) 0.90  (0.70 - 1.16) 0.60  (0.34 - 1.06) 0.59  (0.23 - 1.54)
AIDS bereavement:   yes vs no    1.26  (0.93 - 1.71) 1.98  (1.25 - 3.13) 4.01  (1.84 - 8.72) 1.54  (0.57 - 4.21)  
Table 4.3 Adjusted odds ratios for hypothesised determinants of uptake of HIV testing for men and women in selected countries. 
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Footnote: In Lesotho, data on "People with AIDS should be ashamed" were not available for neither men 
nor women, lifetime partners data were not available for women, and ever paid for sex was not available for 
men. In Senegal data on lifetime partners were not available for neither men nor women. Bold type 
indicates significance at the 95% level. 
 
a Condom use refers to last partner, rather than specifically last sex, for men in Lesotho 
b AOR = 2.26e+07 due to large differentials with respect to level of wealth and <2% uptake in the 
reference group (poorest quintile) 
c Variable dropped due to small sample size in comparison group (those reporting an STD in last year)   
 
AOR Adjusted odds ratio 
‡ Borderline significance 
* Indicates significant in univariate analysis (p<0.05) 
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4.5 Discussion  
These analyses provide a cross-sectional illustration of the highly varied levels of uptake 
of HIV counselling, testing, and results collection in ten African countries, each of which 
represents a very different epidemiological context in terms of HIV prevalence and 
access to testing services. Overall, knowledge of serostatus was limited during this 
period. Despite considerable variations in the percentage of individuals who had tested, 
from 2% to 27%, trends in reported time since testing were largely similar across 
countries, for men and for women, indicating that the majority of respondents who have 
tested have done so within the last two years. Furthermore, despite varying levels of 
uptake, crude analyses indicated that the socio-demographic profiles of testers (well-
educated, wealthier individuals living in urban areas) were remarkably similar across 
countries. However, for a smaller sub-set of countries, many of these associations did not 
persist as significant determinants of uptake of testing in adjusted analyses. Despite large 
differentials in uptake with respect to level of wealth and living in an urban area versus a 
rural area, multivariate analyses indicate that a secondary or higher level of education and 
an awareness that treatment exists are the key determinants of uptake of  testing, once 
other possible factors have been taken into account. However, the association between an 
awareness that treatment exists and uptake of testing may reflect the fact that individuals 
receive information regarding treatment during pre- and post-test counselling.  
 
The socio-demographic and behavioural-risk profile of individuals who test for HIV has 
implications for HIV prevention and equitable access to treatment. In terms of 
prevention, these analyses showed the behavioural profile of those coming forward for 
testing to be mixed. It is encouraging that testing is not preferentially attracting a 
“worried-well” low-risk group, but, on the other hand, evidence that some high-risk 
behaviours, such as transactional sex, are not prompting testing may be of concern. In 
terms of testing as a means of identifying those in need of treatment, an over-
representation of infected individuals is encouraging. However, in terms of equitable 
access to treatment, the emergence of those with little or no education who live in rural 
areas in the poorest households, and who are unaware of treatment, as an under-
represented group amongst those accessing testing, may also be of concern. 
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The strongest independent predictor of testing among both sexes is level of education. 
For example, when compared to those with primary education, women in Senegal who 
had a third level education had 50 times the adjusted odds of having tested. Education has 
been found to be a key determinant of the uptake of testing in many other settings. [43, 
97, 125, 126, 134, 238]. This finding indicates that there may be a need to increase the 
awareness of the benefits of counselling and testing in a way that is accessible to those 
with little or no formal education.  
 
Increased uptake of testing among those living in urban areas, as compared to rural areas, 
may be due to increased availability of services in urban areas as there is likely to be an 
urban bias in provision of testing services (i.e. initially setting up sites in urban areas and 
then gradually extending to rural areas). The finding that uptake increases substantially 
with increasing level of wealth is surprising, given that HIV counselling and testing 
services are generally either inexpensive or provided for free. However, in rural areas 
transport costs may be a barrier to accessing testing services for some individuals. 
Disagreeing with stigmatising attitudes towards people with HIV was associated with 
increased odds of testing and results collection, but not significantly so. This provides 
some evidence to suggest that AIDS-related stigma may be a barrier to testing in these 
populations.  
 
Due to the cross-sectional nature of the data, a caveat regarding uptake with respect to 
HIV status is that some individuals may have seroconverted between the time they tested 
and when the DHS survey, and anonymous testing, was carried out. However, the 
majority of individuals reported to have tested quite recently (within the last year or two 
years), which would reduce this misclassification. Moreover, non-response for 
participation in the DHS HIV testing, among men in particular, may bias these results 
with respect to HIV status. However, it has recently been shown that non-response did 
not bias HIV prevalence estimates in six selected DHS surveys, all of which are included 
in this analysis [243]. With respect to self-reported data regarding the uptake of testing, 
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one may expect social desirability bias to lead to underreporting of testing among those 
who have previously tested positive.  
 
In this analysis, it was not possible to test the hypothesis that individuals, if infected, may 
only seek testing once they are showing symptoms of advanced HIV infection and 
suspect that they may be infected. However, a population-based study in Rakai, Uganda, 
has found evidence that counselling and testing is associated with reported illness and 
potential AIDS-related symptoms among women, but not men [133]. Also, it was also not 
possible to test the hypothesis that death of one’s spouse may prompt an individual to 
seek testing. Although knowing someone who has, or has died from, AIDS was 
associated with increased uptake data on the relationship to that person was not available. 
However, this indicator may be capturing denial of AIDS, rather than experiencing 
bereavement. For example, in Lesotho, only 28% of women and 29% of men reported 
knowing someone with, or who had died from, AIDS, despite Lesotho having a high level 
of HIV prevalence.      
 
A clear relationship between uptake of testing and HIV prevalence at a national level is 
not apparent. Rwanda with an HIV prevalence of less than 5% had the highest level of 
uptake overall, whereas Lesotho, with the highest HIV prevalence had a much lower 
uptake. However, provision of testing services and demand for testing also play an 
important role in determining the level of uptake of testing [45]. For example, in Kenya, 
in 2000 there were 3 facilities which provided VCT and 1,100 individuals received VCT, 
whereas in 2005, there were 680 sites (75% of which were in health care facilities) and 
545,000 individuals received VCT [61].   
 
The finding that an awareness of treatment is a predictor of testing is not surprising. 
However, none of these surveys were carried out in the context of treatment availability, 
although the timing of some surveys, such as that in Malawi, coincided with the initiation 
of ART programmes. Lack of treatment is a key impediment to uptake of testing, as in 
the absence of treatment, knowing that one is infected may be viewed as futile [95].  
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A key determinant of uptake of testing, not included in these analyses, is availability of 
and access to testing services. Ideally, the denominator for these analyses would be those 
who have access to testing services and then analyse who chooses to test. Recent data 
indicate much heterogeneity in the level of service provision across countries, even when 
using the comparative measure of number of adults per testing and counselling facility. It 
is not possible to directly compare the level of uptake of testing and level of service 
provision for each country, as available data regarding service provision refer to 2007-
2008 and the availability of testing services has changed during the period from 2003-
2005 to 2007-2008. Furthermore, the scale-up of testing services begun at different times 
and is likely to have progressed at different speeds in each country. Also, the availability 
of rapid testing and hence receipt of results within an hour of testing may have influenced 
uptake of testing. However, data regarding time from testing to receiving test results for 
those who tested were not available. Future analyses of testing uptake should focus on 
analysing the extent to which increasing availability of (i) testing services and (ii) ART, 
influences the profile of those who test.  
 
Current levels of uptake of testing in these countries are certainly higher, as testing 
services continue to be scaled-up in the context of the shift towards provider initiated opt-
out testing and increased access to treatment. Monitoring the socio-demographic and 
behavioural characteristics of testers will provide useful information for the evaluation of 
these programmes. This work provides a baseline for monitoring trends in testing and 
exploring changes in the profile of those who get tested as provision of services increase.  
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Chapter 5: Trends in self-reported sexual risk behaviour in 
Manicaland, Zimbabwe 
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5.1 Aims and organisation of chapter 
The aims of this chapter are to describe trends in behaviour in the Manicaland cohort and 
to assess data quality of age at event reporting. This chapter begins with a brief 
discussion of measurement of sexual behaviour. The socio-demographic context and 
epidemiologic context of the study population are described. This is followed by an 
overview of previous analyses of behavioural data for this population. In Section 5.3 the 
Manicaland Cohort Study is described in terms of study design and methodology, 
followed by the data analysis procedure. The results are then presented in two sections. 
Firstly, data on age at first sex and age at marriage are analysed. The level of inconsistent 
reporting is quantified and its effect on observed trends is assessed. Reporting biases are 
identified and the temporal trends in age at first sex and age at marriage are described. 
The length of time spent single, between first sex and marriage is also described. 
Secondly, behavioural data for those who have started sex are analysed. In terms of 
number of sexual partners, indicators referring to different time periods are described in 
increasing resolution, from partners in the last year, to partners in the last month, to the 
number of current sexual relationships. Levels of consistent condom use with regular and 
non-regular partners are also analysed.  Finally, a discussion of the main findings is 
provided in Section 5.5. 
 
5.2 Background 
 
5.2.1 Measuring sexual behaviour 
As the HIV/AIDS epidemic in sub-Saharan Africa is primarily heterosexually driven 
[244, 245], behavioural risk reduction is imperative for HIV/AIDS prevention efforts, 
especially in the absence of a vaccine [246, 247]. However, a complete view of behaviour 
is needed when defining behavioural risk. For example, having many sexual partners is 
not necessarily risky if condoms are always used consistently. Furthermore, an 
individual’s level of risk is often determined by their partner’s level of risk and their 
position within the local sexual partner network [248, 249]. In a high-level generalised 
epidemic, an individual’s risk of infection may be high, although their own behaviour is 
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inherently low risk. Thus, a nuanced view of sexual behaviour is necessary for analysing 
and interpreting behavioural data [246, 250].  
 
Since the emergence and spread of HIV, the focus of analyses regarding timing of first 
sex and marriage has broadened from investigating their role as proximate determinants 
of fertility to encompass their associations with risk of acquiring HIV [251-253]. 
Identifying trends in the timing of age at first sex and marriage is essential for evaluating 
the impact of the investment made in HIV prevention interventions to promote abstinence 
(by delaying first sex) and to assess the contribution of these changes to any downturn in 
the epidemic [99, 254-256]. Delays in reported age at sexual debut have coincided with 
declines in HIV prevalence in Uganda and Zimbabwe [106, 230, 257-259]. Mathematical 
modelling, however, has indicated that these changes are unlikely to have contributed 
substantially to reductions in lifetime risk of infection or HIV incidence [260].  
 
In general, the age at which first sex occurs lies within a narrow range, generally the later 
teenage years [261, 262]. Thus, changes in the median age at first sex of just a year or 
two are considered epidemiologically significant. However, even modest degrees of 
social desirability bias, recall bias, digit preference or random mis-reporting could 
potentially generate spurious trends. For example, social desirability would be expected 
to bias reports of age at first sex upwards. Slaymaker and Buckner found that declines in 
reporting of sex before age 15 in Zambia were partially due to a change in reporting bias, 
when comparing two survey methodologies and accounting for the socio-demographic 
composition of the survey samples [263].  
 
The relationship between age at marriage and risk of infection has received also attention.  
Recently, Bongaarts argued that late marriage can facilitate the spread of HIV via a long 
period of premarital sexual activity [264]. However, it is also possible for early marriage 
to pose an increased risk of infection if marriage leads to regular unprotected sex in sero-
discordant partnerships [173].  
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5.2.2 The Manicaland cohort study: background 
 
Socio-demographic context 
The Manicaland province in Eastern Zimbabwe is one of ten administrative provinces in 
Zimbabwe, is predominantly rural, and had a population of 1.5 million in the 2002 
census.  Recent DHS data indicate that Manicaland has similar education levels to the rest 
of Zimbabwe (excluding the cities of Harare and Bulawayo which have much higher 
levels of educational attainment), but is a relatively underdeveloped province in terms of 
available healthcare and economic wealth (as measured by a households material assets) 
[265, 266].   
 
The Manicaland project was initially set up in 1993 to investigate the early socio-
demographic impacts of the HIV epidemic [267, 268]. This first study was carried out in 
two sites close to the Mozambiquan border; the Honde Valley in Mutasa district and the 
Rusitu Valley in Chimanimani district. This study had two components: a socio-
demographic and behavioural survey and HIV testing among all women attending ANC 
over a 15-month period (n=487) and a population-based survey among 1,237 females 
aged 15-49 years. The population-based sample represented 96% of eligible women 
identified in a sample containing 95% of all the households in these two communities. 
HIV prevalence among ANC attendees was 24% in the Honde Valley and 14% in the 
Rusitu Valley. Following adjustment for differences in age structure among the ANC 
attendees (younger women were overrepresented), the female population prevalence 
decreased from 24% to 18% in the Honde Valley and from 14% to 13% in the Rusitu 
Valley. This study also found increasing levels of mortality and orphanhood, as well as 
decreasing fertility rates. Overall, this study provided clear evidence for a well-
established HIV epidemic in rural Eastern Zimbabwe. 
 
In 1998, HIV prevalence in the Mutasa district of Manicaland was 16.0% and 22.8% 
among 15-54 year old men and women, respectively [269]. Given this prevalence, it was 
estimated (using age specific prevalence data and maximum likelihood techniques to 
calculate cumulative incidence), that an individual entering the sexually-active population 
had a two in three chance of becoming infected before reaching 55 years of age [269]. 
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This work highlighted the imperative need for effective interventions in this context. As a 
follow-on from these initial findings, the Manicaland HIV and STI prevention project 
commenced in 1998. A detailed description of the study design and methodology follows 
in Section 5.3   
 
Since 1998, the study has provided a detailed documentation of the spread of HIV and the 
associated demographic impact in the study population. During the first two surveys 
(1998-2000 and 2001 to 2003), it was estimated that HIV accounted for 61% of adult 
male and 70% of adult female deaths, and had reduced life expectancy to an estimated 34 
years and 38 years, respectively [270]. During the third survey, the proportion of adult 
deaths attributable to HIV/AIDS had increased to 69% and 74% among men and women, 
respectively [271]. High levels of HIV associated mortality have led to an increase in 
prevalence and incidence of orphanhood [272]. The prevalence of orphanhood (all types: 
maternal, paternal and double) among children aged 0 to 14 years increased from 12.5%, 
to 19.4%, to 20.8% in the first, second and third surveys, respectively [273]. The HIV 
epidemic has contributed to a decline in fertility in this population [274]. The average 
total fertility rate for the study period (1998 – 2005) was 3.46 [275]. However, based on 
the fertility of uninfected women, the total fertility rate would have been 3.73 in the 
absence of HIV [275].  Overall, the HIV epidemic has more than doubled the crude death 
rate, reduced the crude birth rate and hence substantially reduced, although not reversed, 
population growth [275].  
 
Epidemiological context 
Nationally, HIV prevalence in adults (15 - 49 years) is estimated to have peaked at 29% 
in 1997, to have fallen to 21% by 2004, and decreased further to 16% by 2009 [276]. 
These trends have been reflected in the Manicaland study population, in which 
considerable declines in HIV prevalence and incidence have occurred (Figure 5.1). 
 
 
 
 
  117
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1 HIV prevalence and incidence in Manicaland Zimbabwe, 1998-2005. Source: 
Professor Simon Gregson.  
 
HIV prevalence declined from 23.0% to 20.5%  in the three year inter-survey interval 
between the first and second surveys [adjusted odds ratio 0.87 95% CI 0.80-0.95]  [230]. 
This decline was greatest among younger ages. In women aged 15 to 24 years HIV 
prevalence fell by 49% (from 15.9% to 8.0%) [230]. In men aged 17 to 29 years HIV 
prevalence fell by 23% (from 10.6% to 8.1%) [230]. Gregson et. al. explain how such 
rapid reductions in prevalence are unlikely to be a consequence of the natural dynamics 
of the HIV epidemic alone (i.e. as a result of saturation of infection and selective AIDS-
related mortality within high-risk groups) and demonstrate how these declines in 
prevalence are associated with reductions in sexual risk behaviour [230]. These 
behavioural changes are described in the following section regarding behavioural context. 
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In addition to HIV, the prevalence of cofactor STI’s in this population has been 
measured. A three month survey (February – April) in two districts in 1998 found a high 
prevalence of  Herpes Simplex Virus Type 2 (61.1%), a considerable prevalence of 
trichomoniasis (9.5%) and low prevalence of chlamydia (2.5%), gonorrhoea (1.8%), 
syphillis (rapid plasma reagin) (1.4%) and syphilis (Treponema pallidum 
haemagglutination) (1.2%) [277]. During the first survey, high levels of self-reported STI 
symptoms were observed, with 25% of men (aged 17-54 years) reporting urethral 
discharge and 30% of women (aged 15-44 years) reporting vaginal discharge [278]. In 
addition, significant gender differences in seeking treatment were observed, with 92% of 
men and 62% of women having sought treatment for their symptoms in the past year 
[278]. 
 
Behavioural context 
Levels and trends in sexual risk behaviour in this study population have been well-
characterised. In the first survey, patterns of partnership formation were found to be dis-
assortative with respect to age, with young women (17 to 24 years) forming partnerships 
with men 5 to 10 years older than themselves and almost one quarter forming 
partnerships with men at least ten years older [279]. This has been associated with 
increased exposure to HIV infection among these women and is thus a behavioural 
determinant of the more rapid increase in HIV prevalence in young women as compared 
to young men [279].  
 
It was also found that among young men (17 to 24 years) a greater proportion of reported 
sexual partnerships are casual as compared to young women (17 to 24 years) (46% vs. 
9%) and more of their regular partnerships are premarital (55% vs. 5%) [279]. The first 
survey also found reported levels of consistent condom use to be relatively common in 
casual partnerships but as low as 5% within marital relationships [279].  However, this is 
a high contraceptive use population, with 52% of married women in the first survey 
reporting contraceptive use and of these, 96% reported using a modern (mostly hormonal) 
method [274].   
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In an effort to identify high-risk sub-groups and places to target prevention activities, it 
was found that attendance at beer halls was associated with higher levels of risk 
behaviour, commercial sex in particular [280]. This was reflected by increased risk of 
HIV infection (odds ratio 1.9, 95% CI 1.6 – 2.3), and experience of STI symptoms 
(genital sores or discharge) among men attending beer halls [280]. Attending beer halls is 
relatively common among men in the study population, with 50% of men in the first 
survey reported having been to a beer hall in the last month [280].  
 
Changes in sexual behaviour have been documented in this population. Early work, in 
1994, found that 44% of women reported to have taken some action to prevent acquiring 
HIV infection. The level of behaviour change was found to be substantial (e.g. 24% of 
women reported abstinence). Behaviour change was found to be facilitated by an 
individual’s psychosocial status (i.e. knowledge, experience of HIV/AIDS and personal 
risk perception) but hindered by factors such as low female autonomy, marital status, 
economic status, male labour migration and alcohol consumption.  
 
Large declines in reported risk behaviour were observed between the first and second 
surveys [230]. Statistically significant reductions in the reported numbers of new sexual 
partners in the previous year, sexual partners in the previous month and current sexual 
partners were observed among men and women. Declines in reported number of casual 
sex partners were also documented. This trend was most apparent among men, for whom 
a 49% reduction in the number who reported having casual partners was observed (25.9% 
versus 13.2%, P<0.001) [230].   
 
The findings summarised above are based on data from the first two surveys. Data from 
all three surveys are presented in the following section to illustrate trends in selected 
behavioural indicators. 
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5.3 Methods  
 
5.3.1 Manicaland cohort study: methodology 
 
Study population and design 
 
The Manicaland HIV/STD Prevention Project is an ongoing longitudinal, population-
based open cohort study in the Manicaland province of Eastern Zimbabwe [230, 281]. 
Participants are recruited from 12 predominantly rural study sites which consist of four 
subsistence farming areas, two forestry plantations, two coffee and tea estates, two 
roadside trading areas and two small towns. Each of these 12 communities includes at 
least one Government or Mission Health Centre. At each survey, local residents are 
enumerated initially in a household census of all households in each study site.  Eligible 
individuals are then invited to participate in the study. Local community health workers 
are employed to help identify and locate households and eligible individuals. The 
baseline survey took place from July 1998 to February 2000 and was carried out in a 
phased manner (one site at a time). Follow-up surveys were conducted from 2001 to 2003 
and from 2003 to 2005. 
 
Initial sample-size calculations for the first survey assumed a HIV prevalence of 20%, a 
30% loss to follow-up after two years and 80% power to detect a 40% reduction in HIV 
incidence, assuming a background incidence of 2% per year [281]. The required sample 
size was calculated to be 1,000 in each community, based on six pairs of communities. In 
practice, the sample size was revised to 800 individuals per community and the length of  
follow-up revised to three years, due to funding constraints and delayed implementation 
of interventions [281]. However, this also yielded 80% power to detect a 40% reduction 
in HIV incidence, assuming a proportionate increase in loss to follow-up [281].  
 
Men aged 17 to 54 years and women aged 15 to 44 years who were present in the 
household for at least four nights in the past month and at the same time one year ago 
were eligible to participate. Three attempts are made to interview each eligible individual. 
Only one member of each cohabiting marital union, selected at random, was eligible to 
participate. At the third survey, extended entry criteria allowed men and women aged 15 
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to 54 years and both members of a marital union to participate. In the second survey 
(from site five onwards) and the third survey, in-migrants to the study areas were also 
invited to participate.   
 
Written informed consent was sought from every individual invited to participate at each 
survey, as a condition of enrolment. Ethical approval for the study was granted by the 
Medical Research Council of Zimbabwe (number 02187), the Applied and Qualitative 
Research Ethics Committee in Oxford (N97.039) and St. Marys Local Research Ethics 
Committee, London (03.66 R&D 03/SB/004E).  
 
HIV prevention interventions 
A community-randomised trial of HIV prevention was conducted in the study sites 
between the first and second surveys [281]. This intervention included three main 
components: (i) syndromic management and counselling for STIs, (ii) peer education and 
free condom distribution targeted to commercial sex workers and their clients and (iii) 
information, education and communication (IEC) activities, such as AIDS-awareness 
meetings, at local health centres to encourage safer sexual behaviour. It was intended to 
also provide income-generating projects for commercial sex workers, but this was not 
possible due to hyper-inflation and the national economic decline.  
 
This intervention did not reduce overall HIV incidence (intervention vs. control 
communities, incidence rate ratio 1.27, 95% CI 0.92 – 1.75) [281], although, males who 
attended programme meetings had lower HIV incidence (incidence rate ratio 0.48, 95% 
CI 0.24 – 0.98) [281]. 
 
At each survey, all participants were offered an information sheet about HIV/AIDS and 
free VCT. The provision of VCT by the study is described in detail in Chapter 6, Section 
6.3.1. At the first survey, all participants were offered their results from a diagnostic test 
for Trichomonas vaginalis and free treatment for T. vaginalis and other STI’s (syphilis, 
gonorrhoea, chlamydia and Herpes Simplex Virus Type 2). At the second and third 
surveys, all participants were offered free treatment for STI’s. 
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Specimen collection and laboratory testing 
A finger prick was used to obtain a blood spot for the anonymous HIV serosurvey. Dried 
blood spots were collected on filter paper and stored at 4°C. A dipstick dot Enzyme 
Immunoassay (EIA) (ICL-HIV 1 & 2 Dipstick, Thailand) was used to test for HIV 
antibodies. This test has been evaluated in Zimbabwe, and was shown to have high 
sensitivity and specificity (both 99.6%) [282]. A plate EIA was used to confirm all 
positive test results and a 10% sample of negatives. At each survey, there was 100% 
agreement between the dipstick dot EIA and the plate EIA.  When a seroconversion was 
identified, the participant’s blood specimen from the previous survey was re-tested.  If 
this sample tested negative, a plate EIA was used to confirm both samples and verify 
seroconversion. All laboratory work was carried out at the Biomedical Research and 
Training Institute (BRTI) laboratory in Harare.  
 
Behaviour data  
A structured questionnaire on socio-demographic characteristics and sexual behaviour 
was used to interview participants. Interviews were led by social science graduates who 
were familiar with the local language and culture but were not known locally. 
Interviewers were trained to adopt an informal and non-prejudicial approach, to build up 
a good rapport with respondents, and to carefully explain the confidentiality procedures. 
Interviewers were matched for sex with respondents.  
 
An informal confidential voting interview (ICVI) method was used to collect sensitive 
behavioural data, as a means of reducing social desirability bias [283, 284]. Interviewers 
explained to participants that by writing their answer, the interviewer would not be aware 
of the participant’s response. Participants placed colour-coded voting slips containing 
their responses into a locked “voting” box, thus ensuring confidentiality (Figure 5.2). 
This box was only unlocked and linked to the questionnaire data by data managers at the 
field site.   
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Figure 5.2 Use of the informal confidential voting box method for collecting sexual 
behaviour data. Source: Gregson et al. [284].  
 
In the first survey the ICVI method was used for three-quarters of literate respondents 
(randomly selected). All illiterate respondents (8%) were interviewed face-to face. At the 
second and third surveys behavioural data was collected using the same method as in the 
previous survey and all new literate participants were interviewed using the ICVI method.  
The ICVI method has been evaluated within the study population and it’s use has shown 
to be associated with increased disclosure of sexual behaviours [283]. All data on age at 
first sex and age at first marriage were collected using the face-to-face interview method, 
even when the ICVI method was used to collect subsequent behavioural data in the same 
interview.   
 
Participants were asked if they had been married or had ever been in a long-term or 
cohabiting relationship, which for the purposes of this work have been classified together 
as being ‘married’. In the first survey, relationships of six months or longer were defined 
as long-term, but in the subsequent two surveys, this was changed to be relationships of 
twelve months or longer. Ever married individuals were asked their age when they first 
entered such a relationship.  
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In the section of the questionnaire regarding sexual behaviour, participants were asked 
initially how old they were when they had sex for the first time. Subsequent questions on 
sexual behaviour were asked in order of increasing sensitivity. In the first survey, the 
behavioural section of the questionnaire was skipped if a participant reported that they 
have never had sex, whereas in the second and third surveys, the full behavioural section 
of the questionnaire was completed for those reporting to not have had sex (i.e. these 
participants reported 0 when asked about behavioural indicators such as number of sexual 
partners). The questions used to define each of the behavioural indicators analysed and 
their position in the questionnaire are shown in table 5.1. 
 
Behavioural indicator Position in Question
Questionnaire
Age at marriage Q251 How old were you when you first entered such 
a relationship?
(asked after Q249: Have you ever been married
or in a long-term or cohabiting relationship?)
Age at first sex Q402 How old were you when you had sex for the
first time?
Visited bar/beer hall in the last month Q242 How many times have you visited a bar or
beer-hall in the last month?
New sexual partner in the last year Q422 How many of these partners were you having 
sex with for the first time?
(asked after Q421: How many different sexual
partners have you had in the last 12 months?)
Sexual partner in past month Q425 How many different partners have you had sex
with in the last month?
Multiple concurrent partners Q424 How many sexual relationships do you consider
yourself to be involved in at the moment?
Consistent condom use in last 2 weeks Q427 How many times have you had sexual
intercourse with this partner in the last 2 weeks?
Q428 On how many of these occasions did you and
your partner use condoms throughout?  
Table 5.1 Questions used to define behavioural indicators.  
 
Footnote: Questions were asked in a consistent manner over the three surveys. The question numbers 
presented are from the third survey. Some question numbers have changed from survey to survey due to the 
addition and removal of questions. The order, however, remains the same.   
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5.3.2 Data Analysis 
 
Age at first sex and age at marriage 
A number of methods have been developed to analyse data on age at first sex (which also 
apply to age at marriage). The data used are current status (the current age of the 
individual and whether they have ever had sex) and recall (retrospective reports of age at 
first sex) [250]. Survival analyses combine the two sources. These techniques can also be 
adapted to analyse data from successive surveys to assess trends in age at first sex and 
distinguish underlying trends from reporting errors [285].  
 
Here, survival analysis techniques were employed to analyse timing of first sex, with 
individuals represented as surviving until first sex. In this scheme, the failure event is 
starting sex, and follow-up time is censored if individuals had not started sex by the time 
of their last interview. Censoring is independent (of the probability that sex occurs) since 
no information on sexual behaviour was obtained prior to recruitment. Kaplan-Meier 
failure curves were plotted to illustrate the cumulative onset of sexual activity. A 
Wilcoxon rank-sum test was used to test if median age at frst sex was significantly 
different between two age groups within a birth cohort, for men and for women. This 
procedure was also followed when analysing trends in age at marriage.  
 
Age at first sex and age at marriage were reported as years in integers, which correspond 
to age at last birthday at those events. A random proportion of a year was added to each 
age to capture the distribution of exact ages within a year. Reports of age at first sex and 
age at marriage were classified according to consistency, to assess the quality of 
reporting. Four categories were defined to classify reports: (i) consistent, (ii) inconsistent: 
can be corrected, (iii) inconsistent: can be estimated (iv) unreliable: can’t be estimated or 
corrected (Table 5.2).  
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Category 1 2 3+ Imputed response
Reliable
Unreliable
Number of age at event reports
Consistent     Report ≤ age   at survey
Both reports same            
AND                       
both reports ≤ age at survey
All reports same            
AND                     
all reports ≤ age at survey
Reported age
Inconsistent:    
can be 
corrected
N/A
Reports differ by 1 year        
AND                       
both reports ≤ age at survey
2 ages reported which differ 
by 1 year                 
AND                     
both reports ≤ age at survey
The older of the 2 
ages
The most frequent 
report that is ≤ age at 
survey
Unreliable:      
can't be 
estimated or 
corrected
     Report > age   
at survey
                          
Reports differ by > 1 year AND  
both reports ≤ age at survey OR 
Both reports > age at survey
< 50% of reports same       
OR                      
≥50% reports same AND 
reports> age at survey 
The mean of all 
reported ages
Inconsistent:    
can be 
estimated
N/A 1 report ≤ age at survey ≥50% of reports same AND   these reports ≤ age at survey
 
Table 5.2 Definitions of reliable and unreliable reporting. Source: Wringe and Cremin et. 
al. [286]. 
 
A number of non-mutually exclusive classifications were observed for those individuals 
with three reports (827/3270) (i.e. when two reports were consistent and the other report 
differed by one year). In such cases the consistently reported age was used. These criteria 
were also applied when classifying reports of age at marriage. A detailed description of 
these classifications, by frequency of reporting, is given by Wringe and Cremin et. al. 
[286].  
 
Temporal trends in sexual behaviour 
Analyses on behavioural indicators were restricted to the non-virgin population. Data 
regarding number of partners were analysed as numeric variables to calculate summary 
statistics. However, the distributions of number of partners varied substantially, thus 
these were categorised for comparison and presentation purposes. Defining 
categorisations was based on a number of considerations which included categorisations 
used in previous analyses of these data and ensuring statistical power for comparisons. 
Categorisations were also determined by prior knowledge of behavioural risk and HIV 
epidemiology in this population.  
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Consistent condom use was defined by combining data from (i) number of sex acts in the 
past two weeks and (ii) number of times a condom was used throughout (for sex acts in 
the past two weeks). Condom use was classified as inconsistent if the number of condoms 
used was less than the number of sex acts reported.  
 
Behavioural indicators were compared for those lost to follow-up and those followed-up 
(i) from the first to the second survey and (ii) from the second to the third survey. Chi-
squared tests were used to assess the statistical significance of differences in behaviour 
variables for men and for women, adjusting for age.  
 
5.4 Results 
 
5.4.1 Study participation and participant characteristics 
The household participation rates were high at 98%, 94% and 96% in the first, second 
and third surveys, respectively. The participation rates for the individual interviews were 
79% in both the first and the second survey and 83% in the third survey. The rate of 
follow-up in the closed cohort, with known deaths excluded, was 60.8% from the first to 
second survey and 62.5% from the second to third survey. This is a highly mobile 
population [287], and out-migration was the principal reason for loss to follow-up [230]. 
The rates of participation and loss to follow-up are similar to those from other large-scale 
population-based African HIV cohort studies [288-291]. 
 
The full open-cohort consists of 23517 participants, with 9530, 8210 and 16266 
participants in the first, second and third surveys, respectively. Of these 23517 
individuals, 16680 were interviewed in only one survey, 3185 were interviewed in two 
surveys, and 3652 were interviewed in all three. Most of the individuals who were 
surveyed only once were new entrants at the third survey, for which the eligibility criteria 
for the study were expanded, as described above.  
 
When restricted to the non-virgin population, the open-cohort consisted of 17874 
individuals, with 8273, 6559 and 12533 participants in the first, second and third surveys, 
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respectively. Of these 17874 individuals, 11931 were interviewed in only one survey, 
2395 were interviewed in two surveys, and 3548 were interviewed in all three. The mean 
length of follow-up time was 4.2 years. An overview of the socio-demographic 
composition of this sample is presented in Table 5.3. 
 
Round 1 Round 2 Round 3
(1998-2000) (2001-2003) (2003-2005)
N    (%) N    (%) N    (%)
Sex
Male 3787 (45.8) 2771 (42.3) 4711 (37.6)
Female 4486 (54.2) 3788 (57.7) 7822 (62.4)
Age
15 - 19 1326 (16.0) 764 (11.7) 1037  (8.3)
20 - 29 3363 (40.7) 2415 (36.8) 4808 (38.4)
30 - 39 2010 (24.3) 1647 (25.1) 3155 (25.2)
40 + 1574 (19.0) 1733 (26.4) 3533 (28.2)
Marital status
Single 2321 (28.1) 1334 (20.3) 1833 (14.6)
Married 4715 (57.0) 4227 (64.5) 8465 (67.6)
Previously married 1237 (14.9) 998 (15.2) 2235 (17.8)
Education
None 306  (3.7) 127  (1.9) 9   (0.1)
Primary 3343 (40.4) 2582 (39.4) 4779 (38.1)
Secondary 4474 (54.1) 3672 (56.0) 7032 (56.1)
Higher 150  (1.8) 68  (1.0) 208  (1.7)
Missing 0  (0.0) 110  (1.7) 505  (4.0)
Total 8273 6559 12533  
Table 5.3 Socio-demographic characteristics of non-virgin study participants, at each 
survey. 
 
5.4.2 Timing of first sex and marriage 
 
Age at first sex 
All respondents were asked what age they were when they first had sex. Over all 
surveyed individuals, 23.2% (5446/23517) reported never having had sex. Slightly more 
men than women reported never having had sex (24.3% vs. 22.3%, respectively, χ2, 
P<0.001). Of the individuals who provided a report of age at first sex, 69.3% 
(12448/17953) only reported in one survey. A small proportion of individuals did not 
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respond to the question regarding age at first sex (first survey, 63 (0.66%); second survey, 
36 (0.44%); third survey, 48 (0.30%)).  
 
Reports were classed as unreliable for 32.1% of women and 52.2% of men who reported 
age at first sex in at least two surveys (Figure 5.3). Of these unreliable reports, 31.2%, 
21.2% and 15.9% of reports differed by 2, 3 and 4 years, respectively. The remaining 
31.6% of reports differed by more than 4 years. Similar levels of unreliable reporting 
were observed among only those who participated in all three surveys. The quality of 
reporting among those in all three surveys was very similar across birth cohorts, as 
described by Wringe and Cremin et. al. [286]. 
 
0%
50%
100%
Men Women Men Women
Unreliable: cannot be
corrected or estimated
Inconsistent: can be
estimated
Inconsistent: can be
corrected
All reports consistent
Age at first sex Age at marriage
 
Figure 5.3 The consistency of reporting of age at first sex and age at marriage among 
men and women aged 15-54 reporting in at least two surveys. 
 
Excluding unreliable reports had little effect on the failure curves when compared to 
analysing all reports (regardless of consistency) for both men and women. Median age at 
first sex remained largely unchanged when unreliable reports were excluded (Table 5.4).  
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Men
Birth cohort Median (IQR) Median (IQR) Median (IQR) Median (IQR)
1950-59 20.1 (18.3 - 22.4) 19.9 (18.0 - 22.2) 24.5 (22.0 - 27.0) 24.6 (21.9 - 27.0)
1960-69 19.6 (17.9 - 21.6) 19.5 (17.8 - 21.7) 24.7 (22.0 - 27.4) 25.0 (22.0 - 27.7)
1970-79 19.0 (17.3 - 20.9) 19.0 (17.2 - 20.9) 23.2 (21.2 - 25.2) 23.4 (21.3 - 25.4)
Women
Birth cohort Median (IQR) Median (IQR) Median (IQR) Median (IQR)
1950-59 19.0 (17.3 - 20.6) 18.9 (17.2 - 20.5) 19.1 (17.4 - 20.8) 18.9 (17.2 - 20.7)
1960-69 18.7 (17.0 - 20.6) 18.7 (17.0 - 20.6) 18.9 (17.2 - 20.9) 18.8 (17.0 - 20.8)
1970-79 19.0 (17.4 - 20.8) 19.0 (17.5 - 20.8) 19.3 (17.7 - 21.1) 19.3 (17.7 - 21.2)
All data Reliable data
Age at first marriage
All data Reliable data All data Reliable data
Age at first sex
All data Reliable data
 
Table 5.4 Median and IQR for age at first sex and age at marriage, by reliability of data, 
and birth cohort for men and women. IQR Inter Quartile Range.  
 
Age at first sex is significantly older for men than women (Log-rank test for equality of 
survivorship functions: χ2 = 110, P< 0.001), (Figure 5.4). Over all surveys, 12.6% of 
males and 12.0% of females reported experiencing first sex at 15 years or younger.  
 
Figure 5.4 Kaplan-Meier failure curve for age at first sex for men and women. Data 
includes all reports, after corrections and estimations for inconsistent reports have been 
made. 
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Comparing medians by birth cohort indicates age at first sex has declined gradually 
among men, from 20.7 years among those born before 1955 to 19.1 years among those 
born after 1975, whereas, for women, median age at first sex has remained relatively 
constant between 19.2 and 19.0 years. 
 
Next, reports from those reporting in at least two surveys were combined and analysed in 
a life-table format to compare reports by the same individuals as they age. Median age at 
first sex should remain unchanged as a cohort ages. Among those in older birth cohorts 
(1965-69 to before 1955), trends in age at first sex remained unchanged as these 
individuals aged (reading across the table), indicating the absence of reporting biases 
(Table 5.5). However, among those in younger birth cohorts (1970-74 and after 1975), 
reported age at first sex increased as they aged. This trend was only statistically 
significant for those born after 1975. 
Age group 15-19 20-24 25-29 30-34 35-39 40-44 45-49 15-19 20-24 25-29 30-34 35-39 40-44 45-49
Birth Cohort
Before 1955 20.0 20.0 19.3 19.0
(22) (224) (42) (436)
1955-59 19.5 20.0 20.0 19.0 19.0 18.7
(23) (257) (172) (50) (667) (544)
1960-64 19.0 19.0 19.0 18.3 18.0 18.0
(48) (379) (239) (65) (816) (671)
1965-69 19.3 19.0 19.3 18.0 18.3 18.0
(45) (352) (231) (69) (656) (496)
1970-74 18.8 19.0 19.0 18.0 18.3 18.3
(68) (609) (388) (62) (750) (599)
After 1975 17.0 18.0 18.3 17.0 18.0 18.6
(415) (1047) (458) (448) (1103) (586)
Men Women
 
Table 5.5 Median age at first sex and number reporting (N), for men and women 
reporting in at least two surveys, by five year birth cohort and age group. Bold type 
indicates differences significant at the 95% level. 
Footnote: Reading across follows a birth cohort as they age, reading down allows comparison of an age-
group across different time periods and reading diagonally compares age-groups within a fixed period i.e. 
what a cross-sectional survey would show. Data includes all reports, after corrections and estimations for 
inconsistent reports have been made. Small sample sizes are indicated in italic, along the leftmost diagonal 
for men and for women. These are low due to the timing of the surveys in relation to birth cohorts e.g. the 
majority of individuals in the 1970-74 birth cohort had aged past the 20-24 age group when they were 
surveyed.   
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Age at marriage 
Across all respondents, 36.9% (8676/23517) reported never having been married. A 
higher proportion of men than women, had never been married (50.3% vs. 26.8%, χ2, 
P<0.001). Participants who reported to have been ever married or in a long-term 
relationship were asked at what age they first entered such a relationship. Thus, this 
question is capturing the participants age at the beginning of a marital or long-term 
relationship which may not be the age at which the marriage took place. Of these, 43 
(0.72%), 45 (0.85%) and 59 (0.55%) did not respond to the question regarding age at 
marriage in the first, second and third surveys, respectively. Of the individuals who 
reported an age at marriage, 68% (9874/14508) only reported it in one survey.  
 
Reports were classed as unreliable for 33.2% of women and 52.5% of men who reported 
age at marriage in at least two surveys (Figure 5.3). Of these unreliable reports, 26.5%, 
17.8% and 13.7% of reports differed by 2, 3 and 4 years, respectively. The remaining 
41.9% of reports differed by more than 4 years. Excluding unreliable reports when 
plotting failure curves did not change the overall trends, when compared to trends based 
on all reports (regardless of consistency). The median age at marriage remained largely 
unchanged when unreliable reports were excluded (Table 5.4). Men marry at significantly 
older ages than women (Log-rank test: χ2 = 5647, P< 0.001), (Figure 5.5).  
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Figure 5.5 Kaplan-Meier failure curve for age at marriage for men and women. Data 
includes all reports, after corrections and estimations for inconsistent reports have been 
made. 
  
Comparing median age at marriage across birth cohorts indicates a stable age at marriage 
among men (approximately 25 years) and women (approximately 19 years). Next, reports 
from those reporting in at least two surveys were combined and analysed in a life-table 
format. Men generally reported an increased age at marriage as they aged, in particular 
those in the youngest birth cohort (reading across the table) (Table 5.6). Women in older 
birth cohorts (1955-59 and before 1955) reported decreasing ages at marriage as they 
aged. However, among women in younger birth cohorts (1965-69 to after 1975), reported 
age at marriage increased, as they aged. This trend was only statistically significant for 
women born after 1975. 
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Age group 15-19 20-24 25-29 30-34 35-39 40-44 45-49 15-19 20-24 25-29 30-34 35-39 40-44 45-49
Birth cohort
Before 1955 23.8 24.0 19.0 18.7
(22) (219) (41) (425)
1955-59 21.0 23.0 23.0 19.0 18.0 18.0
(22) (254) (168) (49) (661) (541)
1960-64 23.5 23.0 23.0 18.0 18.0 18.0
(45) (364) (234) (63) (803) (664)
1965-69 24.2 23.7 23.3 18.0 18.7 18.3
(42) (324) (216) (67) (645) (492)
1970-74 22.6 23.0 23.0 18.0 19.0 18.7
(50) (441) (307) (59) (710) (573)
After 1975 19.5 21.0 22.0 17.0 18.0 18.3
(55) (313) (244) (357) (963) (542)
Men Women
 
 Table 5.6 Median age at marriage and number reporting (N), for men and women 
reporting in at least two surveys, by five year birth cohort and age group. Bold type 
indicates differences significant at the 95% level. 
 
Footnote: Data includes all reports, after corrections and estimations for inconsistent reports have been 
made. Small sample sizes are indicated in italic, along the leftmost diagonal for men and for women. These 
are low due to the timing of the surveys in relation to birth cohorts e.g. the majority of individuals in the 
1970-74 birth cohort had aged past the 20-24 age group when they were surveyed.  
 
Time spent single after sexual debut 
The average number of person years spent between first sex and marriage has remained 
constant for men and women (Figure 5.6). The mean duration of time spent single after 
sexual debut is much longer for men than for women, 4.1 (SD 4.1) years and 0.3 (SD 1.6) 
years, respectively. Greater proportions of women than men indicated that their first 
sexual experience was within marriage; 69.8% (6748/9666) and 15.3% (729/4760) of 
married women and men, respectively, reported age first sex to coincide with age at 
marriage.  
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Figure 5.6 Distribution of person years spent as a virgin, sexually active and unmarried 
and married, between the ages of 10 and 25, for men and women.   
 
5.4.3 Trends in behavioural indicators 
This section describes behaviour once an individual has entered the sexually active 
population. Thus, analyses are restricted to the non-virgin population. The open cohort of 
non-virgin individuals consisted of 17874 individuals; 7559 men (42%) and 10315 
women (58%). 
 
Formation of new partnerships 
Within a one year period the majority of individuals, women in particular, do not form 
new sexual partnerships (Figure 5.7). Overall, men reported forming more new 
partnerships than women. The reported number of new partnerships decreased from the 
first survey to the second survey and remained relatively constant from the second survey  
to the third survey, for both men and women.  
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Figure 5.7 Formation of new partnerships in the last year, among sexually active men 
and women.  
 
Among men, the rate of formation of new partnerships was highest among 20-24 year 
olds, at each survey. After 24 years of age the proportion of men reporting formation of 
more than two new partnerships in the last year decreased with increasing age. However, 
the high rate of new partnership formation (more than two) among 20-24 year old men 
decreased dramatically between the first and second surveys; from 15.2% to 6.4% to 
8.2% in the first, second and third surveys, respectively.  
 
The age-specific trends in partnership formation are somewhat different among women. 
The proportion of women reporting to form more than two new partnerships in the last 
year was highest among: 25-29 year olds in the first survey at 3.1%; 30-34 year olds in 
the second survey at 1.9%; and 20-24 year olds in the third survey at 0.7%. Thus, the age 
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at peak rates of partnership formation were older than that of men, although the level of 
partnership formation was lower than that of men and declined substantially over time.   
 
At each survey, single men (i.e. never married) and previously married men (i.e. 
widowed, divorced or separated) reported the highest rates of new partnership formation. 
As expected, rates of partnership formation were lower among married men, but were 
higher among those who were married but living apart compared to those who were 
married and cohabiting. As for men, the majority of new partnerships were formed by 
women who were never married or were previously married. Unlike men, however, a 
higher proportion of married women who cohabited with their husbands reported more 
than two new partnerships in the last year compared to married women who lived apart 
from their husbands, at each survey. 
 
Partners in the last month 
Unsurprisingly, the majority of participants report having either zero or one sexual 
partners in the last month (Figure 5.8). Although at each survey a similar proportion of 
men and women reported no partners in the last month, overall, men report more partners 
in the last month than women. A decrease in the proportion of participants, men in 
particular, reporting more than one partner in the last month was observed. 
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Figure 5.8 Reported number of partners in the last month among sexually active men and 
women.  
 
In the first survey, the highest number of partners in the last month was reported among 
15-19 year old men, with 4.4% reporting more than two partners. By the second survey, 
20-24 year old men were reporting the most partners in the last month, with 2.3% 
reporting more than two. By the third survey, 35-39 year old men were reporting the 
greatest number of partners in the last month, with 1.9% reporting more than two.    
 
Among women in the first survey, the proportion reporting more than two partners in the 
last month was constant at about 1% for all those aged 15 – 34. Whereas, in the second 
survey, the proportion of women reporting more than two partners was highest among 
those aged 20-24, at 0.8%, and subsequently declined with increasing age. In the third 
survey, the highest proportion of women reporting more than two partners in the last 
month was also among those aged 20 – 24, but this proportion had decreased to 0.4%.  
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With respect to marital status, no consistent trend was observed for partners in the last 
month among men. In the first survey, the proportion of men reporting more than two 
partners in the last month was highest among those who were previously married (4.1%). 
Whereas in the second survey, the highest proportion was among those who were married 
but lived apart from their spouses (3.4%) and in the third survey those who were never 
married had the highest proportion reporting more than two partners (1.9%). 
 
Among women, the highest proportion reporting more than two partners in the last month 
was observed among those who were never married, at 2.5%, 1.2% and 1.4% in the first, 
second and third surveys respectively.  
 
Multiple partnerships 
Overall, the majority of participants reported to be in a single sexual relationship, at the 
time of each survey (Figure 5.9). There is a strong gender differential in reporting of 
multiple partners, as observed for the other measures of number of partnerships referring 
to different pre-survey time periods. Declines in the reported number of concurrent 
partnerships have occurred between the three surveys. Among men, 18.3%, 10.6% and 
9.2% reported multiple (>1) partnerships in the first, second and third surveys, 
respectively.  Among women, 2.3%, 1.1% and 0.51% reported multiple partnerships in 
the first, second and third surveys, respectively.   
 
  140
Number of current sexual relationships
0%
20%
40%
60%
80%
100%
Round 1 Round 2 Round 3 Round 1 Round 2 Round 3
Males Females
>2
2
1
0
Mean
(SD)
1.03
(0.76)
0.85
(0.66)
0.88
(0.62)
0.83
(0.47)
0.73
(0.48)
0.73
(0.46)
 
Figure 5.9 Reported number of current sexual relationships, among sexually active men 
and women. 
 
Among men, decreases in multiple current partnerships were most pronounced among 
younger men. In the first survey the highest levels of multiple current partnerships were 
observed among 15-19 year olds, with 10.8% reporting more than two current sexual 
relationships, whereas this proportion had dropped to 2.8% in the second survey and 
3.5% in the third survey. Among women, the highest levels of multiple current 
partnerships were observed among 15-19 year olds in the first and second surveys, at 
1.4% and 1.1%, respectively. By the third survey, the age at highest levels of multiple 
current partnerships had increased to 25-29 years (0.4%).  
 
Trends in multiple partnerships changed over time with respect to marital status, among 
men and women. Among men in the first survey, levels of multiple partnerships were 
highest among never married men, at 10.3%. However, in the second survey, the level of 
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multiple partnerships was highest among married men who lived apart from their wives, 
at 4.1%. By the third survey the level of multiple partnerships was highest among never 
married men, at 4.6%. Among women, levels of multiple partnerships were highest 
among those who were never married at all three surveys, at 2.5%, 1.2%, and 0.8%, 
respectively.  
 
Consistent condom use 
Consistent condom use with regular partners was low, similar for men and women and 
did not substantially change over time (Figure 5.10).   
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Figure 5.10 Reported condom use with regular partners, among sexually active men and 
women. 
 
Consistent condom use was relatively high with non-regular partners, men and women 
reported similar levels and the overall level remained reasonably constant over time 
(Figure 5.11).  
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Figure 5.11 Reported condom use with non-regular partners, among sexually active men 
and women. 
 
Sexual behaviour among those lost to follow-up 
 
First survey to second survey 
The characteristics of those lost to follow-up (due to migration, death, refusal or 
unavailability at the time of the follow-up visit) between the first and second surveys 
were compared to the characteristics of those who were followed-up from the first to the 
second survey. The age profile of men and women lost to follow-up was younger than 
that of those followed-up (Table 5.7). Men lost to follow-up reported higher numbers of 
new partners in the last year, but were less risky with respect to consistent condom use 
with regular partners, and did not differ significantly with respect to other behavioural 
indicators (Table 5.7). Women who were lost to follow-up had lower levels of risk with 
respect to consistent condom use with regular and non-regular partners (Table 5.7).    
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Males Females
Characteristic (at round 1) Lost to follow-up Followed-up P-value* Lost to follow-up Followed-up P-value*
(n = 1704) (n = 2083) (n = 1378) (n = 3108)
Age (years)
15-19 18.3 17.8 <0.001 16.7 12.4 <0.001
20-24 32.0 21.8 29.8 15.4
25-29 19.3 17.3 21.1 16.2
30-35 11.4 11.4 13.3 13.8
35-39 5.8 10.5 8.7 17.4
≥ 40 13.2 21.3 10.4 24.7
Visits to bar/beer hall in last month
None 45.4 46.8 0.7328 95.8 95.1 0.5302
Less than once a week 21.0 17.9 2.3 2.7
Once to twice a week 15.3 15.7 0.7 1.0
More than twice a week 12.8 12.4 0.5 0.7
Everyday 5.5 7.1 0.7 0.6
New partners in past year
0 50.3 57.6 0.0373 78.0 84.7 0.0599
1 28.7 26.9 19.0 13.5
2-4 17.7 13.5 2.7 1.5
5-9 2.1 1.8 0.2 0.1
≥10 1.1 0.3 0.1 0.2
Partners in last month
0 - 1 90.7 89.8 0.7657 98.2 98.7 0.0616
2 6.7 7.9 0.9 1.0
>2 2.5 2.4 0.9 0.3
Current partners
0 - 1 84.7 84.3 0.5590 97.6 98.4 0.0733
2 10.5 11.6 1.4 1.2
>2 4.9 4.1 1.0 0.4
Consistent condom use in last 2 weeks
Regular partners:
None/inconsistent 82.8 89.1 0.0404 91.0 93.4 0.0486
Consistent 17.2 11.0 9.0 6.6
Non-regular partners:
None/inconsistent 51.9 57.6 0.6747 54.4 77.1 0.0116
Consistent 48.1 42.4 45.6 22.9
Values are given as percentages.
* Chi-squared tests adjusted for age (for behavioural indicators)   
Table 5.7 Age profile and behavioural characteristics of non-virgin participants at round 
1, by sex, for those lost to follow-up and those followed-up from round 1 to round 2.   
 
Previous work by Mundandi et. al. found no difference in sexual behaviour between 
those lost to follow-up due to migration from the first to the second survey and those 
followed-up to the second survey, for either sex [292]. It was found that at the first survey 
future migrants were significantly younger and had higher education levels than those 
followed-up to the second survey. Unlike this analysis, the analysis by Mundandi et. al. 
included all participants regardless of whether they have had sex or not, and adjusted for 
  144
age, education, marital status and location (i.e. area of residence) and focused on loss to 
follow-up due to migration only (which the majority of loss to follow-up is attributable 
to). 
 
Second survey to third survey 
The characteristics of those lost to follow-up between the second and third surveys were 
compared to the characteristics of those who were followed-up from the second to the 
third survey. As for the earlier surveys, the age profile of men and women lost to follow-
up between the second and third surveys was younger than that of those followed-up 
(Table 5.8).  
 
Among men, the distribution of number of new partners in the last year differed by 
follow-up status; with a greater proportion of those followed-up reporting 5-9 new 
partners, but a greater proportion of those lost to follow-up reporting 2-4 new partners 
(Table 5.8). Similarly, among women, the distribution of number of new partners in the 
last year differed by follow-up status, with those lost to follow-up reporting higher 
numbers of new partners. However, none of the women lost to follow-up reported having 
ten or more new partners, as compared to 0.2% of those who were followed-up (Table 
5.8). Women who were lost to follow-up also attended bars and beer halls more 
frequently than those followed-up (Table 5.8).   
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Males Females
Characteristic (at round 2) Lost to follow-up Followed-up P-value* Lost to follow-up Followed-up P-value*
(n = 1144 ) (n = 1627 ) (n = 1115 ) (n = 2673)
Age (years)
15-19 13.0 13.1 <0.001 15.6 7.9 <0.001
20-24 29.1 19.9 27.4 11.5
25-29 21.8 17.8 18.1 15.0
30-35 11.3 11.8 13.2 14.6
35-39 9.0 10.5 9.7 15.4
≥ 40 15.8 26.9 16.0 35.6
Visits to bar/beer hall in last month
None 51.1 51.3 0.2158 95.3 96.3 0.0096
Less than once a week 20.2 22.1 2.4 2.5
Once to twice a week 15.2 13.8 1.2 0.5
More than twice a week 8.6 8.1 0.7 0.4
Everyday 5.0 4.7 0.4 0.3
New partners in past year
0 66.1 74.6 0.0370 83.3 92.4 <0.001
1 23.2 17.2 14.7 6.5
2-4 10.0 7.2 1.6 0.8
5-9 0.5 0.9 0.5 0.2
≥10 0.3 0.2 0.0 0.2
Partners in last month
0 - 1 93.0 93.1 0.6433 99.3 99.4 0.7716
2 5.5 5.6 0.5 0.4
>2 1.6 1.3 0.2 0.2
Current partners
0 - 1 90.8 90.8 0.7362 98.8 99.1 0.7261
2 7.3 7.7 0.8 0.6
>2 1.9 1.5 0.4 0.3
Consistent condom use in last 2 weeks
Regular partners:
None/inconsistent 88.8 91.4 0.6812 91.2 93.8 0.0627
Consistent 11.2 8.6 8.8 6.2
Non-regular partners:
None/inconsistent 47.1 55.7 0.3384 56.1 61.8 0.9746
Consistent 52.9 44.3 43.9 38.2
Values are given as percentages.
* Chi-squared tests adjusted for age (for behavioural indicators)   
Table 5.8 Age profile and behavioural characteristics of non-virgin participants at round 
2, by sex, for those lost to follow-up and those followed-up from round 2 to round 3. 
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5.5 Discussion 
In this rural Zimbabwean population, women initiate sex and enter marriage at younger 
ages than men, but spend much less time between first sex and marriage. Comparisons 
across all surveys, by birth cohorts which span a period of over forty years, indicate 
median age at first sex has remained constant over time among women but has declined 
gradually among men. Median age at marriage has remained relatively stable for both 
men and women. However, tracing birth cohorts between surveys revealed reporting 
biases. It is possible that some individuals (young people in particular) deliberately report 
an older age at first sex due to exposure to HIV prevention campaigns promoting 
delaying age at first sex and abstinence, in addition to the pressure of other social norms. 
With respect to reported age at first sex, one may expect increasing recall bias as an 
individual ages.  
 
Including reports of age at first sex and age at marriage identified as unreliable in survival 
analyses did not alter the results, suggesting that much of the unreliability may be 
attributable to random misreporting rather than systematic biases such as social 
desirability bias. This absence of alteration of trends indicates that the observed trends 
can be interpreted with some confidence, despite the high levels of misreporting. 
Furthermore, this provides some reassurance when interpreting trends in serial cross-
sectional data, such as from DHS, where such inconsistencies cannot be identified.  
However, consistency of reporting does not always signify accuracy – an individual may 
consistently report an incorrect age at first sex, a bias which cannot be detected.  
 
Delays in sexual debut among teenage men and women in the first three years of follow-
up of this cohort have been reported previously [230]. In this earlier analysis, trends in 
the percentage of individuals reporting to have had sex, within a small population sub-
group who were starting sex at that time (17-19 year old males and 15-17 year old 
females) were compared. These age restrictions were chosen to analyse an entirely new 
group of maturing adolescents at each survey, thus focusing on very recent trends. 
Therefore, these previous findings, using current status data only, are not directly 
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comparable to the longer-term trends in median age at first sex in the entire population 
presented here by birth cohorts spanning a period of over forty years.  
 
In Zimbabwe, information on timing of sexual debut has been collected in four DHS 
surveys since 1988, and median age at first sex has been calculated by province for the 
most recent three surveys [266, 293-295]. In Manicaland, medians among women aged 
25 to 49 years, are relatively constant at; 18.3, 18.2 and 18.4 years in 1994, 1999 and 
2005-06, respectively. Among men, aged 25 to 54 years (25 to 49 in the 2005-06 survey), 
median age at first sex increased from 19.5 in 1994 to 22.0 in 1999, and subsequently 
decreased to 20.6 in 2005-06. Thus, the medians calculated for women in this study 
population are a good representation of those in the wider population in the Manicaland 
province, whereas, for men, the medians calculated for this study population are generally 
younger. These estimates of median age at first sex are relatively high in comparison to 
other African countries, such as Kenya, Tanzania, Uganda and Zambia where median age 
at first sex ranges from 16.4 to 18.1 years [285].  
 
The substantial gender differential in age at marriage observed here is not surprising as 
women are expected to marry younger than men in Shona society [296]. Women may 
seek to marry at a relatively young age in order to obtain the security associated with 
marriage and subsequent motherhood. Men are expected to obtain employment in order 
to afford bridewealth thus re-enforcing the expectation that they wait until reaching their 
mid-twenties before marrying. Recall bias may influence quality of reporting of age at 
marriage, among older individuals in particular. In this society, marriage is a long process 
and individuals may be unable to distinguish their age when the actual ceremony took 
place, from that when bridewealth was paid, from when the relationship begun. The 
biases identified in reporting of age at marriage may also be partially attributable to the 
change in the definition of a long-term relationship. 
 
A mathematical modelling study, parameterised for this population, has shown that the 
effect of delaying age at first sex on subsequent risk of HIV infection depends on the 
length of time spent single (between first sex and marriage) [260]. When sexually active 
  148
and unmarried, risk of infection is double that when married, 2% and 1% per person-year 
at risk, respectively [260]. Thus, the extended duration of time spent sexually active and 
single among men, and the brief duration of time spent sexually active and single among 
women observed here, support previous findings in this population that, in general, young 
men acquire HIV from pre-marital relations (as well as extra-marital relations), whereas 
for women - who typically spend much less time single - the strongest determinants of 
infection are their spouse’s behaviours [279].    
 
Previous cross-sectional analyses (using the first survey) investigating age at first sex in 
relation to subsequent risk of HIV infection found that, among both males and females in 
this population, riskier sexual behaviour was observed among those reporting an early 
age at first sex (younger than 18) as compared to those who reported an older age of 
sexual debut [253]. However, for men, an early age at first sex which coincided with age 
at marriage did not lead to subsequent riskier behaviour, compared to men who initiated 
sex at an older age. This suggests that, among men, early marriage may be somewhat 
protective against the riskier effects of early age at first sex. However, the change in age 
at first sex observed here among men may not translate to additional risk of infection 
because the average number of years spent single, between first sex and marriage, has 
remained the same. Thus, the circumstances in which first sex occurs may be more 
important than the timing.  
 
The behavioural indicators with respect to number of partnerships followed a highly 
skewed distribution. This is a characteristic observation for behavioural data, with many 
individuals reporting few sexual partners and few individuals reporting many sexual 
partners. In addition, data heaping was observed in the tails of these distributions, with 
increased reports observed for multiples of ten. Analysing data from the first survey of 
this cohort, Lewis showed that the distribution of lifetime partners among women 
followed a power law of the form P(X=x) α X –γ, where X represents the number of 
lifetime partners and γ is the scaling exponent [265]. This suggests that classifying 
women as either “high activity” or “low activity” is not straightforward, with high 
activity women falling into the extremes of the distributions of low activity women [265]. 
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A network, such as a sexual network, can be classified as “scale-free” if the distribution 
of connections (i.e. partnerships) follows a power law. Analysing data from the first 
survey, Schneeberger et. al. calculated the scaling exponent (γ) for lifetime partners to be 
3.07 and 2.51 for men and women, respectively [297], and found the distribution of 
number of lifetime partners to be scale-free. In theory, this eliminates the epidemic 
threshold, thus allowing the spread of a pathogen of low transmissibility (such as HIV) to 
be maintained [297].  
 
Large gender differentials in reported numbers of partners were observed, with men 
reporting greater numbers of sexual partners than women. This may be due to reporting 
bias, whereby men over-report and women under-report [298]. It may also be due to 
sampling or participation issues, whereby high activity women are excluded or under-
represented. Alternatively, the observed gender differentials may be a combination of 
both these effects.  Inclusion of a single member of a marital union in the first and second 
surveys is likely to have led to an under-representation of those in long-term 
relationships. 
 
Issues of validity and reliability are common problems in HIV/AIDS evaluation research 
[299], as survey data on sexual behaviour can be subject to participation, recall and social 
desirability bias [300]. There is no “gold standard” with which to validate behavioural 
data. An additional challenge to collecting reliable behavioural data is participant fatigue.  
In addition to data quality, care must be taken when interpreting behavioural indicators. 
Slaymaker outlines how behaviour has many dimensions (e.g. number of partners, 
relationship to partner, frequency of sex and condom use) and how an individuals risk is 
determined by the interaction of these different aspects of behaviour and HIV prevalence 
[250]. For example, individuals reporting one new partners in the last year could have 
very different levels of risk depending on the explanation; they may be in a long-term 
partnership and have formed a casual partnership, they may practice serial monogamy, or 
they may have started their first long-term relationship. Despite these caveats, there is 
evidence for considerable reductions in reported risk behaviour in this population. In the 
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following chapter patterns of self-reported behaviour change associated with having 
received VCT are analysed.   
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Chapter 6: Voluntary Counselling and Testing in Manicaland, 
Zimbabwe: service provision, uptake and patterns of self-
reported behaviour change associated with receiving VCT 
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6.1 Aims and organisation of chapter 
The aim of this chapter is to describe the provision and uptake of VCT services in the 
Manicaland study population and to assess the patterns of behaviour change associated 
with receiving VCT. Firstly, the provision of counselling and testing services in 
Zimbabwe is described. The counselling and testing services provided by the study, the 
behavioural measures used and the data analyses are described in Section 6.3. The results 
are structured into four main sections: firstly, the participant characteristics are described; 
secondly, the trends in uptake, reported barriers to testing and reasons for testing, and 
determinants of uptake of VCT are presented; thirdly, the behavioural outcomes 
following testing are presented; and finally some qualitative insights from a focus group 
discussion regarding the uptake of testing are provided. A discussion of the main findings 
is provided in Section 6.5.    
 
6.2 Background 
Knowing and disclosing one’s serostatus to facilitate safer sexual behaviour, are 
promoted as HIV prevention measures [20, 58, 301]. As discussed in Chapter 3, there has 
been mixed evidence for the efficacy of VCT in promoting safer sexual behaviour in sub-
Saharan Africa. The greatest changes observed in studies of the impact of VCT on 
behaviour were among those testing positive and those in sero-discordant partnerships 
and little evidence exists for behavioural risk reduction among those found not to be 
infected [134, 218]. There is concern as to whether the standard of VCT administered in 
trials can realistically be provided and maintained routinely. Given the importance of 
longevity of behaviour change and the lack of behavioural risk reduction among the 
majority of those testing (i.e. HIV negative individuals), the evidence to date for the 
effectiveness of VCT as a primary HIV prevention measure is relatively weak.  
 
HIV counselling and testing services in Zimbabwe 
In Zimbabwe, the National AIDS Council was established in 2000 to coordinate a multi-
sector response to the HIV epidemic. However, VCT had first become available in the 
mid 1990s, with the Matebeland AIDS Council opening the first VCT centre in 1996. 
Population Services International (PSI), the largest provider of VCT in Zimbabwe, 
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opened their first socially-marketed “New Start” VCT centre in Harare in 1999 and 
subsequently established free-standing and integrated centres across Zimbabwe. Since 
then, New Start has developed into a national network of 20 centres, which are largely 
located in urban areas, and had tested one million Zimbabweans by the end of 2007 [302, 
303]. Thirteen of these centres are integrated into health services infrastructure such as 
public clinics, hospitals, private health facilities and non-governmental organizations 
(NGOs). By integrating the New Start network within existing health services, the stigma 
associated with receiving VCT is reduced. The other seven centres are “free-standing” 
sites which are operated directly by PSI. Additionally, there are four mobile units which 
target rural areas. The success of the New Start network in Zimbabwe led to PSI 
developing VCT programmes in 19 other developing countries [302]. In addition to PSI, 
a number of other NGO’s, such as Family AIDS Caring Trust (FACT), and faith-based 
organizations, had also established VCT services by the late 1990s. Since the initiation of 
the Manicaland HIV/STD Prevention Project, BRTI has been offering mobile counselling 
and testing services during the study periods.  
 
6.3 Methods 
 
6.3.1 Voluntary counselling and testing services provided by the Manicaland study 
All study participants were offered free HIV counselling and testing at each survey, at the 
stage of the interview before a blood spot was obtained for an anonymous serosurvey. 
Participants were given a slip which they would use to receive VCT. This service was 
available at a mobile clinic which was present within the study site at the time the survey 
was being conducted. Participants receiving VCT from the research programme did so 
after completing the survey questionnaire. During the baseline and second surveys, VCT 
clients were asked to return two weeks after testing to receive their results and post-test 
counselling. At the third survey, rapid testing was introduced and clients received their 
results and post-test counselling on the same day of testing.  
 
Counselling and testing was provided by trained male and female nurse counsellors. A 
systemic approach to counselling was used. This is a holistic approach and emphasises 
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the background of the individual and tailors pre- and post-test counselling accordingly 
[56]. Participants could attend VCT with their partner if they wished. It was explained to 
the participants that attending the clinic and discussing the advantages and disadvantages 
of knowing one’s HIV status with a nurse counsellor did not mean that they had to 
receive their test results. The study participants were also told they could access VCT 
services provided by the Ministry of Health and NGOs, which became increasingly 
available in the study areas over time.  
 
For those who participated in the third survey and had previously received VCT, the 
mean duration of pre- and post-test counselling was 37 and 21 minutes, respectively. Data 
regarding duration of counselling was not collected in the earlier surveys.  
 
6.3.2 Measures 
In the first and second surveys participants were asked “Have you ever had a test for HIV 
before?”. In the third survey this question was changed and participants were asked if 
they had thought about having an HIV test, to which there were five possible responses, 
each corresponding to Prochaska’s stages of change model (discussed in chapters 2 and 
3) [176]: (i) No (pre-contemplation); (ii) Yes: but not done anything (contemplation); (iii) 
Yes: and found out how to get one (preparation); (iv) Yes: and planning to have a test 
(planning); and (v) Had a test (action).  
 
The behavioural indicators that were analysed have been described in Chapter 5. These 
included the number of times the participant had visited a bar/beer hall in the previous 
month (which is known to be associated with risky sexual behaviour [280]), whether the 
participant had a sexual partner in the last month, the number of new partners in the last 
year and whether the participant had multiple concurrent partnerships (self-defined).  
Consistent condom use (i.e. condoms used in all acts of intercourse over the most recent 
two week period) with regular (i.e. partnerships of greater than one year’s duration) and 
non-regular partners was also analysed. Reported number of lifetime sexual partners was 
not included in this analysis as it is a cumulative measure.  
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6.3.3 Data analyses 
All analyses considered the non-virgin population who had an unambiguous anonymous 
dipstick HIV test result. Participants who reported having been tested for HIV and having 
received their results were defined as having received VCT. Unfortunately, in the first 
survey, receipt of results was not established.  
 
An indicator based on time since last test and collection of results was created which 
captured whether or not an individual had previous experience of VCT at each survey 
(Table 6.1). Reports given by respondents in the second survey were used to identify 
those who had received VCT previous to the second survey (i.e. at the first survey and 
between the first and second survey). Reports given by respondents in the third survey 
were used to identify those who had received VCT previous to the third survey (i.e. at the 
second survey and between the second and third survey).  
 
Round 1 Round 2 Round 3
Tested r1-r2  0 1 1
Tested r2-r3 0 0 1
Didn’t test 0 0 0  
Table 6.1 Coding of VCT indicator to capture testing status at each round 
 
In analyzing the relationship between sexual behaviour and VCT, comparing behaviour 
before and after receiving VCT was of primary interest. Most reported behaviours refer to 
the month previous to the survey, so only those receiving VCT before that month are 
defined as having received VCT. However, number of new partners in the last year 
relates to a longer pre-survey period, so to avoid misclassification of exposure, for this 
variable, only those who tested over 12 months previously are defined as having received 
VCT. 
 
To analyse the impact of VCT on behaviour the sample was restricted to the closed 
cohort (i.e. those individuals who participated in all three surveys, N=3548). In the closed 
cohort there were 1254 men (35.3%) and 2294 women (64.7%). At baseline, the median 
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age among men and women who remained in the cohort was 29 and 34 years, 
respectively. 
 
For each behavioural indicator, the difference in reported behaviour between successive 
rounds was used to define the outcome variable in order to analyse behaviour change, 
rather than behaviour, as the outcome. Thus, the distribution of the outcome was 
continuous and centred around zero. Data from the first round was subtracted from 
second round data to calculate the change in behaviour from the first to the second round. 
Equally, data from the second round was subtracted from third round data to calculate 
behaviour change from the second to third round. Thus, negative values indicate a 
decrease in risk, zero represents no change and positive values represent an increase in 
risk.  
 
Next, the dataset was reshaped from wide to long format, so that for each individual there 
was three records (i.e. one per study round). Linear regression models with robust 
standard errors were fitted to investigate the reported behaviours in the study, including 
VCT as a variable in the model. Models adjusting for age (5 year categories) and marital 
status were fitted. Marital status was dropped from the model if inclusion did not 
significantly improve the fit of the model (P<0.05, likelihood ratio test). In effect, these 
models assess behaviour change over time, comparing those who received VCT to those 
who did not receive VCT, stratified by sex and HIV status.  
 
Given that consistent condom use is a dichotomous variable coded as either 
none/inconsistent or consistent, the value for change in condom use can take three values: 
-1 (an increase in condom use), 0 (no change) or 1 (a decrease in condom use). Thus, 
ordinal logistic regression was used to analyse the impact of VCT on consistent condom 
use. Ordinal logistic regression is an extension of logistic regression and can be used 
when the outcome is ordered categorical [304]. 
 
Although many individuals reported having a non-regular partner, much fewer reported 
having a non-regular partner in two successive surveys. Thus, the sample size regarding 
  157
change in consistent condom use with non-regular partners was small (n=46), and was  
too small to stratify the analysis by sex and HIV status. Therefore, data was analysed for 
change in condom use with regular partners only. 
 
For those who tested, HIV status at the time of receiving VCT was used for stratification. 
This stratification was performed to examine whether those who received a positive test 
result changed their behaviour more than those with similar initial risks who did not 
receive VCT. However, changes in behaviour among those who received VCT and were 
negative at the time of testing are also of interest. If those who seroconverted subsequent 
to VCT were included as positive in this analysis, the results would be biased for those 
testing negative to only those who remain negative. Therefore, those who seroconverted 
following VCT were considered as HIV negative in the analysis, as this was their 
serostatus when they received VCT. Those who did not test and who seroconverted 
during follow-up were categorized as positive in the analysis. This assumption applied to 
169 individuals (119 seroconversions among non-testers between baseline and the second 
survey and 50 between the second and third surveys). A sensitivity analysis showed that 
overall findings were unchanged when these individuals were assumed to be negative in 
the analysis.  
 
6.4 Results 
 
6.4.1 Uptake of VCT 
 
Provision, awareness and uptake of counselling and testing services 
The proportion of participants wishing to know their status was high and increased from 
76.0% at the first survey to 87.5% at the second survey (this question was not asked in 
the third survey). In the third survey (from site 7 onwards), participants were asked about 
the availability of VCT services. The majority (52.4%) did not know where VCT was 
available, 36.3% were certain of the availability of a VCT service and the remaining 
7.8% were unsure. When asked about distance to the nearest VCT centre in the third 
survey, 16.5% reported that they have never heard of VCT.  
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The reported uptake of testing, counselling and collection of results at each survey is 
shown in Figure 6.1. The high desire to know serostatus reported in the first and second 
surveys was not translated into actual uptake and completion of VCT. In the second 
survey, 18% (1216/6559) of participants reported having had a previous HIV test. 
However, of these, only 56% (680/1216) reported collecting their test results. In the third 
survey, 10% (1248/12 533) of participants reported having tested. Of these, 86% 
(1079/1248) received their results. Overall, 8.6% (1079/12 533) of participants in the 
third survey were defined as having previously received VCT. Individuals who only 
received VCT from the research programme at the third survey are not defined as having 
received VCT for analysis purposes, as they received VCT after completing the survey 
questionnaire.  
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Figure 6.1 Previous uptake of testing and results collection reported by individuals at 
each survey. In earlier surveys (1998-2000 and 2001-2003) those who reported to have 
tested may include those who were tested for medical purposes but did not receive their 
results.  
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In terms of Prochaska’s stages of change model relatively few participants were in the 
contemplation and planning stages, however, a much larger proportion reported to having 
thought about going for an HIV test, but had not done anything about it (Figure 6.2). 
Nonetheless, approximately half of participants (50.11% overall) reported that they have 
not thought about having an HIV test.  Although a greater proportion of women had 
completed VCT, these findings were similar for both men and women and also for 
infected and uninfected individuals. These trends in the stages leading to the uptake did 
not vary by age group (data not shown).  
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Figure 6.2 The stages leading to the uptake and completion of VCT at the third survey, 
by sex and HIV status.  
 
Service provision varied between the study communities (Figure 6.3). In the two small 
towns the majority of participants who had tested had done so at a government hospital or 
clinic. A similar proportion of participants reported testing with BRTI (i.e. with the 
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study) and PSI, 18.5% and 18.7% respectively. However, the majority of those who 
tested with the study lived in the more rural areas i.e. the subsistence farming areas and 
the tea, coffee and forestry estates. The majority of those who received testing from 
FACT were resident in towns and roadside trading areas.  
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Figure 6.3 Distribution of providers of counselling and testing services in the study 
communities at the third survey, as reported by those who tested.  
 
At the third survey, the mean distance travelled to receive VCT was 4.6 kilometres 
(standard deviation 17.3). Participants were asked how much they had to pay for their 
HIV test (from site 7 onwards). The majority (86%) reported that the counselling and 
testing they received was free.  
 
Reported reasons for and deterrents from testing 
In the first and third surveys all participants were asked, hypothetically, what their 
reasons for going to receive counselling and testing would be. In the second survey only 
those who reported to have received a HIV test were asked what their reason for testing 
was. A list of reasons for testing was provided. Those reasons not listed were specified 
and then categorised as “other”. At each survey the most commonly reported reason that 
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people would test was “general concern”, with much fewer participants identifying 
specific circumstances, such as planning for the future (Figure 6.4). “Wanted reassurance 
not infected”, which was added at the second survey, was the second most frequent 
reason for testing in the second and third surveys. Apart from this, the trends in reasons 
for testing were similar across the three surveys.  
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Figure 6.4 Reported reasons for testing at each survey.  
* Round 2 illustrates the reasons for testing only among those who actually tested. The response: Wanted 
re-assurance not infected was added at the second survey. The category “other reasons” includes reasons 
which were listed but infrequently reported: anxiety regarding other risks; contemplating marriage; avoid 
infecting partner(s); anxiety regarding ill or deceased partner; contemplating having a child; prevent mother 
to child transmission; anxiety regarding ill or deceased child; anxiety regarding past blood transfusions or 
medical injections; doctor or nurse suggested it; partner tested HIV positive; and for an insurance policy.   
 
At each survey participants were asked, hypothetically, what factors would deter them 
from testing and a list of possible responses was given. A comparison of deterrents across 
surveys is not strictly appropriate as new deterrents were added at the second and third 
surveys. However, as with the reasons for testing, general responses such as 
“psychological effects” were most commonly reported rather than specific deterrents 
such as partnership dissolution (if in a stable relationship) (Figure 6.5).  
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Somewhat surprisingly, at each survey a considerable proportion of participants did not 
find their main concern on the list of suggested responses. An examination of a sample of 
120 questionnaires from the third survey revealed that when these individuals specified 
their concerns the majority said that they had no reason for not testing.  
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Figure 6.5  Reported deterrents from testing at each survey.  
The response “Positive result accelerates death” was added at the second survey and “fear of being 
positive” was added at the third survey. The category “other reasons” includes reasons which were listed 
but infrequently reported: partnership breakdown (divorce/separation); job loss; and a number of responses 
which were only included during the third survey: could not face friends or family; fear of violence; harm 
to partner; lack of confidentiality and too expensive.  
 
Socio-demographic and behavioural determinants of uptake of VCT 
At the second survey, 12% of men and 10% of women in the study population had tested 
and received their results. The associations between demographic and sexual behaviour 
variables and uptake of  HIV testing among those in the second survey are shown in table 
6.2. 
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Among both men and women, there was a strong positive association between age and 
uptake of VCT. Large differentials with respect to socio-economic site-type were 
observed, with uptake of VCT being particularly low in roadside trading centres among 
men, but not among women.  Among men, uptake of VCT was highest among those who 
were married or previously married (i.e. separated or divorced), whereas among women 
uptake was highest among those who were widowed.  
 
A relatively high uptake of VCT among the small proportion of men and women who had 
a higher level education was observed. However, this association was only statistically 
significant among women. With respect to recent health, there was little difference in 
VCT uptake among men, whereas women who reported to be seriously ill were twice as 
likely to have tested than those reporting to be in good health.  
 
Regarding HIV status, infected individuals are more likely to have received VCT than 
uninfected individuals. However, this association was only statistically significant among 
women. With respect to sexual risk behaviour, uptake of VCT was lowest among women 
reporting multiple lifetime partners, partners in the last three years, partners in the last 
year and current partners, whereas the opposite was generally true for men.  
 
Among women, adjusted analyses found increasing age, a positive HIV status, living in a 
subsistence farming area or a roadside trading centre, and a higher education to be the 
key determinants of uptake of VCT. Among men, increasing age and area of residence 
were found to be the key determinants of uptake, following adjusted analyses.   
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% N OR (95% CI) AOR (95% CI) % N OR (95% CI) AOR (95% CI) 
Age     
  17-19 3% 199 1 1.18† **** (1.08-1.28) 5% 266 1 1.08† ** (1.01-1.18)
  20-24 10% 608 3.39 *** (1.44-7.98) 10% 612 1.99 ** (1.09-3.62)
  25-29 11% 549 3.79 ** (1.61-8.95) 9% 605 1.76 * (0.96-3.23)
  30-34 12% 346 4.56 **** (1.90-10.9) 9% 570 1.69 * (0.92-3.12)
  35-39 14% 256 5.43 **** (2.24-13.1) 10% 483 2.03 ** (1.09-3.75)
  40-44 15% 216 5.8 **** (2.37-14.2) 11% 501 2.17 * (1.18-3.99)
  45 and older 18% 416 6.84 **** (2.92-16.0) 12% 632 2.38 * (1.32-4.31)
HIV status
  Negative 12% 2015 1 9% 2661 1 1
  Positive 13% 575 1.14 (0.87-1.41) 12% 1008 1.33 *** (1.08-1.72) 1.63 **** (1.25-2.12)
Socio-economic site-type
  Town 11% 479 1 6% 495 1 1
  Estate 13% 1105 1.21 (0.86-1.69) 8% 1010 1.38 (0.89-2.14)
  Subsistence farming 14% 630 1.27 * (0.88-1.83) 11% 1353 2.02 *** (1.34-3.04) 1.56 *** (1.18-2.26)
  Roadside trading centre 4% 303 0.36 ** (0.19-0.67) 0.29 *** (0.15-0.56) 11% 735 2.07 *** (1.34-3.21) 1.52 *** (1.14-2.26)
Marital status
  Never married 8% 842 1 7% 232 1
  Widowed 8% 36 1.05 (0.31-3.51) 14% 419 1.99 ** (1.12-3.51)
  Divorced 15% 73 2.05 ** (1.03-4.08) 8% 291 1.13  (0.48-1.59)
  Separated 17% 35 2.39 * (0.96-5.96) 8% 136 1.11  (0.48-2.05)
  Married 14% 1604 1.84 **** (1.38-2.46) 9% 2591 1.32  (0.77-2.08)
Education
 Primary/None 13% 784 1 9% 1849 1
  Secondary 11% 1728 0.89 (0.69-1.15) 10% 1717 1.09 (0.87-1.36)
  Higher 18% 49 1.56 (0.73-3.31) 32% 19 4.50 *** (1.69-11.99)
Knowledge index (per 10 points / 100) 1.01 (0.96-1.13) 1.18 *** (1.09-1.28) 1.17 *** (1.05-1.24)
Recent health
  Good health 13% 1803 1 10% 2647 1
  Recurring sickness 15% 181 1.18 (0.78-1.81) 10% 430 0.98 (0.69-1.31)
  Serious illness 13% 91 0.98 (0.52-1.83) 20% 66 2.13 ** (1.14-3.96)
Visited bar or beer hall
  No 11% 1279 1 10% 3521 1
  Yes 13% 1311 1.16 (0.91-1.51) 7% 148 0.66 (0.34-1.26)
Thinks spouse has other partners
  No 12% 2275 1 10% 2307 1
  Yes/Don’t know 13% 314 1.09 (0.79-1.56) 10% 1355 1.04 (0.83-1.30)
Age at first sex 1.01 (1.00-1.02) 0.97 * (0.95-1.00)
Males Females
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  Lifetime total partners 
one 9% 471 1 10% 2360 1
many 13% 2120 1.42 ** (1.01-1.99) 9% 1302 0.92 (0.73-1.16)
  Lifetime regular partners 
none 7% 442 1 14% 70 1
one 13% 994 1.99 **** (1.32-3.02) 10% 2556 0.66 (0.33-1.31)
many 13% 1155 2.08 **** (1.38-3.13) 9% 1036 0.58 (0.29-1.17)
  Lifetime non-regular partners 
none 9% 600 1 10% 2920 1
one 11% 422 1.24 (0.82-1.87) 11% 402 1.12 (0.86-1.67)
many 13% 1569 1.55 *** (1.13-2.12) 7% 340 0.74 (0.48-1.13)
  Different regular partners in last 3 years
none 8% 713 1 13% 650 1
one 13% 1286 1.79 **** (1.30-2.45) 9% 2766 0.71 *** (0.54-0.92)
many 14% 592 1.89 **** (1.32-2.70) 7% 246 0.51 ** (0.29-0.89)
  Different non-regular partners in last 3 years 
none 12% 1343 1 10% 3274 1
one 9% 471 0.71 * (050-1.01) 10% 245 1.04 (0.68-1.60)
many 13% 777 1.11 (0.85-1.44) 6% 143 0.54 * (0.26-1.12)
  Different partners in last month
none 9% 962 1 11% 1521 1
one 13% 1408 1.49 *** (1.14-1.95) 9% 2107 0.85 (0.68-1.06)
many 15% 221 1.72 ** (1.12-2.65) 12% 34 1.13 (0.39-3.26)
  Different partners in last 12 months
none 8% 484 1 11% 1202 1
one 13% 1428 1.57 ** (1.09-2.24) 9% 2324 0.83 (0.66-1.04)
many 13% 679 1.57 ** (1.06-2.32) 5% 136 0.44 ** (0.20-0.96)
  Current sexual relationships 
 none 8% 617 1 10% 953 1
one 13% 1685 1.60 *** (1.16-2.20) 9% 2666 0.91 (0.72-1.17)
many 13% 289 1.71 ** (1.10-2.65) 9% 43 0.90 (0.31-2.56)
Condom use in regular partnerships in last 2 weeks
  None/inconsistent 13% 1299 1 10% 2065 1
  Consistent 56% 135 0.86 (0.50-1.48) 10% 136 0.99 (0.58-1.82)
Condom use in nonregular partnerships in last 2 weeks
  None/inconsistent 15% 223 1 7% 117 1
  Consistent 16% 86 1.05 (0.53-2.07) 8% 39 1.12 (0.28- 4.46)
 
* p<0.1, ** p<0.05, *** p<0.01, **** p<0.001
† Included as a continuous variable  
Table 6.2 Associations between demographic and sexual behaviour variables and uptake of  HIV testing, 2001-2003. Source: Sherr et. al. [125]. 
  166
At the third survey, 6% of men and 10% of women in the study population had tested and 
received their results. The associations between demographic and sexual behaviour 
variables and uptake of HIV testing among those in the third survey are shown in table 
6.3. 
 
For both men and women, age was strongly positively associated with knowing one’s 
status in univariate analyses. Overall, large differentials in uptake of VCT with respect to 
community were observed; from 2.9% in the Eastern Highlands tea estates, a remote area, 
to 17.3% in Nyabadza, a roadside trading area, reflecting differences in access to VCT 
services. Women who had tested were more likely to be married or have been previously 
married (i.e. widowed or separated). In particular, widows were five times more likely to 
have tested, compared to women who had never been married. As for women, men who 
had tested were more likely to be married, separated or divorced. Men who reported to be 
seriously ill were twice as likely to have tested compared to those who reported to be 
healthy. Higher education was associated with significantly increased uptake of VCT 
among men, but not women. 
 
As was observed at the second survey, those who were infected, both men and women, 
were more likely to have received VCT. However, this association was not statistically 
significant. In terms of risk behaviour, women who tested tended to report low risk 
behaviour, whereas the opposite was true for men. With respect to behaviours such as 
concurrent sexual relationships and having many partners in the last month, those most at 
risk of infection are not going for VCT.  
 
Among women, adjusted analyses found marital status and area of residence to determine 
uptake of VCT. Among men, however, education level and poor health were found to be 
the key determinants of uptake, following adjusted analyses.   
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% N OR (95% CI) AOR (95% CI) % N OR (95% CI) AOR (95% CI)  
Age   
  15-19 1% 1930 1 1.00 † (0.99 - 1.02) 4% 2158 1 0.99 † (0.98 - 1.00)
  20-24 7% 1306 9.79 *** (5.65 - 16.97) 9% 1735 2.41 *** (1.84 - 3.16)
  25-29 6% 902 8.29 *** (4.66 - 14.76) 9% 1413 2.34 *** (1.76 - 3.10)
  30-34 7% 790 10.12 *** (5.70 - 17.96) 10% 1148 2.60 *** (1.95 - 3.48)
  35-39 7% 530 9.03 *** (4.89 - 16.66) 10% 870 2.75 *** (2.02 - 3.73)
  40-44 6% 442 7.65 *** (4.00 - 14.64) 11% 919 2.84 *** (2.10 - 3.84)
  45 and older 7% 781 9.11 *** (5.10 - 16.28) 12% 1496 3.15 *** (2.41 - 4.12)
HIV status
  Negative 5% 5703 1 8% 7911 1
  Positive 6% 1022 1.18 (0.88 - 1.58) 10% 1892 1.17 * (0.98 - 1.39)
Socio-economic site-type
  Town 5% 1239 1 11% 1416 1 1
  Estate 5% 2149 0.92 (0.67 - 1.27) 4% 2681 0.34 *** (0.27 - 0.44) 0.31 *** (0.24 - 0.41)
  Subsistence farming 6% 2175 1.10 (0.80 - 1.50) 9% 3785 0.76 ** (0.62 - 0.93) 0.72 ** (0.58 - 0.89)
  Roadside trading centre 4% 1166 0.82 (0.56 - 1.20) 13% 1924 1.14 (0.92 - 1.41) 1.16 (0.92 - 1.45)
Marital status
  Never married 3% 3284 1 3% 2380 1 1
  Widowed 4% 100 1.45 (0.52 - 4.01) 14% 961 5.02 *** (3.75 - 6.70) 2.03 *** (1.32 - 3.13)
  Divorced 8% 188 3.01 *** (1.71 - 5.30) 9% 782 2.80 *** (1.20 - 3.93) 1.28 (0.82 - 2.02)
  Separated 6% 48 2.31 (0.71 - 7.58) 7% 196 2.30 ** (1.28 - 4.15) 1.21 (0.62 - 2.35)
  Married 7% 3109 2.64 *** (2.06 - 3.39) 10% 5487 3.31 *** (2.60 - 4.23) 1.35 (0.92 - 2.00)
Education
 Primary/None 4% 1616 1 1 9% 3672 1
  Secondary 5% 4816 1.19 (0.90 - 1.57) 1.44 ** (1.03 - 2.01) 9% 5611 0.99 (0.85 - 1.15)
  Higher 18% 181 4.97 *** (3.15 - 7.81) 2.72 *** (1.50 - 4.92) 11% 76 1.22 (0.58 - 2.57)
Recent health
  Good health 7% 2790 1 1 10% 4742 1
  Recurring sickness 7% 191 1.08 (0.61 - 1.89) 1.14 (0.64 - 2.00) 12% 604 1.25 * (0.96 - 1.63)
  Serious illness 13% 113 2.08 ** (1.19 - 3.66) 2.22 ** (1.26 - 3.92) 9% 140 0.87 (0.48 - 1.58)
Males Females
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Visited bar or beer hall
  No 4% 4299 1 9% 9498 1
  Yes 6% 2426 1.44 *** (1.15 - 1.79) 7% 302 0.75 (0.47 - 1.18)
Thinks spouse has other partners
  No 7% 3239 1 11% 5146 1
  Yes/Don’t know 6% 170 0.92 (0.49 - 1.72) 10% 2092 0.91 (0.77 - 1.07)
Age at first sex 1.04 ** (1.01 - 1.08) 1.04 ** (1.01 - 1.07) 1.02 † * (0.99 - 1.05)
  Lifetime total partners 
one 6% 917 1 11% 5277 1 1
many 7% 3956 1.14 (0.84 - 1.55) 8% 2407 0.69 *** (0.58 - 0.82) 0.81 * (0.64 - 1.04)
  Lifetime regular partners 
none 4% 1201 1 10% 347 1
one 7% 2293 1.68 ** (1.22 - 2.31) 11% 5905 1.17 (0.81 - 1.69)
many 7% 1439 1.63 ** (1.16 - 2.30) 8% 1507 0.81 (0.54 - 1.21)
  Lifetime non-regular partners 
none 7% 848 1 11% 6049 1 1
one 6% 870 0.82 (0.55 - 1.20) 10% 1016 0.95 (0.77 - 1.19) 1.18 (0.88 - 1.58)
many 6% 3212 0.91 (0.67 - 1.22) 6% 684 0.49 *** (0.35 - 0.68) 0.60 ** (0.40 - 0.91)
  Different partners in last month
none 6% 1666 1 11% 2909 1
one 7% 2951 1.03 (0.80 - 1.31) 10% 4808 0.86 ** (0.74 - 1.00)
many 4% 314 0.58 * (0.31 - 1.06) 3% 37 0.22 (0.03 - 1.61)
  Current sexual relationships 
 none 5% 1185 1 11% 2133 1
one 7% 3305 1.37 ** (1.03 - 1.83) 10% 5583 0.84 ** (0.71 - 0.98)
many 4% 444 0.77 (0.45 - 1.31) 5% 41 0.39 (0.09 - 1.65)
Condom use in regular partnerships in last 2 weeks
  None/inconsistent 7% 2468 1 9% 3786 1
  Consistent 5% 330 0.72 (0.42 - 1.20) 12% 278 1.31 (0.89 - 1.92)
Condom use in nonregular partnerships in last 2 weeks
  None/inconsistent 3% 90 1 5% 75 1
  Consistent 6% 68 1.81 (0.39 - 8.38) 13% 15 2.73 (0.45 - 16.48)
 
* p<0.1, ** p<0.05, *** p<0.01, **** p<0.001
† Included as a continuous variable  
Table 6.3 Associations between demographic and sexual behaviour variables and uptake of  HIV testing, 2003-2005. Source: Cremin, MSc thesis. 
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6.4.2 Outcomes following counselling and testing 
 
Disclosure of serostatus 
In the third survey those who reported to have tested were asked about disclosure. Of 
those who had previously received VCT, 23.8% (257/1079) reported to have tested 
together with a spouse or prospective spouse. Those who reported that they did not 
receive counselling and testing with a spouse or prospective spouse were asked about 
disclosure (N=719). Participants were not asked about disclosure to casual sex-partners. 
 
Overall, the rate of disclosure among those who report having a spouse or regular partner 
(N=640) was similar among men and women (80.4% vs. 84.2%, p=0.272) and 
significantly higher among uninfected individuals than infected individuals (84.6% vs. 
76.9%, p=0.050). Rates of disclosure for married individuals stratified by gender and  
HIV infection status are shown in table 6.4.    
Positive Negative Positive Negative
(N=79) (N=408) (N=29) (N=124)
% % % %
Disclosed test result:
Yes 74.7 86.0 82.8 79.8
No 25.3 14.0 17.2 20.2
Total 100 100 100 100
Women Men
 
 
Table 6.4 Level of disclosure of HIV test results among married individuals at the third 
survey, stratified by gender and HIV status. 
 
Among men, an increase in the level of disclosure was observed with increasing age: 
from 56.8% among 15-24 year olds, to 86.4% among 25-34 year olds, 81.8% among 35-
44 year olds and 100% among those older than 44 years. No clear relationship between 
age and disclosure was observed among women, with disclosure being greatest among 
25-34 year olds (at 89.2%) and lowest among those aged 35-44 (at 77.5%).   
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Those who reported to have received a positive test result (N=128), were asked who they 
disclosed to, with 35.9% disclosing to their spouse or regular partner, 19.5% to a family 
member, 12.5% to someone else and 32.0% did not disclose to anybody. Of those self-
reported positives who did disclose (N=87), 72.4% reported that response they received 
was supportive.   
 
Of those who tested and had a spouse or regular partner, 2.57% (25/974) reported that 
they separated from their partner after receiving the test results. Surprisingly, of those 
who separated (N=25), 19 had received a negative test result, suggesting that the test 
result was unlikely to be the only reason for separation.   
 
VCT and subsequent sexual behaviour 
As discussed in Chapter 5, there have been declines in reported risk behaviours, among 
both men and women, during the study period. Against this background of considerable 
declines in risk behaviour, including reductions in casual sex [230], no significant 
additional behavioural risk reduction associated with VCT was observed among either 
HIV positive or negative men (Table 6.5).  
 
Women who received a negative test result increased their frequency of bar attendance 
and their number of partners in the last month relative to negative women who did not 
test. However, for both indicators the magnitude of these effects are small and are driven 
by modest changes in behaviour among a small number of individuals (Table 6.5).  
 
With respect to bar attendance, the majority of negative women reported that they had not 
visited a bar or beer hall in the last month -  96.1%, 96.2% and 98.0% in the first, second 
and third rounds, respectively. The majority (94.6%) of negative women did not change 
their behaviour over the three rounds. The mean change among negative women who had 
not tested was a reduction of 0.096 visits, whereas, the mean change among negative  
women who had tested was an increase of 0.007 visits (a very small change driven by an 
increase among a small number of women (<10)).  
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The vast majority of negative women reported having zero or one partners in the last 
month – 99.6%, 99.8% and 100% in the first, second and third rounds, respectively. The 
majority (69.8%) of negative women did not change their reported number of partners in 
the last month over the three rounds.  The mean change among negative women who had 
not tested was a reduction of 0.027 partners, whereas, the mean change among negative 
women who had tested was an increase of 0.038 partners (a very small effect driven by an 
increase among a small number of women).  
 
Coefficient 95% CI Coefficient 95% CI
Visited bar/beer hall in the last month 1.32 (‐0.83, 3.47)  0.11 (‐0.14, 0.37) 
New sexual partner in past year a ‐0.01 (‐0.24, 0.23) ‐0.03 (‐0.23, 0.17)
Sexual partner in past month  0.01 (‐0.19, 0.22)  0.05 (‐0.06, 0.16)
Multiple concurrent partners   0.11 (‐0.04, 0.27) 0.004 (‐0.08, 0.09)
Coefficient 95% CI Coefficient 95% CI
Visited bar/beer hall in the last month ‐0.08 (‐1.06, 0.90) 0.10 * (0.01, 0.20) 
New sexual partner in past year a 0.09 (‐0.06, 0.23) 0.02 (‐0.01, 0.06)
Sexual partner in past month  0.03 (‐0.06, 0.12) 0.07 * (0.01, 0.13)
Multiple concurrent partners   0.08 (‐0.03, 0.18) 0.02 (‐0.02, 0.07)
a Those who had tested within the year before the survey were categorized as not 
tested when defining the indicator for having received VCT.
* P < 0.05
Males Females
HIV positive
Males Females
HIV negative
 
Table 6.5 Sexual behaviour change following VCT, from linear models predicting 
change in behaviour. A coefficient of zero indicates no change. 
 
Footnote: All models were adjusted for age, however marital status was only adjusted for if inclusion 
significantly improved the fit of the model. The following models adjusted for marital status: multiple 
concurrent partners – men and women, positive and negative; partners in the last month – negative men, 
positive and negative women; and new partners in the last year – negative men and negative women.  
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No significant change in consistent condom use in the last two weeks with a regular 
partner associated with having received VCT was observed among neither men nor 
women (Table 6.6).  
Odds ratio Std. Err 95% CI
HIV positive:
  Males 0.79 0.48 (0.24 ‐ 2.58)
  Females 0.54 0.26 (0.21 ‐ 1.39)
HIV negative:
  Males 0.83 0.35 (0.36 ‐ 1.91)
  Females 1.00 0.33 (0.52 ‐ 1.92)
Std. Err: Standard error 
* P < 0.05  
Table 6.6 Change in consistent condom use in the last two weeks with a regular partner 
associated with having received VCT. 
 
An analysis of the impact of VCT on HIV incidence is not presented due to a low number 
of seroconversions between the second and third surveys and, as a result, large 
uncertainty in the estimate of incidence exists among those who had received VCT. 
 
6.4.3 Qualitative insights from a focus group discussion 
A focus group discussion was carried out to gain insight into some of the issues relating 
to the uptake of counselling and testing services and the behavioural impact following 
testing. This focus group discussion was carried out in January 2009 at Hauna growth 
point (one of the study sites) by one of the study’s nurse counsellors. A small group of 
individuals from households (randomly selected) in the community were invited to join. 
Five men and three women participated, none of whom had tested previously. An outline 
of open-ended questions was used in order to guide the discussion.  
 
The participants had a good understanding of the purpose of VCT and what it involves. 
Family planning was cited, by two of the women, as one of the reasons for testing. The 
main barriers to testing raised by the participants were: fear of marital breakdown (in 
particular for sero-discordant couples); emotional stress; apprehension regarding the cost 
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of treatment and lack of confidentiality. One woman outlined how knowing her status 
would be futile if she was faithful to an unfaithful husband who infected her: 
“..maybe I would have been faithful, and the husband promiscuous, so if I hear 
that I now have the disease, one might say it’s better to die than be seen ill or 
suffering when I wouldn’t have been responsible for bringing the virus.”  
 
It was noted by the participants that going for testing with one’s partner would be best as 
going alone would not be helpful because they would continue having sex with their 
partner whose serostatus would be unknown. One woman hypothetically outlined the 
difficulty of testing alone and the risk of marital breakdown as a barrier to testing: 
“Yes, it [testing] breaks a marriage, that’s why it results in other people not 
getting tested. I might be willing and have decided to go for testing and my 
husband will be unwilling, then I decide to go for a test and discover that I’m 
positive and my husband will be the only partner I would have slept with, and he 
will be thinking he is negative, so it’s not easy to disclose my status to him 
because in his mind he also believes I’m also his first wife. So it results in 
dissolution of marriages, that’s why many people we do not get tested.”  
 
This issue was raised later in the discussion by another participant: 
“It is not easy to test negative whilst you don’t know about your husband’s status, 
because I will not feel comfortable when I have sex with him, thinking probably he 
is going to infect me today.” 
 
Conversely, another participant expressed that it was better for a woman to get tested 
alone, as if she was infected she could hide her ART card with the nurses and not disclose 
to her partner. However, there was a misunderstanding regarding the efficacy of 
treatment, with this woman saying that despite being on treatment the virus would 
continue to multiply if you continued to have unprotected sex.  
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One man described how one’s perception of their own serostatus may influence their 
decision to test: 
“...you know you are healthy and you may never had developed abscesses or 
other signs and symptoms related to HIV, so these occur and through your past 
history you might be sure you now have the disease, so it’s meaningless to get 
tested.”  
Despite citing more barriers to testing than positive aspects, overall they agreed that the 
advantages of knowing one’s HIV status outweighed the disadvantages.  
 
The participants were reluctant to discuss changing sexual behaviour following 
counselling and testing, saying that maybe some people will and some people won’t. 
When asked about condom use, it was noted that it is uncommon within a marital union 
and that it is difficult to begin using condoms, unless both partners have gone for 
counselling.  
 
6.5 Discussion 
As a scale-up in provision of VCT services and access to treatment in sub-Saharan Africa 
is underway, it is important to monitor the uptake of VCT and its impact on sexual 
behaviour. In this rural Zimbabwean population, the uptake of VCT services is increasing 
gradually, but remains low compared with some other countries with generalized HIV 
epidemics [305]. In Zimbabwe, there have been widespread reductions in risk behaviour 
over the study period [230]. The analysis compared behaviour change among those who 
tested to those who didn’t to distinguish behavioural changes associated with receiving 
VCT from background reductions in risk. It was found that receiving VCT did not 
influence subsequent sexual behaviour, regardless of sex and serostatus, with the 
exception of very slightly increased bar attendance and reported number of partners in the 
last month among women testing negative.  
 
The findings that at the most recent survey, approximately 90% of respondents were 
unaware of their HIV status and half (50.1%) reported that they have not even thought 
about having an HIV test are of concern, given that the HIV prevalence in this population 
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at this time was 16.5% among men (17-54 years) and 20.5% among women (15-44 
years). Previous community surveys in Zimbabwe have found that 50-70% of adults 
believed themselves to be infected despite the fact that most were not [60]. The 
consequences of such a combination of perception and reality, in the context of high HIV 
prevalence and scarce available treatment, may result in low motivation for attending 
VCT. Learning one’s HIV status is likely to be a daunting proposition in a country in 
which up to one in five adults (aged 14 – 49) are infected, an estimated 3,000 people die 
each week from AIDS-associated illnesses, and there is very limited treatment.  
Furthermore, when VCT is still uncommon the psychological and social barriers to its use 
may be substantial. 
 
One possible explanation for the unusual trend in receipt of test results is that the question 
regarding HIV testing at the second survey may have been misinterpreted. At the second 
survey, participants were asked “Have you ever had a test for HIV before?” It was 
explained that they did not need to know the result. It is possible that participants may 
have confused the blood taken for the anonymous serosurvey, which they did not receive 
results for, as a HIV test as a component of VCT. However, at the third survey, the 
question was re-phrased and participants were asked “Have you thought about having an 
HIV test?” to which there was a choice of five responses.  
 
Although the uptake of counselling and testing in the Manicaland cohort is low, the level 
of disclosure following testing is relatively high, is broadly representative of the level of 
disclosure found in a recent national DHS survey (2005-2006), and is consistent with 
reported disclosure rates among women in other developing countries [306]. Although 
marital breakdown was discussed as one of the main deterrents of uptake of testing and 
disclosure in the focus group discussion, this is not supported by the data, as the reported 
frequency of separation subsequent to disclosure in Manicaland is low (2.5%), unlike in 
other settings in developing countries [306]. Whilst the focus group discussion provides 
some interesting insights regarding the uptake of testing, the findings cannot be over-
interpreted given that it is a single discussion among just eight people.  
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Previous analyses regarding behavioural change associated with receiving VCT in this 
study population used data from two surveys and different statistical methods, and found  
greater reductions in risk behaviours among individuals testing positive - but increased 
risk among individuals testing negative - than in the general (i.e. untested) population 
[125]. The differences in findings between this analysis and previous work may reflect 
changes occurring over time in the context, nature (including quality), profile of testers, 
and effect of VCT, as well as the differences in the statistical methods used. Unlike in the 
earlier analysis, account was taken here of the magnitude of change in particular 
behavioural variables, using behaviour change as the outcome. Furthermore, the current 
analysis is stratified by HIV infection status, whereas the earlier report was based on 
separate comparisons between positive and negative individuals who took up VCT and 
all individuals (i.e. positive and negative individuals combined) who had not received 
VCT.  
 
Increases in risk following receipt of a negative test result have been reported elsewhere. 
A recent study among commercial sex workers in Senegal found that previous HIV 
testing was inversely associated with consistent condom use with regular partners. In 
addition, women who reported that they tested negative were over 80% less likely to 
always use condoms with their regular partner (adjusted prevalence ratio = 0.17 , 95% CI: 
0.08 – 0.36) as compared to women who had not tested [307]. Studies in developed 
countries, among homosexual men in particular, have found evidence for increased risk 
behaviour following a negative test result [308, 309]. Sherr et. al. outline how receipt of a 
negative test result may be interpreted as “permission for risk” or enhancing a belief of 
being “impervious to risk”, in particular following a risk exposure [125].  
 
The potential for VCT to have the unintended effect of increasing risk behaviour is of 
concern and is something which should be addressed when planning for VCT service 
provision. Avoiding unintended consequences of VCT highlights the importance of good 
quality post-test counselling which emphasises the importance of the practice of safe sex, 
even following a negative HIV test result.  
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As discussed in Chapter 3, evaluating the evidence for the impact of VCT on sexual 
behaviour is difficult because studies are diverse with respect to design, outcome 
measures, statistical analyses and comparison groups, participant characteristics and 
service provision. The lack of behavioural impact following VCT reported here is in 
contrast to the findings from the VCT Efficacy Study Group’s multi-centre RCT [310]. 
However, this study reports reductions in formation of new partnerships, whereas the 
outcome of interest in the RCT was unprotected intercourse. In addition, these findings 
are in contrast to the conclusions of two previous meta-analyses (one in developed 
settings and the other in developing settings) which concluded that VCT can be effective 
for risk reduction among those testing positive   [69, 200]. However, these findings are 
consistent with those of Matovu et al., who report no difference in number of sexual 
partners among acceptors and non-acceptors of VCT, and no significant change in risk 
during follow-up among those who accepted or refused VCT, in Rakai, Uganda [134]. 
However, as noted in Chapter 3, almost half of participants (50.9% of VCT acceptors and 
41.2% of non-acceptors) had previously received home-based VCT from the Rakai 
program.   
 
Previous studies of VCT services in Zimbabwe have achieved higher levels of uptake 
than was observed in the current study in contexts such as ANC [311], workplace VCT 
programmes [138], and mobile same day testing [128]. The profile of testers and the 
effect of VCT are likely to differ according to the method of VCT provided and the 
specific context in which it is offered, so it is uncertain to what extent these results can be 
generalised beyond the particular study setting i.e. rural Eastern Zimbabwe [231, 312, 
313]. The effect of the introduction of rapid testing on the uptake of counselling and 
testing remains to be seen in the forthcoming data from the fourth survey. Furthermore, 
the current study was undertaken in the pre-ART era. The expansion of VCT services, 
provision of treatment, and the switch to provider-initiated VCT will likely have 
important implications for the demand for VCT and its effect on sexual behaviour. Lack 
of treatment has almost certainly been a barrier to uptake of VCT in this population, as 
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the majority (83%) of participants at the third survey reported that they would test if 
cheap treatment was available.  
 
One of the limitations of these analyses is that these data do not capture short-lived 
changes in behaviours measured over the short-term, such as consistent condom use and 
concurrency. Thus, if an individual reduced their risk immediately after VCT, but this 
risk reduction was not maintained until the subsequent study survey, this change would 
not be identified. Mathematical modelling studies of the population-level impact of VCT 
have found that a critical determinant of the preventive benefits of VCT is the duration of 
changes in behaviour [237]. If high risk sexual behaviour is reduced following VCT, but 
these reductions are not maintained, the epidemiological impact of the intervention will 
be greatly reduced. Furthermore, slight changes in behaviour among negative individuals 
can result in substantial impact at the population level, as the majority of the population 
will be uninfected. 
 
VCT can present an opportunity for encouraging sexual behaviour change, which is 
essential if the transmission of HIV is to be abated and the provision of ART is to be 
sustainable. Provision and uptake of testing is increasing as efforts to find infected 
individuals to start therapy intensify. But, for VCT to be a successful prevention 
intervention, it must lead to sustained risk reduction among both infected and uninfected 
individuals. Thus, research is required as to how counselling can best be provided to 
facilitate behaviour change. Furthermore, the importance of adopting and maintaining 
reductions in risk behaviour must be emphasized through high-quality counselling. 
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Chapter 7: Discussion 
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7.1 Aims and organisation of chapter 
Detailed discussions of the topics covered in this thesis have been presented at the end of 
each relevant chapter. The aim of this chapter is to provide an overview of this thesis as a 
whole. It draws together the main findings of each chapter, outlines the limitations of the 
analyses presented and considers the future direction of this research. 
 
7.2 Summary of main findings  
Given the self-selection of individuals who come forward for counselling and testing, the 
determinants of uptake of testing are of importance. Additionally, the role of testing for 
prevention has to date been uncertain. Thus, the effectiveness of receiving counselling 
and testing for behavioural risk reduction is central to this thesis.  
 
For these reasons, a theoretical framework was developed for the determinants of uptake 
of testing and the behavioural outcomes following testing. This framework was 
subsequently used to guide the statistical analyses within this thesis. In terms of outcomes 
following testing, the focus is on behavioural change. Thus, a review of studies assessing 
the impact of counselling and testing on sexual behaviour was carried out. This review 
found evidence regarding the efficacy of VCT for behavioural risk reduction to be mixed. 
The largest changes in behaviour have been observed among those in sero-discordant 
partnerships and among individuals testing positive, while little evidence exists for risk 
reduction following receipt of a negative result.  
 
Patterns of uptake of testing among sexually active adults was compared using data from 
ten DHS from the period 2003 to 2005 in sub-Saharan Africa. Across these ten countries, 
knowledge of serostatus was lowest among women in Guinea, at 2%, and highest among 
women in Rwanda, at 27%. Despite varied levels of testing, univariate analysis indicate 
the socio-demographic profile of testers to be remarkably similar across countries, with 
those who are younger, well-educated, relatively wealthy and living in urban areas to be 
more likely to have tested. Overall, infected individuals are more likely to have tested and 
received their results than uninfected individuals, with the exception of those in Senegal 
and Guinea. Adjusted analyses indicate that a secondary or higher level of education and 
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an awareness that treatment exists are the key determinants of uptake of testing, once 
other characteristics have been taken into account.  
 
To understand the impact of counselling and testing on sexual behaviour, trends in sexual 
behaviour must first be described. Hence, the overall trends in sexual behaviour in the 
Manicaland study population were analysed. Overall, there have been declines in reported 
risk behaviour during the study period, in particular between the first and second surveys. 
As has been previously reported [265], substantial gender differentials in reporting of 
number of sexual partners were found.  
 
The impact of VCT on subsequent sexual behaviour in the Manicaland cohort was 
analysed. Uptake of VCT in the Manicaland cohort was low, with 8.6% of participants in 
the third survey reporting to have previously received counselling and testing. While 
almost half of participants reported that they have not thought about having an HIV test, 
when asked, the majority reported that they would like to know their serostatus. Although 
uptake of testing was low, disclosure of serostatus following testing was relatively high, 
at over 80%. In the context of considerable declines in risk behaviour in the study 
population overall, no significant additional behavioural risk reductions associated with 
having received VCT were observed among neither men nor women, regardless of 
serostatus. Conversely, slightly increased bar attendance and new partners in the last 
month was found among some women testing negative.  
 
7.3 Limitations 
The limitations of the analyses presented in this thesis fall into three broad categories, 
that of data deficiency, data quality and analytical issues. Although DHS data are ideal 
for cross-country comparative analyses, the cross-sectional nature of these data meant 
that it was only possible to use this data to analyse the uptake of testing and not the 
impact of VCT on subsequent sexual behaviour also. However, large-scale behavioural 
surveys which follow-up individuals over the long-term are logistically challenging and 
expensive to conduct. This highlights the value of data from longitudinal cohort studies in 
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addressing questions such as those regarding thee effectiveness of VCT for behavioural 
risk reduction.  
 
It was not possible to test certain aspects of the theoretical framework. Data regarding the  
availability and type of testing service provision, as well as the level of treatment 
availability, were not available to be included in the cross-country comparative analyses 
of uptake. Also, data on certain individual-level measures were not collected by the DHS, 
general health status for example. Thus, the hypothesis that ill health may act as a 
motivation to receive counselling and testing could not be tested.   
 
There are many issues surrounding the quality and reliability of sexual behaviour data, 
which have been well documented. For example, social-desirability bias and recall bias 
can lead to under-reporting and inconsistent reporting. However, an informal confidential 
voting method was used when collecting sexual behaviour data in the Manicaland cohort 
to minimise social-desirability bias. Furthermore, although high levels of inconsistent 
reporting of age at first sex and age at marriage were identified, this did not introduce 
bias to the observed trends in these indicators.    
 
In terms of analytical issues, low uptake of VCT within the Manicaland cohort meant that 
there was insufficient sample-size to analyse incidence of HIV as an outcome following 
VCT. However, there may be sufficient statistical power to analyse the impact of VCT on 
subsequent incidence using a forthcoming survey data collected from 2006 to 2008.  
 
7.4 Public health implications  
The profile of individuals who test for HIV, in terms of socio-demographic 
characteristics, has implications for equitable access to treatment. In terms of testing as a 
means of identifying those in need of treatment, an over-representation of infected 
individuals, as described in chapter 4 (figure 4.2), is encouraging. In addition, uptake of 
testing was found to be higher among women than among men in many of the countries 
analysed, perhaps reflecting pregnant women receiving testing through ANC and PMTCT 
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services. The increasing provision of testing through PMTCT programmes (largely 
attributable to the expansion of provider-initiated opt-out testing in health care settings 
and the use of rapid testing with same day results) implies increasing access to treatment 
among women. Indeed, recent data regarding treatment provision show that women are 
slightly advantaged compared with men. In 35 countries in sub-Saharan Africa (those 
with disaggregated data), 64% of adults receiving ART were women, while women 
represent 60% of adults in need of ART [17]. Thus, effort is required to promote testing 
among men in order to avoid a “gender-gap” in access to treatment, whereby women 
have more access.  
 
In terms of equitable access to treatment, the  under-representation of those with little or 
no education who live in rural areas in the poorest households, and who are unaware of 
treatment, amongst those accessing testing, is concerning. Thus, testing services need to 
be targeted to these groups and outreach services should continue to be used to provide 
services in rural areas where access to testing is low.   
 
The relationship between access to treatment and type of treatment provided is not clear. 
However, in low and middle-income countries, the most common first-line treatment 
regimens among adults are: stavudine + lamivudine + nevirapine (45%), followed by 
zidovudine + lamivudine + efavirenz (18%), zidovudine + lamivudine + nevirapine 
(17%), stavudine + lamivudine + efavirenz (11%) and tenofovir-based regimens (8%) 
[17]. 
 
In the Manicaland cohort it was found that neither individuals testing positive nor 
individuals testing negative reduced their risk behaviour relative to untested positive and 
negative individuals, respectively. While these findings regarding the impact of VCT on 
subsequent sexual behaviour do not support VCT as an effective preventive strategy, this 
does not negate the need to expand access to VCT services. However, expansion should 
be carried out concomitantly with evaluation of testing services in order to determine (i) 
how to gain preventive benefit from VCT and (ii) how VCT can be improved so as to 
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maximise its behavioural impact. In terms of service provision, emphasis must be placed 
on providing high quality risk reduction counselling.  
 
A challenge in analysing the impact of VCT on sexual behaviour is that factors 
determining uptake may confound the impact of VCT. In settings where VCT has been 
shown to reduce risk behaviour, individuals coming forward for VCT may have already 
committed to behaviour change. It is not clear how increasing the provision of VCT  
services will increase demand and therefore increase uptake of VCT.  Furthermore, it is 
not clear if, and how, the behavioural profile of those coming forward for VCT will 
change as provision of services increase. When uptake is low and knowing one’s HIV 
status is uncommon an average VCT client may differ substantially (in terms of their 
level of risk and intention to reduce their risk) from an average VCT client when uptake 
is high and knowledge of one’s HIV status is a social norm. Importantly, the uncertainiy 
of how supply of VCT influences demand for VCT limits the extent to which conclusions 
about the impact of VCT on sexual behaviour can be generalised and extrapolated. 
 
7.5 Future direction 
The field of research related to HIV testing and the context of HIV testing itself is 
changing. Rapid testing and oral swabs mean that testing can be done quickly and 
painlessly. Newer more convenient approaches to service provision, such as home-based 
testing is making testing more accessible and convenient. Large increases in provision of 
services and new policy regarding provider-initiated opt-out testing are leading to 
increased uptake. Importantly, the availability of treatment is removing a major barrier to 
testing and is also playing an increasingly important role in prevention.  
 
However, tension can arise between individual-level benefit and population-level benefit  
regarding HIV testing. Although there are benefits to knowing one’s HIV status, the 
decision to test is not an easy one, as there are also many psychological barriers and 
potential negative outcomes as a HIV diagnosis cannot simply be reduced to its medical 
content, as discussed in chapter two. However, the public health importance of HIV 
counselling and testing is great, given the central role of testing for treatment and 
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potentially for prevention of HIV. This tension between what is best for an individual and 
what is best for a population is a recurring theme in public health and has been widely 
discussed, particularly with regard to vaccination uptake. In the absence of treatment 
there is a conflict between what is best for the individual and what is best for the 
population and for public health. However, as treatment becomes increasingly available 
this conflict is reduced, even removed. It is rare to override an individuals right in the 
interest of public health, (one example is the WHO recommendation for obligatory 
vaccination during the smallpox eradication campaign), but HIV testing is not a situation 
where this should occur. HIV testing without informed consent and confidentiality is a 
violation of human rights and should be discouraged.  
 
Confidentiality is one of the key guiding principles of expanded counselling and testing 
services [26, 27]. A perceived lack of confidentiality is often reported as a deterrent from 
counselling and testing [90, 92, 174, 314-316]. For example, rumours may spread about 
counsellors in certain clinics not maintaining confidentiality of test results, and this 
discourages others from seeking counselling and testing. A lack of anonymity may also 
be an issue in rural areas where the counsellor is local and knows many of those from the 
surrounding area who attend a health facility to receive VCT. Qualitative work in rural 
Malawi found that respondents expressed a preference for counsellors who are not local 
or known in the area [161]. In addition, confidentiality is essential for maintaining trust 
between the client and the counsellor, which can facilitate an open discussion for 
behavioural risk reduction. For these reasons, the importance of confidentiality and 
privacy must be emphasised when training those who provide counselling and testing.   
 
Despite much variability in the published literature regarding the impact of VCT on 
behaviour, it is apparent that VCT can and does motivate behaviour change. However, it 
is equally apparent that VCT does not always lead to reductions in risk behaviour, as 
evidenced by the findings from the Manicaland cohort presented in chapter 6.  It is clear 
that there are many factors which influence the potential effectiveness of VCT for 
behavioural change. Potential influencing factors can be broadly categorised as those 
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surrounding the service provision and quality of counselling and those relating to the 
individual.  
 
Firstly, the availability of well-trained staff to provide good quality counselling is of 
importance. The provision of follow-up counselling may be important for continued 
support and encouragement, if required. The nature, amount and quality of the 
counselling itself is important as poor quality counselling may hinder the effectiveness of 
VCT for behavioural change. However, VCT services with the Manicaland cohort was 
provided by trained nurse counsellors and so the lack of impact is unlikely to be a 
consequence of the standard of counselling provided.  
 
Secondly, it is necessary for the individual to have the intention and motivation to adopt 
safe behaviour. However, an individuals sexual behaviour may not be intrinsically 
“risky”. For example, in Lesotho, an estimated 35% and 62% of incident infections in 
2008 occurred among people who reported a single sexual partner in the last year [317]. 
Thus, an individuals partner also needs to be willing to adopt safe behaviour. This 
underscores the importance of couple counselling and testing for facilitating behaviour 
change.  
 
Thirdly, there are a number of psychological factors which may influence behaviour 
change, such as an individuals perception of their own risk of infection and vulnerability, 
as well as the balance between the anticipated positive and negative outcomes of 
preventive behaviours, such as condom use, as outlined in chapter 3. Weinhardt et. al. 
argue that research explicitly guided by theories of behaviour change is required to 
understand  and enhance the effectiveness of VCT for reducing risk behaviour [200].  
  
Although counselling and testing services are essential for treatment provision, their role 
in prevention is still debated. In a call for a shift in prevention priorities, Potts et. al. 
questioned the efficacy of VCT, among other “established” prevention measures (i.e. 
condom promotion and distribution and treatment of other STIs) [318]. However, this 
proved to be controversial. UNAIDS responded to note that with respect to VCT, it has 
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been proven to reduce risk behaviour among those testing positive [319]. Given that there 
is some evidence for VCT to be a strategy which can promote risk reduction, attention 
should now be focused on addressing how VCT services can be improved to maximise 
behavioural impact. 
 
The importance of HIV testing, in terms of positive prevention (i.e. prevention for 
positive individuals), has recently been emphasized [320]. It has been proposed that HIV 
negative partners in sero-discordant couples are likely to be the largest risk group for 
infection in sub-Saharan Africa [320]. Hence, partner counselling and testing needs to be 
promoted in order to reduce transmission.   
 
To date,  research regarding the impact of VCT has focused on the level of the individual 
or couple, and the social impact in terms of decreasing denial, increasing support, 
increasing acceptance of condoms etc, of VCT has not been investigated. At a community 
level, increasing levels of uptake of HIV counselling and testing may have important 
social impact through individuals knowing and disclosing their serostatus, thus paving the 
way for changes in social norms (moving away from silence and stigma surrounding HIV 
and moving towards improved social support) regarding HIV/AIDS [185]. A large RCT 
of community mobilisation, mobile HIV testing, same-day results and post-test support, 
known as Project Accept, was begun in 2004 to investigate, among other outcomes, the 
community-level impact of a counselling and testing intervention [321]. This trial is 
being carried out in forty-eight communities in Zimbabwe, South Africa, Tanzania and 
Thailand. The first year of the study saw a four fold increase in uptake of counselling and 
testing in the intervention versus the control communities that received clinic-based 
standard VCT [322]. The results regarding impact on individual behaviour change, on 
community outcomes and, most importantly, on HIV incidence, are expected in June 
2011.  
 
The recent expansion of treatment programmes in sub-Saharan Africa have raised the 
question: what is the impact of receiving treatment on behaviour? There are some 
encouraging early findings. The first study to address this question was among a cohort of 
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882 infected individuals attending an organisation called The AIDS Support Organisation 
in Uganda [11]. Baseline data was collected within two weeks of initiating treatment and 
follow-up data was collected five to seven months after initiating treatment. Overall, 
there was a 70% reduction in reported risky sex, which was defined as inconsistent or no 
condom use with a negative partner or a partner whose HIV status is unknown [11]. 
When reductions in viral load were also taken into consideration, it was estimated that 
there was a 98% reduction in risk of HIV transmission to partners of negative and 
unknown status (from 45.7 per 1000 person years at baseline to 0.9 per 1000 person years 
at follow-up) [11]. Importantly, concerns regarding reductions in viral load being offset 
by increases in risky behaviour were not confirmed by this study. On the contrary, this 
study provides compelling evidence for integrated prevention and treatment programs to 
reduce HIV transmission.  
 
There has recently been increasing interest in the use of ART for prevention, i.e. 
“treatment prevention” [323-326]. Grannich et. al. proposed that annually testing all 
individuals over the age of fifteen years for HIV and providing immediate treatment for 
those found to be infected (irrespective of CD4+ cell count) could lead to the elimination 
of HIV (defined as an incidence of less than 0.1%) within a decade, based on an analysis 
using mathematical modelling [327]. This “test and treat” strategy would require 
increased funding, constant access to testing supplies and first and second line drugs, high 
levels of treatment adherence and careful programme monitoring. The advantages of this 
approach are that it would simplify clinical management (i.e. no CD4+ counts and viral 
load measurements), it may reduce high mortality due to late diagnosis [328], it may also 
reduce stigma and it could be cost-saving over the long-term [327]. However, this 
strategy poses many challenges. Implementation of a test and treat strategy would be 
expensive and would be intensive in terms of the human resources required. There are 
serious concerns surrounding evolution of drug resistance, adverse side-effects of ART 
and the long-term sustainability of ART provision. There are also human rights concerns 
regarding protection of voluntariness and individual rights as well as the ethics of 
utilitarianism versus individualism [329].  
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Given the provocative nature of a claim to “eliminate” HIV, this proposed new direction 
for the field of HIV prevention, and counselling and testing, has stimulated much debate. 
In addition to the programmatic, clinical, behavioural, financial, social and ethical 
barriers to implementation noted by Granich et. al. [327], a number of specific criticisms 
of the model and general cautions regarding a test and treat strategy have been raised by 
others. Many of the modelling assumptions and parameter values have been questioned, 
including unrealistic behavioural assumptions [330-332], an unrealistically short 
epidemic doubling time [330], a highly optimistic assumption regarding reductions in 
infectiousness [332], and the assumption that second-line therapy is immediately 
available upon failure of first-line therapy [332]. It is noted that the model would be 
highly sensitive to drop-out rates, infectivity while on treatment and the coverage of 
testing [330, 333]. It is also argued that the model underestimates the role of acute 
transmission [330, 334], and does not adequately account for concurrency [331]. More 
generally, it has also been highlighted that the long-term toxic effects and the relative 
benefits and risks of treatment for people with CD4+ cell counts above 350 per μL are 
unknown [334, 335]. Furthermore, Garnett and Baggaley note that although dramatic 
reductions in incidence could be achieved, real elimination of HIV is unlikely, as not all 
individuals will be tested and treated, and if these unscreened individuals have high risks 
of acquisition and transmission of HIV they will maintain infection within the population 
[336]. 
 
In response, Grannich et. al. acknowledged these concerns, emphasised that more 
research is needed, but affirmed that, in theory, it is possible to substantially reduce HIV 
transmission using their proposed strategy of universal testing with immediate treatment 
[337]. In a follow-up editorial regarding the test and treat debate, De Cock et. al. propose: 
“how to use ART for the greatest simultaneous therapeutic and prevention benefit“, to be 
the most pressing question in HIV research presently [338].  
 
Interestingly, the issues raised regarding a test and treat strategy, as outlined above, have 
been concerned with the technicalities of model specification and issues surrounding 
treatment, while the testing aspect of this strategy has received very little attention. There 
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are many barriers to the uptake of HIV counselling and testing, such as stigma, as 
outlined in Chapter 2. Even if opt-out testing is being implemented, this relies on 
individuals attending health centres. Thus, large outreach testing programmes will need to 
be provided in order to achieve “universal” voluntary counselling and testing. 
Furthermore, the logistics of providing annual testing to an entire adult population are 
formidable. Universal coverage of HIV testing has not yet been achieved in wealthy 
countries committed to HIV prevention [332, 334]. However, the recent rapid increases in 
testing and treatment provision in sub-Saharan Africa demonstrate that logistical barriers 
can be overcome, given adequate financial resources and political will. Furthermore, the 
test and treat strategy is now being implemented in the Bronx in New York city and in 
Washington DC, to investigate if it is feasible [339].   
 
Although the work presented in this thesis does not show behavioural risk reduction 
following counselling and testing,  there is some evidence from other settings, albeit 
limited, for risk reduction associated with receiving counselling and testing. Thus, the 
potential role for testing as a prevention measure (through behavioural risk reduction) 
should not be completely overshadowed by the role of testing to identify infected 
individuals in order to provide treatment.  
 
7.6 Recommendations regarding improved implementation of counselling and 
testing for HIV 
The move towards provider-initiated counselling and the introduction of rapid tests are 
important developments which have meant that HIV testing is being offered routinely and 
more conveniently. However, there are a number of ways in which the implementation of 
counselling and testing can be improved.  
  
Firstly, counselling and testing should be more actively promoted. Mass media 
campaigns have been shown to be effective for increasing uptake of HIV counselling and 
testing [340]. For example, in Kenya, a linear increase in testing sites and an exponential 
increase in client utilization was observed nationally from 2001 to 2005 and this increase 
in VCT utilization over and above the increase in service provision has been attributed to 
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a mass media campaign promoting VCT carried out during this period [341]. Media 
campaigns should be used to increase awareness of the benefits of knowing one’s HIV 
status and to promote testing as being socially acceptable. Social marketing has also been 
shown to be successful for promoting VCT and should be continued [303]. Greater 
involvement of people living with HIV/AIDS in promoting VCT and providing 
awareness may be important for providing a more “relevant” service [9]. Over the long-
term, there should be continued effort to overcome social barriers to HIV counselling and 
testing, such as stigma, discrimination and gender inequalities. 
   
Secondly, counselling and testing should continue to be scaled-up in a broad-range of 
settings, as although uptake is increasing, knowledge of serostatus is unsatisfactorily low 
in many places. In addition, new approaches to the provision of counselling and testing, 
such as home-based testing and mobile testing should be implemented in more settings, 
as many people do not use formal health services. Community-based counselling services 
should be expanded, particularly in rural areas. Monitoring and evaluation of provider-
initiated counselling and testing programs and adequate training of staff is required to 
avoid potential coercion of patients and insure that informed consent is obtained.  
 
Thirdly, there is a need to ensure sufficient capacity of health care workers to deliver 
quality counselling. The principles for effective prevention counselling include: tailored 
counselling to deal with an individuals personal risk rather than predetermined 
counselling messages, use of open-ended questions, a personalised risk assessment, 
acknowledging and supporting positive efforts already made, clarifying 
misunderstandings, the use of explicit non-technical language and developing a feasible 
and achievable risk reduction plan [342]. Furthermore, there must be supervision and 
support for counsellors, to help them remain motivated and cope with emotional burnout. 
In addition, monitoring the quality and content of counselling would be useful [9]. 
 
Fourthly, improved supply chain management is important to avoid problems such as 
stock-outs of test kits. Quality control of testing is important to ensure that all individuals 
receive the correct test result. This is becoming increasingly important as testing is 
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expanded and can be improved by training and re-training those providing counselling 
and testing as necessary.  
 
Fifthly, in addition to post-test counselling, those testing positive should receive referral 
for care, support and treatment, if available. Where possible, providers of testing and 
counselling should address factors which may make completing referral difficult (e.g. 
lack of transportation).  
 
7.7 Concluding remarks 
AIDS had has been described as “… potentially the greatest natural tragedy in human 
history” [343]. As the HIV/AIDS epidemic matures, and efforts to achieve universal 
access to testing and treatment continue, it is to be anticipated that counselling and testing 
services will be increasingly available. To achieve a significant public health impact, 
counselling and testing must attain a high coverage of the sexually active population, lead 
to sustained risk reduction among both infected and uninfected individuals and lead to 
timely initiation of treatment for infected individuals. The mitigation of the HIV/AIDS 
epidemic depends on the success of strategies to prevent new infections and to treat 
currently infected individuals. HIV counselling and testing can serve both goals. 
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Appendix A: Multivariate analysis of characteristics associated 
with having tested for HIV in Guinea, Côte D’Ivoire, Malawi, 
Cameroon, Kenya and Ghana (supplement to chapter 4) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  194
Guinea Cote D'Ivoire
Determinants Women Men Women Men
AOR (95% CI) AOR (95% CI) AOR (95% CI) AOR (95% CI)
HIV status:  positive vs negative               2.69 (0.43 - 16.98) 0.70 (0.15 - 3.25) 1.10 (0.42 - 2.86) 3.47 (1.36 - 8.86)
Demographic characteristics:
Age group:       15-24 1 1 1 1
                       25-34 0.56 (0.09 - 3.26) 1.91 (0.98 - 3.73) ‡ 1.06 (0.67 - 1.66) 2.17 (1.23 - 3.84)
                       35-44 0.26 (0.01 - 5.33) 1.24 (0.56 - 2.76) 1.00 (0.52 - 1.93) 2.08 (0.82 - 5.27)
                       45+ 4.09 (0.33 - 50.98) 1.00 (0.40 - 2.49) 0.25 (0.04 - 1.58) 1.45 (0.54 - 3.89)
Education:       none  0.20 (0.01 - 4.26) 0.71 (0.37 - 1.38) 0.86 (0.42 - 1.77) 0.72 (0.29 - 1.82)
                       primary 1 1 1 1
                       secondary 5.30 (0.97 - 29.07) ‡ 1.16 (0.58 - 2.33) 1.31 (0.69 - 2.49) 1.13 (0.54 - 2.38)
                       higher 36.43 (5.10 - 260.47) 1.50 (0.59 - 3.81) 2.55 (0.79 - 8.17) 5.58 (2.55 - 12.22)
Marital status:  married 1 1 1 1
                       never married 4.10 (0.38 - 44.43) 0.48 (0.23 - 0.98) 0.27 (0.15 - 0.50) 0.72 (0.36 - 1.45)
                       previously married §§ 0.75 (0.07 - 8.01) 0.15 (0.03 - 0.74) §§
Residence:       urban vs rural    0.05 (0.01 - 0.26) 1.30 (0.56 - 3.02) 1.11 (0.44 - 2.79) 1.66 (0.87 - 3.14)
Poverty:          richest quintile vs poorest  § 1.55 (0.45 - 5.31) 5.54 (1.43 - 21.42) 2.11 (0.78 - 5.74)
Sexual health & behaviour: 
Condom use at last intercourse:     yes vs no 2.50 (0.85 - 7.38) 1.46 (0.82 - 2.58) 1.44 (0.81 - 2.54) 0.75 (0.44 - 1.28)
Extra-marital partners in last year:    yes vs no   0.19 (0.01 - 2.58) 1.34 (0.73 - 2.47) 1.32 (0.78 - 2.23) 1.30 (0.62 - 2.72)
Lifetime partners: 
                Women              Men
                    1                    1 1 1 1 1
                    2                    2 0.30 (0.35 - 2.54) 1.50 (0.38 - 5.90) 0.23 (0.08 - 0.65) 0.84 (0.18 - 3.90)
                   >2                   3 2.17 (0.64 - 7.42) 1.70 (0.39 - 7.42) 0.72 (0.41 - 1.28) 1.37 (0.34 - 5.52)
                                          4 2.09 (0.50 - 8.73) 0.99 (0.23 - 4.24)
                                        >4 2.74 (0.68 - 10.97) 1.09 (0.33 - 3.59)
Ever paid for sex (men only):       yes vs no ─ 0.78 (0.10 - 6.16) ─ ─
Had an STD in last year:             yes vs no 1.24 (0.24 - 6.36) 1.06 (0.41 - 2.74) 0.26 (0.07 - 1.03) 2.51 (1.02 - 6.18)
Treatment awareness:                yes vs no/unsure 3.44 (0.89 - 13.35) 3.36 (2.00 - 5.65) ─ ─
Expression of stigma & experience of AIDS: 
People with AIDS should be ashamed:
                               agree vs disagree/don't know 0.33 (0.11 - 1.02) ‡ 0.25 (0.08 - 0.75) 0.85 (0.44 - 1.67) 0.74 (0.38 - 1.42)
AIDS bereavement:   yes vs no    3.29 (1.16 - 9.34) 1.02 (0.53 - 1.96) 3.28 (1.93 - 5.59) 0.97 (0.50 - 1.89)
Note: In Cote D'Ivoire, data on treatment awareness were not available for neither men nor women, and ever paid for sex was not available for men.  
Bold type indicates differences significant at the 95% level
 ‡ Bordeline significance
§  AOR = 1.54e+08 due to large differentials with respect to level of wealth and <0.5% uptake in the reference group (poorest quintile)
§§ Variable/category dropped due to small sample size in comparison group   
AOR Adjusted odds ratio
 
Table A.1 Adjusted odds ratios for hypothesised determinants of uptake of HIV testing 
for men and women in Guinea and Côte D’Ivoire. 
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Malawi Cameroon
Determinants Women Men Women Men
AOR (95% CI) AOR (95% CI) AOR (95% CI) AOR (95% CI)
HIV status:  positive vs negative               0.98 (0.65 - 1.49) 0.88 (0.52 - 1.49) 1.03 (0.72 - 1.46) 1.13 (0.75 - 1.70)
Demographic characteristics:
Age group:       15-24 1 1 1 1
                       25-34 1.43 (0.94 - 2.16) 1.40 (0.85 - 2.29) 1.40 (1.11 - 1.76) 2.94 (2.20 - 3.93)
                       35-44 1.17 (0.74 - 1.85) 1.07 (0.60 - 1.89) 0.92 (0.70 - 1.21) 3.15 (2.21 - 4.50)
                       45+ 0.88 (0.43 - 1.81) 1.31 (0.67 - 2.55) 1.03 (0.67 - 1.58) 3.86 (2.67 - 5.58)
Education:       none  0.48 (0.30 - 0.78) 0.64 (0.31 - 1.32) 0.20 (0.12 - 0.35) 0.56 (0.35 - 0.91)
                       primary 1 1 1 1
                       secondary 2.66 (1.77 - 3.97) 1.49 (1.00 - 2.21) 1.78 (1.42 - 2.23) 1.83 (1.42 - 2.34)
                       higher 1.61 (0.45 - 5.78) 3.64 (1.68 - 7.86) 3.23 (1.93 - 5.58) 3.96 (2.72 - 5.75)
Marital status:  married 1 1 1 1
                       never married 0.45 (0.13 - 1.52) 1.16 (0.57 - 2.37) 0.47 (0.34 - 0.66) 0.89 (0.66 - 1.19)
                       previously married 0.47 (0.17 - 1.33) 0.89 (0.26 - 3.08) 0.91 (0.48 - 1.71) 0.76 (0.54 - 1.07)
Residence:       urban vs rural    0.98 (0.63 - 1.51) 1.27 (0.82 - 1.96) 1.16 (0.89 - 1.51) 1.06 (0.80 - 1.40)
Poverty:          richest quintile vs poorest  1.35 (0.71 - 2.58) 1.68 (0.89 - 3.16) 4.23 (2.56 - 7.02) 3.99 (2.35 - 6.79)
Sexual health & behaviour: 
Condom use at last intercourse:     yes vs no 1.31 (0.68 - 2.51) 1.94 (1.28 - 2.95) 0.98 (0.76 - 1.27) 1.29 (1.00 - 1.64)
Extra-marital partners in last year:    yes vs no   2.67 (1.02 - 6.99) 1.07 (0.58 - 1.97) 1.01 (0.79 - 1.30) 1.24 (0.95 - 1.61)
Lifetime partners: 
                Women              Men
                    1                    1 ─ ─ ─ ─
                    2                    2 ─ ─ ─ ─
                   >2                   3 ─ ─ ─ ─
                                          4 ─ ─
                                        >4 ─ ─
Ever paid for sex (men only):       yes vs no ─ 0.78 (0.53 - 1.14) ─ ─
Had an STD in last year:             yes vs no 6.14 (2.27 - 16.56) 0.46 (0.08 - 2.55) 0.84 (0.55 - 1.28) 1.29 (0.85 - 1.96)
Treatment awareness:                yes vs no/unsure 2.63 (1.80 - 3.84) 1.16 (0.82 - 1.63) ─ ─
Expression of stigma & experience of AIDS: 
People with AIDS should be ashamed:
                               agree vs disagree/don't know ─ ─ ─ ─
AIDS bereavement:   yes vs no    1.06 (0.76 - 1.48) 0.59 (0.38 - 0.92) 1.49 (1.24 - 1.78) 1.52 (1.24 - 1.85)
Note: In Malawi, data on lifetime partners and "People with AIDS should be ashamed" were not available for neither men nor women.
         In Cameroon data on lifetime partners, awareness of treatment and "People with AIDS should be ashamed" were not available for neither men     
         nor women, and ever paid for sex was not available for men.   
Bold type indicates differences significant at the 95% level
 ‡ Bordeline significance
AOR Adjusted odds ratio
 
Table A.2 Adjusted odds ratios for hypothesised determinants of uptake of HIV testing 
for men and women in Malawi and Cameroon. 
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Kenya Ghana
Determinants Women Men Women Men
AOR (95% CI) AOR (95% CI) AOR (95% CI) AOR (95% CI)
HIV status:  positive vs negative               1.17 (0.72 - 1.92) 1.39 (0.87 - 2.23) 1.61 (0.86 - 2.99) 0.97 (0.26 - 3.69)
Demographic characteristics:
Age group:       15-24 1 1 1 1
                       25-34 0.68 (0.49 - 0.94) 1.35 (0.82 - 2.23) 1.48 (0.97 - 2.23) 3.14 (1.71 - 5.79)
                       35-44 0.42 (0.29 - 0.62) 1.04 (0.58 - 1.85) 1.28 (0.84 - 1.97) 2.43 (1.21 - 4.85)
                       45+ 0.58 (0.31 - 1.09) 0.78 (0.42 - 1.43) 1.03 (0.56 - 1.90) 2.01 (0.94 - 4.27)
Education:       none  0.61 (0.32 - 1.17) 0.62 (0.28 - 1.40) 0.53 (0.33 - 0.85) 0.42 (0.21 - 0.81)
                       primary 1 1 1 1
                       secondary 1.81 (1.31 - 2.48) 1.16 (0.84 - 1.62) 1.78 (1.23 - 2.58) 0.84 (0.53 - 1.34)
                       higher 2.51 (1.53 - 4.13) 1.94 (1.33 - 2.82) 1.98 (0.91 - 4.31) 1.06 (0.52 - 2.17)
Marital status:  married 1 1 1 1
                       never married 0.46 (0.24 - 0.90) 0.51 (0.26 - 0.99) 0.49 (0.26 - 0.94) 1.43 (0.81 - 2.53)
                       previously married 1.09 (0.36 - 3.26) 1.82 (0.69 - 4.81) 0.52 (0.21 - 1.27) 0.92 (0.25 - 3.44)
Residence:       urban vs rural    1.14 (0.76 - 1.72) 1.28 (0.83 - 1.97) 1.08 (0.69 - 1.68) 1.04 (0.67 - 1.62)
Poverty:          richest quintile vs poorest  3.37 (1.89 - 6.02) 1.30 (0.69 - 2.45) 2.09 (1.09 - 4.00) 3.32 (1.71 - 6.42)
Sexual health & behaviour: 
Condom use at last intercourse:     yes vs no 1.58 (0.96 - 2.61) 1.18 (0.74 - 1.87) 1.43 (0.86 - 2.38) 0.93 (0.59 - 1.47)
Extra-marital partners in last year:    yes vs no   1.07 (0.59 - 1.95) 1.05 (0.68 - 1.63) 1.13 (0.65 - 1.98) 0.70 (0.45 - 1.08)
Lifetime partners: 
                Women              Men
                    1                    1 ─ ─ ─ ─
                    2                    2 ─ ─ ─ ─
                   >2                   3 ─ ─ ─ ─
                                          4 ─ ─
                                        >4 ─ ─
Ever paid for sex (men only):       yes vs no ─ ─ ─ ─
Had an STD in last year:             yes vs no 0.42 (0.12 - 1.47) 0.48 (0.15 - 1.60) 1.19 (0.52 - 2.71) 0.53 (0.12 - 2.36)
Treatment awareness:                yes vs no/unsure ─ ─ ─ ─
Expression of stigma & experience of AIDS: 
People with AIDS should be ashamed:
                               agree vs disagree/don't know ─ ─ ─ ─
AIDS bereavement:   yes vs no    1.93 (1.27 - 2.91) 2.52 (1.60 - 3.97) 1.63 (1.24 - 2.15) 2.19 (1.61 - 2.97)
Note: In Kenya, data on lifetime partners, treatment awareness and "People with AIDS should be ashamed" were not available for neither men nor  
         women, and ever paid for sex was not available for men. 
         In Ghana, data on lifetime partners, treatment awareness and "People with AIDS should be ashamed" were not available for neither men nor 
         women, and ever paid for sex was not available for men.  
Bold type indicates differences significant at the 95% level
 ‡ Bordeline significance
AOR Adjusted odds ratio
 
Table A.3 Adjusted odds ratios for hypothesised determinants of uptake of HIV testing 
for men and women in Kenya and Ghana. 
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Appendix B: Measuring trends in age at first sex and age at 
marriage in Manicaland, Zimbabwe (published manuscript) 
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Appendix C: Patterns of Self-reported Behaviour Change 
Associated with Receiving Voluntary Counselling and Testing 
in a Longitudinal Study from Manicaland, Zimbabwe 
(published manuscript) 
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